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Ischemic mitral regurgitation (IMR) occurs when the heart’s mitral valve is rendered 
incompetent by post-infarction left ventricular remodeling and three-dimensional 
alterations in mitral valve geometry. These alterations include papillary muscle 
displacement and annular dilatation, which ultimately lead to restricted leaflet motion and 
mitral regurgitation. While the severity of this disease can vary, IMR typically presents 
with significant comorbidities yielding the cessation of regurgitation as being necessary 
but not sufficient to improve patient outcomes. For these reasons among others, an 
optimal IMR surgical repair has yet to be established. Finding an optimal surgical 
strategy has included the development of novel implantable devices and techniques for 
both open-chest and percutaneous approaches. Despite published successes, post-
operative device and repair induced complications have been documented. These include 
but are not limited to device fracture in pre-clinical trials, annuloplasty ring dehiscence, 
and post-operative chordal-leaflet tethering. From any of these adverse events recurrent 
regurgitation can ensue, leading to impaired left ventricular function, worsened patient 
health and mortality. A common thread to these outcomes is the presence or imbalance of 
mechanical forces acting on implanted devices, on annuloplasty ring mattress sutures, 
and in the mitral valve’s chordae tendineae. Little or no knowledge exists for the 
magnitude of these forces or their variations with left heart function under healthy and 
IMR conditions. Understanding the relative magnitudes and variation of these forces will 
significantly aid in the development of more robust devices and contribute to improved 
knowledge of IMR surgical procedures and techniques. To this end, three specific aims 
were evaluated. In specific aim 1, a novel transducer was developed to measure the 
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radially directed forces that may act on devices implanted to the mitral annulus. In an 
ovine model, radial forces were found to statistically increase with left ventricular 
pressure and were reduced in the setting of IMR. In specific aim 2, the suture forces 
required to constrain true-sized and undersized annuloplasty rings to the mitral annulus of 
healthy ovine subjects was evaluated. Suture forces were observed to be larger on the 
anterior aspect of the rings and were elevated with annular undersizing. In specific aim 3, 
an in vitro simulator’s ability to mimic healthy and IMR ovine mitral valve function was 
evaluated. After understanding the accuracy of the model, the in vitro IMR model was 
used to evaluate the progressive effects of annuloplasty undersizing on strut and 
intermediary chordal tethering. Compared to the IMR condition, increasing levels of 
undersizing annuloplasty significantly reduced regurgitation, increased coaptation, 
reduced posteromedial papillary muscle strut chordal forces, and reduced intermediary 
chordal forces from the anterolateral papillary muscle. Considered together, the generated 
data and knowledge will contribute to the development of more durable devices and 







From early anatomical studies we’ve learned the human heart consists of two pumps in 
series; with the right heart pumping blood to the lungs and the left ejecting blood to the 
systemic circulation. Both of these pumps consist of an atrium and ventricle and are 
separated by unique one-way valves. Separating the left atrium and ventricle is the mitral 
valve. The sole purpose of the mitral valve is simple. It aims to maintain unidirectional 
flow from the left atrium to the ventricle while preventing the backflow of blood during 
ventricular contraction. Despite its simple purpose, the anatomy that allows for its healthy 
function is complex.  
The healthy function of the mitral valve is made possible by four anatomical 
structures known as the mitral annulus, leaflets, chordae tendineae, and papillary 
muscles. The mitral annulus is a discontinuous band of connective tissue lying in the 
fibrous junction and left ventricle of the heart [1,2]. Due to its unique location, left 
ventricular contraction decreases the mitral annular area and by extension the space for 
which the leaflets must occlude. Hinging at the annulus are the anterior and posterior 
leaflets. Although they differ in size and geometry, each leaflet occupies a similar surface 
area during leaflet closure [1]. The mitral leaflets interact with the left ventricle via the 
chordae tendineae and papillary muscles. These subvalvular structures aid in bringing the 
leaflets into apposition and providing cross-ventricular support [2].  Based on this 
anatomy, it is clear that the mitral valve is both structurally and functionally part of the 
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fibrous junction and left ventricle of the heart. For these reasons, alterations in any of 
these structures contribute to and affect valve function [2].  
Changes in mitral valve function may be most notably manifested in ischemic 
mitral regurgitation. This disease is characterized by post-infarction left ventricular 
remodeling and three-dimensional alterations in mitral valve geometry. These geometric 
alterations include papillary muscle displacement and annular dilatation which ultimately 
lead to restricted leaflet motion and mitral regurgitation [2]. Recent studies estimate the 
prevalence of ischemic mitral regurgitation within the United States to be approximately 
3 million patients [3]. Beyond its wide prevalence, post-myocardial infarction patients 
have been found to exhibit 1-year mortality rates of 52% with severe IMR, 22% for mild 
to moderate IMR, and 11% for no IMR [4].  
While the severity of this disease can vary, ischemic mitral regurgitation typically 
presents with significant comorbidities yielding the cessation of regurgitation as being 
necessary but not sufficient to improve patient outcomes. For these reasons among others, 
an optimal surgical repair has yet to be established. The most common surgical strategies 
have included undersized mitral valve annuloplasty with a complete rigid ring and mitral 
valve replacement with and without coronary artery bypass grafting [5]. The routine use 
of these strategies however has been recently challenged by the growing number of 
patients who are elderly or present with significant comorbidities deemed too high-risk 
for these procedures [6]. This trend, paired with a rising desire for less invasive 
approaches, has led to the development of minimally invasive and percutaneous surgical 
techniques for ischemic mitral regurgitation [7].  While these techniques exhibit potential 
for treating a large number of patients, many challenges remain in demonstrating 
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equivalent or improved clinical therapeutic benefits compared to optimally performed 
mitral annuloplasty or valve replacement [8]. 
In seeking out an optimal ischemic mitral regurgitation surgical strategy, novel 
implantable devices for both open-chest and percutaneous approaches have been 
developed [4,7]. Despite published success, post-operative device and repair induced 
complications have been demonstrated. These include but are not limited to device 
fracture in pre-clinical trials [7,9,10], annuloplasty ring mattress suture dehiscence [11-
22], and post-operative chordal-leaflet tethering [23-29]. From any of these adverse 
events recurrent mitral regurgitation can ensue, leading to impaired left ventricular 
function, worsened patient health and mortality [4]. A common thread to these outcomes 
is the presence or imbalance of mechanical forces acting on implanted devices, on mitral 
annular mattress sutures, and in the MV’s chordae tendineae. At current, no knowledge 
exists for the magnitude of these forces or their variation with left heart function.  
Understanding the relative magnitude and variation of these forces will 
significantly aid the development of more robust devices, improve knowledge for device 
implantation, and contribute to methods designed to predict or reduce postoperative 
chordal-leaflet tethering. The overall objective of the present research therefore is to 
determine the forces that exist at the mitral annular and subvalvular levels under normal, 
IMR, and repair conditions. This objective is assessed by three specific aims that include 
(i) Quantifying the contractile mitral annular forces that may contribute to device 
fracture, (ii) Quantify the suture forces required to constrain true-sized and undersized 
annuloplasty rings to the ovine mitral valve annulus, and (iii) Evaluate the effects of 
mitral valve annuloplasty on chordal-leaflet tethering forces.  
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To independently analyze the variables of interest, in vitro and in vivo animal 
experiments are conducted. This hybrid approach has a clear advantage over clinical 
based studies by independently controlling parameters that are of importance to mitral 
valve mechanics and function. These experiments will provide detailed quantitative 
information on function and mechanics in the normal, IMR and repaired mitral valve. 
Qualitative and quantitative information from these experiments may provide a basis or 
guide which may lead to improved knowledge and results for both open-chest and 



















2.1 Mitral Valve Structure and Function 
The mitral valve (MV) is a complex bileaflet valve lying between the heart’s left atrium 
and left ventricle (LV). Its purpose is to maintain unidirectional flow from the atrium to 
the ventricle while preventing the backflow of blood (regurgitation) during ventricular 
ejection. This critical function is accomplished via four anatomical structures that include 
the mitral annulus, leaflets, chordae tendineae, and papillary muscles (Figure 2-1). The 
unique geometric arrangement of these structures within the left atrium, fibrous skeleton, 
and left ventricle of the heart facilitates healthy MV function. 
 
 
Figure 2-1 Left: Anatomic representation of the mitral valve and left ventricle 
(modified from [1]); Right: En-face view of the mitral leaflets with anatomical 
nomenclature (modified from [1]). 
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2.1.1 The Mitral Annulus 
Of the mitral valve’s anatomical structures, the mitral annulus is a discontinuous band of 
connective tissue existing within the atrioventricular junction of the left heart. The 
annulus is not visible from the atrium and is deeper and 2 mm external to the hinge of the 
mitral leaflets (Figure 2-2) [1]. Due to the proximity of the annulus to the dynamic LV 
and aortic root, the shape and size of the mitral annulus changes throughout the cardiac 
cycle.  
The three-dimensional shape of the mitral annulus changes throughout the cardiac 
cycle [30-37].  During ventricular diastole the annulus is approximately planar while 
during ventricular contraction the annulus conforms to the shape of a hyperbolic parabola 
or annular saddle [30-34]. Two complimenting theories have been proposed to explain 
the mechanism by which the annulus systolically conforms to the saddle-shaped 
geometry. In the first, unequal apical-basal translation of the mitral annulus during LV 
contraction (due to aortic root tethering) causes annular folding across the inter-
commissural axis [35].  In the second, expansion of the aortic root during systolic LV 
contraction displaces the anterior annulus laterally, which folds the anterior and lateral 
portions of the mitral annulus across the intercommissural axis [36,37]. 
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Figure 2-2 Left: Schematic representation of the relative location of the mitral 
annulus (modified from [39]); Right: Representative image of the mitral annular 
saddle shape that occurs during ventricular contraction (modified from [40]). 
 
The shape of the annular saddle is quantified by measuring the annular height 
(perpendicular distance between the lowest (most apical) and highest (most basal) two 
points on the annulus) and by quantifying the Annular-Height-to-Commissural-Width-
Ratio (AHCWR) (Figure 2-2). In reference to Figure 2-2, the AHCWR can be calculated 
by dividing the annular height by the intervalley span (commissural width). In healthy 
humans, the annular height has been demonstrated to range from 0.6 mm to 1.4 cm with 
an AHCWR approaching 20 to 30% [32,38]. In ovine animals, the AHCWR has been 
reported to range from 12 to 15% [33,41]. The presence of an annular saddle has been 
demonstrated to exhibit mechanical advantages to both the leaflets and chordae 
tendineae. Numerical and experimental studies have shown the presence of an annular 
saddle to reduce stress in the mitral leaflets and reduce tethering in the chordae tendineae 
[42-45]. 
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In addition to conforming to the shape of a saddle, the mitral annulus reduces its 
effective orifice area during ventricular contraction. This action effectively decreases the 
area for which the mitral leaflets must occlude during leaflet closure. In healthy humans, 
the mitral annulus can systolically reduce its area and circumference by approximately 26 
± 3 % and 13 ± 3 % respectively [30]. In a healthy ovine model, the mitral annular area 
and circumference reduces by approximately 15% and 9% [46,47].  
 
2.1.2 The Mitral Leaflets 
Hinging at the annulus are the anterior and posterior mitral leaflets (Figure 2-1 and 2-3). 
Although they differ in size and shape, with the anterior leaflet extending more radially 
and the posterior leaflet extending more circumferentially, each leaflet occupies a similar 
surface area of the valve [1].The total surface area of both MV leaflets is approximately 
twice that of the MV orifice [1]. This geometric relationship provides redundancy during 
leaflet closure and in part provides a protective mechanism against mitral regurgitation.  
When considered in isolation, both leaflets can be divided into three regions 
known as the base (closest to mitral annulus), belly (central) and free edge (distal to the 
mitral annulus) (Figure 2-3). Due to numerous chordal insertions, the free edge of the 
leaflets is thicker, has an irregular texture, and is identified as the rough zone.  
Conversely, the clear zone lies between the line of coaptation and the MA, has minimal 
CT attachment, is thin, regular in texture, and is approximately translucent. 
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Figure 2-3 Rough, clear, and basal leaflet zones of the anterior and posterior mitral 
leaflets (modified from [39]). 
 
Compared to the anterior leaflet, the posterior leaflet is deeply scalloped by two 
indentations. These indentations morphologically separate the posterior leaflet into 3 
distinct sections and are sequentially numbered from the anterior to posterior 
commissural direction. These three posterior leaflet sections are known as the anterior 
(P1, smallest in size), middle (P2, largest in size) and posterior (P3) scallops. The regions 
of the anterior leaflet geometrically opposing the posterior leaflet are similarly denoted as 
A1, A2 and A3. 
 
2.1.3 Mitral Valve Suspension System 
The leaflets communicate with the LV through the suspension system of the mitral valve. 
This system consists of two papillary muscles that extend upwards from the LV 
endocardium, with chordae tendineae fanning outwards from each papillary muscle tip to 
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the free edge, belly, and base of the mitral leaflets (Figure 2-1 and 2-3). Together, these 
structures perform the dual function of maintaining valvular competence and ventricular 
geometry by providing cross-ventricular support [2].  
Two groups of papillary muscles are attached to the LV free wall and are 
identified based on their relative anatomical position (anterolateral and posteromedial). 
Morphological variability exists for papillary muscles which can be characterized into 5 
distinct groups (Figure 2-4). These groups include (Type 1) single bulky head, (Type 2) 
multiple heads, (Type 3) narrow head, (Type 4) arch-shaped head, and (Type 5) short but 
wide head [1]. 
 
 
Figure 2-4 Morphologic classification of papillary muscle type (modified from [1]). 
 
Given the papillary muscles are functional extensions of the LV; it is not 
surprising these structures exhibit contractile properties.  The papillary muscles have 
been experimentally shown to shorten by as much as 2-5 mm during LV contraction 
[48,49].  Despite their downward contraction, the papillary muscle tips maintain a near 
constant distance with the annulus throughout the cardiac cycle [50]. This phenomenon is 
due to the systolic apical-basal shortening of the left ventricle which effectively maintains 
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the distance between the papillary muscles and LV base. Based on these dynamics, 
leading researchers have hypothesized the papillary muscles to act as mitral valve shock 
absorbers and aid in preventing leaflet prolapse throughout the cardiac cycle [50].  
 
 
Figure 2-5 An excised mitral valve with the types and locations of the chordae 
tendineae identified. 
 
Connecting the papillary muscles to the mitral leaflets is the chordae tendineae. In 
general, three types of chordae are recognized and are characterized by where and to 
which leaflet they attach (Figure 2-5) [51]. Primary (also referred to in literature as 
marginal) chordae are attached uniformly via bifurcations or trifurcations to the free edge 
of both the anterior and posterior leaflets. Two types of secondary chordae exist. Anterior 
strut chordae insert into the belly of the anterior leaflet while posterior intermediate 
chordae insert into the belly of the posterior leaflet.  Tertiary (also referred in literature as 
basal) attach to the base of the anterior leaflet, base of the posterior leaflet, or directly 
into the mitral annulus. Commissural chordae insert to the leaflet commissures and can 
originate from either of the papillary muscles. Anatomically, marginal chordae are 
 12 
typically thinner than basal chordae, while strut chordae are the thickest in both human 
and ovine valves [51].  
Considered in isolation, the chordae tendineae experience counteracting tensile 
loads from the apically contracting papillary muscles and basally directed pressure forces 
acting on the valve leaflets. The magnitude of tensile loading experienced by each chord 
is dependent on chordal type, systolic transmitral pressure, and the total leaflet area 
exposed to the transmitral pressure gradient. As leaflet exposure area is directly related to 
mitral valve geometry, chordal loading is also related to the annular and subvalvular 
mitral valve geometry. Since the relationships between chordal structure, size, leaflet 
insertion, and mitral valve geometry are uniquely complex, many in vitro and in vivo 
investigations have focused on identifying the role and function of the chordae. The most 
complete description of chordal mechanics and function in both healthy and functional 
disease has been described by Rabbah and colleagues [51]. 
 
2.1.4 The Mitral Valve’s Intimate Relationship  
Considered together, the mitral annulus, leaflets, chordae tendineae, and papillary 
muscles are elegantly complex structures that facilitate unidirectional flow and valve 
closure. Due to their anatomical arrangement, the mitral valve is both structurally and 
functionally part of the left atrium, fibrous skeleton, and LV of the heart. For these 
reasons, gross geometric alterations in these structures can result in mitral valve 




2.2. Ischemic Mitral Regurgitation 
 
Changes in mitral valve geometry and function may be most notably manifested in 
Ischemic Mitral Regurgitation (IMR). IMR can be defined as Mitral Regurgitation (MR) 
occurring as a result of chronic myocardial ischemia in the absence of any structural 
damage to the mitral leaflets, chordae tendineae, or papillary muscles [52,53]. This 
disease results from post-infarction LV remodeling with subsequent papillary muscle 
displacement, annular dilatation, leaflet tethering, and malcoaptation (Figure 2-6) [54,55].  
 
 
Figure 2-6 Thinning and remodeling of post-infarction LV result in papillary muscle 
displacement and annular dilatation that is characteristic of an inferior myocardial 
infarction and mitral regurgitation (modified from [56]). 
 
Clinical studies have demonstrated that IMR is more likely to occur after a 
posteroinferior rather than an anterolateral LV infarction [53,57]. A report by Gillinov et 
al. involving nearly 500 patients treated over 13 years at the Cleveland Clinic confirmed 
the clinical importance of infarct location and size on the development of IMR [58]. In 
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this study, 73% of patients had posterior wall motion abnormalities and 63% had inferior 
wall motion abnormalities. Virtually all were found by echocardiography to have 
evidence of posterior and/or inferior myocardial infarctions. While infarctions in 
locations other than the inferior side occurred, they were less common and likely 
represent the diffuse nature of coronary atherosclerosis that is present in most IMR 
patients [54].  
Recent studies estimate the prevalence of IMR within the United States to be 
approximately 1.6 to 2.8 million patients [4]. Beyond its wide prevalence, IMR has been 
found to significantly impact patient prognosis. Post-myocardial infarction patients have 
been found to exhibit 1-year mortality rates of 52% with severe MR, 22% for mild to 
moderate IMR, and 11% for no IMR [4]. The presence of patient comorbidities can 
compound IMR’s effect, yielding the cessation of MR as being necessary but not 
sufficient to improve patient outcomes. If left untreated, the clinical consequence of 
severe IMR is excess morbidity and mortality [59].While infarcts vary widely in age, 
size, and location; several studies have identified the effects of inferior myocardial 
infarctions on ventricular dilatation and geometric MV distortion. 
 
2.2.1 Geometric and Functional Effects of an Inferior Left Ventricular Infarction  
In the setting of an inferior chronic LV myocardial infarction, the mitral annulus and 
papillary muscles are displaced asymmetrically (Figure 2-6) [1,2,4,31,41,48,54].  The 
annulus characteristically dilates towards the posteroinferior direction by as much as 125-
200% of the subject’s healthy annular area [31,33,41,48]. The posteromedial papillary 
muscle commonly distends more than the anterolateral papillary muscle as dictated by the 
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pattern of LV infarction and dilatation [53,57,58]. In combination, these geometric 
distortions result in asymmetric leaflet tethering and asymmetrically directed 
regurgitation jets (Figure 2-7). More centrally directed MR jets can additionally occur 
depending on the pattern of MV geometric tethering. While vector distances between the 
mitral annulus and the papillary muscles have been reported in clinical studies [27,60,61], 
the most complete geometric information for how the mitral-LV apparatus changes, albeit 
in one presentation of an inferior myocardial infarction, has been reported by animal 
studies [55,62,63].  
 
 
Figure 2-7 Example of an asymmetrically directed regurgitation jet from an inferior 
left ventricular infarction. 
 
2.2.2 Current Trends and Operative Strategies for Ischemic Mitral Regurgitation 
No optimal medical treatment or therapy exists for IMR patients. Current surgical 
strategies include mitral valve repair, replacement, and minimally invasive/percutaneous 
mitral valve repair [4,5].  Today, the preferred surgical treatment is undersized mitral 
annuloplasty (UMA). In this procedure, the mitral annulus is constrained to the shape and 
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size of an undersized complete rigid annuloplasty ring (Figure 2-8) [64]. This technique 
forces the mitral leaflets into apposition in order to compensate for excessive subvalvular 
mitral leaflet tethering. This procedure has been demonstrated to be successful for the 
majority of IMR patients by restoring leaflet coaptation, reducing or eliminating MR, and 
promoting reverse LV remodeling [23-25]. 
 
Figure 2-8 Undersized mitral valve annuloplasty (modified from [1]). 
 
When MV repair is not feasible, mitral valve replacement is considered as a 
secondary option. In this procedure, a mechanical or tissue heart valve is implanted in the 
mitral annulus to replace native mitral valve function (Figure 2-9). While historically 
considered as a less effective option for IMR patients, a recent clinical trial has aimed to 
compare the clinical outcomes of mitral annuloplasty and mitral valve replacement in 
patients with severe IMR [5]. Preliminary data has demonstrated no significant difference 
between patient groups in LV reverse remodeling or one year survival. Replacement was 
demonstrated to provide a more durable correction of mitral regurgitation, but there was 
no significant between-group difference in clinical outcomes. This clinical study is 
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currently ongoing whose results may significantly influence the future operative care of 
severe IMR patients.  
 
                                   
Figure 2-9 Left: Mitral valve replacement using a bileaflet mechanical heart valve; 
Right: Mitral valve replacement using a bovine pericardium valve (modified from 
[117]). 
 
A significant challenge in IMR is treating patients who are elderly and are 
presented with significant comorbidities. These characteristics represent a large and 
growing patient population who are considered by many as too high-risk for open-heart 
surgery [6-9].This trend, paired with a rising desire for less invasive approaches, has led 
to the development of minimally invasive and percutaneous surgery for IMR.  The 
devices used in these approaches can be broadly characterized into designs that aim to 
repair mitral valve function by performing direct annuloplasty, indirect annuloplasty, or 
leaflet clipping (Figure 2-10) [7,9,10, 64-72]. Additional technologies dedicated to 
directly replacing the MV are in development but are not yet commercially available 
(Figure 2-10) [7,9,10]. While these techniques exhibit potential for treating a large 




Figure 2-10 Examples of different percutaneous MV devices that include (A) the 
Monarc device for indirect annuloplasty, (B) the Mitralign device for direct 
annuloplasty, (C) the CardiAQ prosthesis for MV replacement, and (D) the 
Mitraclip for edge-to-edge leaflet approximation (images modified from [7]). 
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2.3 Suboptimal Surgical Outcomes in Ischemic Mitral Regurgitation 
2.3.1 Structural Failure of Minimally Invasive Devices 
A key to demonstrating equivalent or improved clinical therapeutic benefits for 
minimally invasive and percutaneous IMR devices is the development of designs that not 
only facilitate delivery but reduce IMR. While reductions in regurgitation have been 
demonstrated in preclinical studies, concerns have been raised regarding the safety of 
annular based devices [7,8,9,10,73]. In specific, these devices are structurally smaller, 
more flexible, and may be less durable than comparably rigid replacement valves or rigid 
undersized complete annuloplasty rings. As a result, these devices may experience 
greater structural deformations and as such may be more prone to strain related material 
failure. For these reasons, it is not surprising that both clinical and preclinical annular 
device failures have been reported [7,9,10]. The number of these failures is likely much 
greater given the pressures within the discipline to reserve reporting to positive results.  
 
2.3.2. Annuloplasty Ring Dehiscence 
The preferred reconstructive surgery for IMR is undersized complete rigid ring 
annuloplasty. While effective in the majority of patients, postoperative complications can 
lead to short-term repair failure [74]. One increasingly acknowledged short-term failure is 
annuloplasty ring dehiscence [11-22]. In IMR, ring dehiscence commonly occurs along 
the posterior annulus [11-18] with select cases resulting in complete separation of the 
ring from the annulus (Figure 2-11) [19,20]. While these failures are often attributed to 
surgical technique, no studies have identified whether suture failure, knot failure, or 
annular tissue tearing is the primary cause of dehiscence. Identifying and understanding 
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these mechanisms may significantly improve patient-ring selection, ring design, and 
surgical implantation.  
 












Figure 1. (A) Philips iE33 3D echocardiographic image of a partially dehisced CE Physio annuloplasty ring (AR). Six months prior to 
this study the patient had undergone valve repair for IMR with an undersized annuloplasty ring  (28 mm). (B) Rendering of the same 
valve made using our group’s novel valve analysis software. The large blue spheres represent the annuloplasty ring (AR). The fine 
blue lines depict the leaflets. Note the papillary muscle tips (PPM, APM) are readily identifiable using our techniques. The green 
shaded region is the regurgitant orifice area (ROA). (C) Magnified portion of image (B) demonstrating our ability to precisely delineate 




Figure 2-11 Annuloplasty ring dehiscence echocardiographic imag s. 
 
2.3.3. Recurrent Mitral Regurgitation Following Undersized Mitral Annuloplasty  
While effective in the majority of cases, approximately 10-15% of patients who present 
with a severely distended left ventricle and undergo undersize mitral annuloplasty suffer 
from recurrent severe regurgitation, have low rates of reverse LV remodeling, and exhibit 
poor survival [23-29]. In these patients, implantation of an undersized ring can hoist the 
posterior annulus anteriorly without displacing the anterior annulus fixed at the aortic 
root (Figure 2-12). This result augments posterior leaflet tethering by increasing the 
distance between the papillary muscle tips and posterior annulus. In the setting of 
progressive LV dilatation, both mitral leaflets can become further tethered leading to 
restrictive leaflet motion and recurrent mitral regurgitation [26-29]. 
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Figure 1: (A) Normal mitral valve anatomy. (B) Illustration of the annular dilitation
and leaflet tethering associated with IMR.  (C) Standard repair with an undersized
annuloplasty ring.  Undersizing results in a mono-leaflet valve and exacerbation
of the posterior leaflet tethering. Post-repair tethering can be so severe as to
result in posterior leaflet “chordalization.” In such cases the leaflet no longer
contributes to valve competence and becomes a linear extension of the chords.
(D), (E), and (F) Depict the leaflet augmentation strategies that will be compared
in this project: posterior augmentation (D), anterior augmentation (E) and bi-leaflet
augmentation (F).
 
Figure 2-12 (A) Normal mitral valve geometry; (B) Illustration of the annular 
dilatation and leaflet tethering associated with ischemic mitral regurgitation; (C) 
With a severely dilated left ventricle, undersized mitral annuloplasty can result in a 
mono-leaflet valve and exacerbation of posterior leaflet tethering. 
 
2.4 Recent Investigations Contributing to the Improvement of Suboptimal Surgical 
Outcomes in Ischemic Mitral Regurgitation 
2.4.1 What Forces May Act On Annular Based Mitral Valve Devices? 
Despite parallel advances in engin eri g and medical image technology, only limite  
information is available for the forces and deformations experienced by devices 
implanted to the mitral annulus. The majority of studies seeking to measure mitral 
annular forces have focused on quantifying cyclic planar compression (Figure 2-13). In 
1994, Hasenkam and colleagues were the first to describe the forces generated by the 
myocardium on 29 mm Edwards-Duromedics mitral valves [75]. Within seven healthy 
porcine subjects, a maximum in-plane force of 6-8 N was observed to act in a direction 
30° clockwise from the transverse annular diameter. 
Later in 2001, Shandas et al. used 3D ultrasound to measure the deformation of 
St. Jude Medical Biocor® stented prosthetic MVs in two healthy porcine subjects (Figure 
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2-13) [76]. Measured ring deformations were used as boundary conditions for finite 
element analysis, which estimated the maximum septal-lateral force to fall between 4.4 
and 13.9 N. This large range of peak force is likely due to the limited number of 
experimental subjects (n=2) and limitations of using 3D intravascular ultrasound to map 
2D deformations of the stented valves for finite element modeling. 
 
         
Figure 2-13 Left: Majority of experimental studies have sought to quantify the 
forces acting in-plane with the mitral valve annulus; Center: Hasenkam et al. [75] 
adhered strain gage rosettes to Edwards-Duromedics mitral valves to quantify 
planar forces; Right: Shandas et al. [76] used 2D deformations of stented prosthetic 
MVs measured by echo as boundary conditions in a finite element model.  
 
Each of these studies was pioneering in estimating the radially-directed forces that 
the myocardium can generate on implanted prostheses. However, the combined results of 
these studies were unable to identify a common direction of maximal force or 
quantitatively compare the magnitude of these forces with other radial directions. 
Moreover, each study provided a large range of forces whose rate, correlation with left 
ventricular pressure, and change with hypertensive and disease conditions remains 
unknown.  
Determining these unknowns are critical for the design and evaluation of 
minimally invasive and transcatheter devices. As many of these devices are directionally 
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heterogeneous, evaluating directional differences in force with increasing ventricular 
afterload can inform worst-case loading conditions. Determining the rate change of these 
forces during ventricular contraction will additionally inform device testing and the use 
of device materials with rate or time dependent material properties. The ability to 
quantify these endpoints in the presence of an inferior left ventricular infarction will 
additionally and significantly contribute to the development of minimally invasive and 
percutaneous IMR devices.  
 
2.4.2. What Causes Annuloplasty Ring Dehiscence? 
No studies have identified whether suture failure, knot failure, or annular tissue tearing is 
the primary cause of annuloplasty ring dehiscence [11-22]. To the author’s knowledge, 
only two studies have evaluated suture failure in ring annuloplasty. In a study evaluating 
the safety of annuloplasty rings for magnetic resonance imaging, annuloplasty ring-tissue 
tear out forces were evaluated. Among patients with varying MV disease, single sutures 
were shown to tear from MV annular tissue with a mean force of 6.0 ± 4.5 N [77]. In the 
second study, Physio
TM
 annuloplasty rings were implanted in explanted ovine hearts. 
With the heart anchored, the ring was pulled upward in a tensile test to evaluate the total 
force required to tear a ring from the annulus (Figure 2-14) [78]. Results demonstrated 
the rings to tear from the annular tissue at approximately 140 ± 33 N (~12 N per suture).  
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Figure 2-14 Left: Ring pull out test experimental set-up; Right: Results of the tests 
for the indicated annuloplasty rings and ring suturing procedure where minor and 
major decrease correspond to momentary drops in force during the tensile test 
which correspond to select ring sutures failing (modified from [78]). 
 
Each of these studies has provided preliminary insight to the forces required to 
pull rings from the annulus but were unable to identify the mechanisms of ring 
dehiscence. The inability to identify the mechanisms has contributed to large uncertainty 
for the conditions under which it is most likely to occur. One route towards addressing 
this challenge is to measure suture forces at ring implantation and during cyclic 
contraction of the heart. Quantifying these forces and comparing them to the forces 
associated with suture failure or tissue tearing will significantly contribute to our clinical 
understanding of dehiscence. Moreover, these data will aid in developing new ring 
designs and surgical approaches to reduce its occurrence.   
 
2.4.3. Can Repair Induced Mitral Leaflet Tethering be Predicted Preoperatively? 
Repair failure after undersized annuloplasty results from progressive LV dilatation, 
leaflet tethering, and LV dysfunction implicating a mal-distribution of annular and 
 25 
subvalvular stresses as a probable mechanism [26,28,51].  In these patients, the severely 
or progressively displacing papillary muscles hinder undersized annuloplasty’s ability to 
sustain coaptation and urges the use of adjunct procedures to directly address subvalvular 
tethering [26-29]. While adjunct procedures have demonstrated effectiveness [64, 79-86], 
several issues impede our ability to optimally treat these patients. 
 A primary issue relates to identifying patients who will benefit from sole 
undersized mitral annuloplasty [87]. While several ventricular- and leaflet-based 
measures have been demonstrated to significantly correlate with patient outcomes [24,87-
91], no metrics directly quantify the geometric papillary muscle distortions that give 
allowance or alternatively impede the compensatory effects of undersized annuloplasty. 
A secondary issue is the need to understand the geometric mechanisms and limits of 
adjunct procedures to assess their suitability for maintaining coaptation with severe or 
progressive papillary muscle displacement. The ability to directly assess these issues will 
aid in identifying patients who may benefit from a given treatment while additionally 
contributing to the improvement and individualization of treatment modalities [87].  
Matching the best IMR surgical procedure to a given patient mitral valve 
geometry may soon be possible with in silico mitral valve models (Figure 2-15). These 
models hold significant potential for preoperative surgical planning, assessing repair 
complexity, and accelerating training for surgical techniques.
 
These models began as 
idealized mitral leaflets and have grown to incorporate anisotropic nonlinear material 
properties, in vivo tissue architecture, structural representation of the subvalvular 
apparatus, and the LV [92-101]. While significant technological advances have been 
made, many challenges remain for these virtual mitral valve models.  
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Figure 2-15 Example progression of data flow for patient-specific surgical planning 
using in silico modeling. 
 
One of the most significant challenges is modeling the complex architecture and 
function of the mitral valve’s chordae tendineae. Current standard-of-care 
echocardiography is unable to spatially resolve detailed chordal architecture requiring 
mitral valve models to employ idealized chordal distributions (Figure 2-16) [92-100, 
102]. These idealized chordal geometries can differ greatly from native valves and have 
been demonstrated to impact mitral valve simulation results [95,101].
 
Compounding this 
uncertainty is the lack of experimental data providing boundary conditions for how the 
tethering of the chordae may change from IMR to UMA.  Addressing both challenges is 
critical for improving IMR surgical planning tools and advancing their predictive 
capabilities.  
    
 
Figure 2-16 Images from recently published in silico mitral valve models showing 
the simplifications in modeling the complex chordae tendineae (images modified 
from [98, 97, 102]). 
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One step towards improving mitral valve modeling therefore is to define 
boundary conditions that describe the changes in chordal-leaflet tethering that occur with 
the mitral’s primary load bearing chordae in IMR and undersized annuloplasty. While 
select in vitro and large animal studies have quantified chordal forces [51], no studies 
have quantified chordal tethering during the sequential transition from a healthy to IMR 
and annuloplasty conditions. The ability to quantify chordal forces in these conditions 
will therefore enhance computational model development and move steps closer to 




























OBJECTIVE AND SPECIFIC AIMS 
Ischemic mitral regurgitation occurs when the heart’s mitral valve is rendered 
incompetent by post-infarction left ventricular remodeling and three-dimensional 
alterations in mitral valve geometry [2]. These alterations include papillary muscle 
displacement and annular dilatation, which ultimately lead to restricted leaflet motion and 
mitral regurgitation [54,55]. While the severity of this disease can vary, IMR typically 
presents with significant comorbidities yielding the cessation of regurgitation as being 
necessary but not sufficient to improve patient outcomes. For these reasons among others, 
an optimal IMR surgical repair has yet to be established [4,5]. Finding an optimal 
surgical strategy has included the development of novel implantable devices and 
techniques for both open-chest, percutaneous, and transcatheter approaches. Despite 
published successes, post-operative device and repair induced complications have been 
documented. These include but are not limited to device fracture in pre-clinical trials 
[7,9,10], annuloplasty ring mattress suture dehiscence [11-22], and post-operative 
chordal-leaflet tethering [23-29]. From any of these adverse events recurrent 
regurgitation can ensue, leading to impaired left ventricular function, worsened patient 
health, and mortality [4]. A common thread to these outcomes is the presence or 
imbalance of mechanical forces acting on implanted devices, on mitral annular mattress 
sutures, and in the mitral valve’s chordae tendineae. Little or no knowledge exists for the 
magnitude of these forces or their variations with left heart function under healthy and 
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IMR conditions [51]. Understanding the relative magnitude and variation of these forces 
will significantly aid the development of more robust devices, improve knowledge for 
device implantation, and contribute to methods designed to predict or reduce 
postoperative chordal-leaflet tethering. To this end, the central hypothesis of this study 
is: Determining the forces that exist at the annular and subvalvular levels under normal, 
IMR, and repair conditions will allow for the development of more durable IMR devices 
and repairs. To this end, the following specific aims have been formulated. 
 
Specific Aim 1: Quantify the contractile mitral annular forces that may contribute to 
device failure. 
Radial forces resulting from mitral annular contraction are currently unknown. 
Determining these forces will help define the appropriate and relevant boundary 
conditions for the development and testing of robust mitral valve devices. For this 
purpose, novel strain gage based transducers will be developed and implanted in normal 
and chronic IMR Dorsett hybrid sheep. Cyclic forces will be measured in the septal-
lateral and transverse annular directions at baseline and elevated levels of left ventricular 
pressure. These analyses will provide key insight to the forces that exist within the 
annulus and their correlation with the condition and function of the native heart. 
 
Specific Aim 2: Quantify the suture forces required to constrain true-sized and 
undersized annuloplasty rings to the ovine mitral valve annulus. 
While ring suture dehiscence is often attributed to surgical technique, no studies have 
identified whether suture, suture knot, or tissue tearing is the primary mechanism of 
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clinical ring dehiscence [11-22,77,78]. Moreover, no data exist for whether patient-ring 
selection contributes to excessive ring suture forces. These factors in combination have 
contributed to large uncertainty for what causes suture dehiscence and under what 
conditions suture forces may be exacerbated. Mattress suture force transducers will be 
developed and fixated to Carpentier-Edwards Physio
TM
 annuloplasty rings. Instrumented 
undersized and true-sized annuloplasty rings will be implanted in eight ovine animals. 
Suture forces will be measured at both baseline and elevated levels of left ventricular 
pressure. These results will demonstrate how suture forces vary with ring-annular sizing, 
ring position, and annular region. The results of this aim will provide insight to the 
mechanisms by which suture dehiscence may occur in the clinic.  
 
Specific Aim 3: Evaluate the effects of mitral valve annuloplasty on chordal-leaflet 
tethering forces. 
Quantifying tethering among all strut chordae in the sequential transition from IMR to 
varying degrees of undersized annuloplasty within patients or animal models is not 
feasible. In vitro models may be a potential solution however the ability of these models 
to mimic healthy and IMR mitral valve function has not been assessed.  In part A of this 
aim, an in vitro mitral valve simulator’s ability to mimic the systolic leaflet coaptation, 
regurgitation, and leaflet mechanics of a healthy and IMR ovine animals will be 
evaluated. In part B of this aim, the in vitro simulator will be used to quantify the isolated 
effects of IMR, oversized, true-sized, and undersized mitral annuloplasty on leaflet 
coaptation, mitral regurgitation, and tethering forces of the anterior strut and posterior 
intermediary chordae tendineae from both the anterolateral and posteromedial papillary 
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muscles. These data will provide key insights into how chordal tethering patterns can 
change from IMR to annuloplasty. These data will aid the further development of 































4.1 Specific Aim 1 Materials 
4.1.1 Mitral Annular Force Transducer 
The mitral annular force transducer was manufactured using 19 materials from five 
suppliers. These items are listed in Table 4-1. Several materials may be substituted for 
others that exhibit similar purpose. These materials include items 5, 6, 11,12, 14, 18, and 



















Rapid Prototpyed Spring element (MicroFine 
Green)









3 M-Prep Conditioner A 
4 M-Prep Neutralizer 5A 
5 Cotton Applicators
6 Gauze sponge
7 EA-031DE-350 resistance strain gages
8 M-Bond 200 Adhesive 
9 M-Bond 200 Catalyst 
10 PCT-2M Gage Installation Tape 
11 M5S-1 Mark V soldering station 
12 361A-20R solder 
13 336-FTE three stranded wire 
14 M-Line Rosin Solvent 
15 M-Coat B Nitrile Rubber 
16 3140 RTV Silicone Rubber 
17 3145 RTV Silicone Rubber 
18 0.005” High Purity Silicone Rubber Sheet McMaster-Carr (Atlanta, GA)





4.1.2 Mitral Annular Force Transducer Calibration Apparatus 
To facilitate mitral annular force transducer calibration, a well-defined calibration 
apparatus was developed (Figure 4-1). The apparatus had the ability to impose septal-
lateral and transverse forces either independently or in concert. Loading of each 
transducer within the apparatus is accomplished through the use of bolt-piston-spring-
pusher assembly located in the septal-lateral and transverse and loading mechanisms. 
This mechanism is shown in detail in Figure 4-2. Based on previous studies, each 
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transducer was calibrated from 0 to 8.4 N (in 1.2 N increments) while submerged in a 
37°C water bath to mimic the physiologic temperature of the ovine subjects [75,76]. 
Loading can be completed in 0.6 N increments by turning the driving screw one-half 
rotation. At each increment, an ultra-precision spring (Gardner Spring GCO300-022-
0688, 0.30 x 0.022 x 0.688, McMaster Carr, Atlanta, GA) is compressed applying a force 
to the pusher in contact with the transducer.  
 
 
Figure 4-1 Bi-axial calibration apparatus with a schematic representation of what 
forces are applied to the device, forces are applied via a spring-piston system such 
that spring compression elicits a force on the transducer. 
 
 
Figure 4-2 (A) Acrylic housing, (B) Bolt, (C) Piston, (D) Precision compression 
spring, (E) Pusher which is in contact with the force transducer. 
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4.1.3 Healthy and Ischemic Mitral Regurgitation Ovine Model 
The animals used in this work received care in compliance with
 
the protocols approved 
by the Institutional Animal Care and
 
Use Committee at the University of Pennsylvania in 
accordance
 
with the guidelines for humane care (National Institutes of
 
Health Publication 
85-23, revised 1996).  
A healthy and chronic IMR ovine model was utilized for these studies. Animals 
randomized to the chronic IMR group received an inferior LV infarction to produce 
progressive chronic IMR. This model has been extensively studied and mimics a 
common clinical presentation of an inferior myocardial infarction described in humans 
[33,41,48].
 
In short, this LV infarction is achieved through a sterile left lateral 
thoracotomy. In this procedure, snares are placed to occlude the proximal second and 
third obtuse marginal branches of the circumflex coronary artery. Following infarction 
the thoracotomy is closed and IMR allowed to progress for a 6 to 8 week period prior to 
carrying out the experimental protocol.  
 
 
4.2 Specific Aim 2 Materials 
4.2.1 Healthy Ovine Model 
The ovine model used in this Aim is identical to that described in Section 4.1.3.  
 
4.2.2 Mitral Annuloplasty Ring Stress Transducer 
A mitral annuloplasty ring stress transducer was manufactured using 18 materials from 
six suppliers. These items are listed in Table 4-2. Several materials may be substituted for 
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others that exhibit similar purpose.  These materials include items 2, 5, 6, 11-13, 16 and 
17.  
 
Table 4-2 Materials used for the manufacturing of the ring stress transducer. 
No. Item Supplier
1 Titanium (6-AL 4V) for the Annuloplasty Ring Core McMaster-Carr  (Atlanta, GA)
2 Loctite® M-31CL
TM
 Hysol® Medical Device Epoxy
Ellsworth Adhesives 
(Germantown, WI)
3 M-Prep Conditioner A 
4 M-Prep Neutralizer 5A 
5 Cotton Applicators
6 Gauze sponge
7 EA-031DE-350 resistance strain gages
8 M-Bond 43
9 PCT-2M Gage Installation Tape 
10 M5S-1 Mark V soldering station
11 361A-20R solder 
12 CEG 25C Bond Terminals 
13 336-FTE three stranded wire 
14 M-Line Rosin Solvent 
15 M-Coat B Nitrile Rubber 
16 1/4” wire heat shrink ACK Electronics (Atlanta, GA)
17 Plasti Dip (Liquid Rubber) Home Depot (Atlanta, GA)
18 611 Double Velour Cardiovascular Fabric C.R. Bard (Murray Hill, NJ) 




4.2.3 Mitral Annuloplasty Ring Suture Force Transducer 
The mitral annuloplasty ring suture force transducer was manufactured using 17 materials 











Rapid Prototpyed Spring element (316L 
Stainless Steel)









3 M-Prep Conditioner A 
4 M-Prep Neutralizer 5A 
5 Cotton Applicators
6 Gauze sponge
7 EA-13-062TZ-350/E strain gages
8 M-Bond 200 Adhesive 
9 M-Bond 200 Catalyst 
10 PCT-2M Gage Installation Tape 
11 M5S-1 Mark V soldering station
12 361A-20R solder 
13 CEG 25C Bond Terminals 
14 336-FTE three stranded wire 
15 M-Line Rosin Solvent 
16 M-Coat B Nitrile Rubber 
17 1/8” wire heat shrink 
ACK Electronics               
(Atlanta, GA)
Vishay Micro-Measurements             
(Wendell, NC)
 
4.2.4 Commercially Available Mitral Annuloplasty Rings 
Size 24-30 Carpentier-Edwards Physio
TM
 rings (Edwards Lifesciences, Irvine, CA) were 




4.3 Specific Aim 3 Materials 
4.3.1 Healthy and Ischemic Mitral Regurgitation Ovine Model 
The healthy and chronic IMR ovine model used in this Aim is identical to that described 
in Section 4.1.3.  
 
4.3.2 Sonomicrometry Array Localization 
Sonomicrometry was used to map the annular and subvalvular geometry of both healthy 
and chronic IMR ovine animals (Figure 4-3). Using published techniques, 2 mm 
hemispherical piezoelectric transducers (Sonometrics, London, Ontario) were localized to 
the mitral annulus (N=12), A2 anterior mitral leaflet (N=5), and papillary muscle tips 
(N=2) [33,41,48]. Each transducer was connected to a Series 5001 Digital 
Sonomicrometer (Sonometrics, London,Ontario).  During each experimental study, the 
distance between sonometric transducers was measured at 200 Hz.  
 
Figure 4-3 Sonocrystal array localization for a chronic IMR animal to (Left) the 




4.3.3 Ovine Mitral Valves for In Vitro Simulation 
Fresh ovine hearts were obtained and MVs excised preserving their annular and 
subvalvular anatomy. MVs were selected for experimentation based on their anterior 
leaflet height, type I or II PMs, and with all leaflet chordae inserting directly into each 
PM. Part A of Specific Aim 3 (3A) utilized MVs with an anterior leaflet height of 18-19 
mm while part B of Specific Aim 3 (3B) utilized MVs with anterior leaflet height of 20-
25 mm. Upon mounting each valve within the Georgia Tech Left Heart Simulator, all 
experimental conditions are consistently completed within 12 hours from initial excision.  
 
4.3.4 Georgia Tech Left Heart Simulator 
In vitro simulation of MV function was conducted in the extensively studied Georgia 
Tech Left Heart Simulator [103-113]. This closed-loop simulator allows for precise 
control of annular and subvalvular MV geometry at physiological left heart 
hemodynamic conditions (Figure 4-4). Excised ovine MVs were sutured to an adjustable 
annulus, designed to allow dilatation and to create an annular saddle shape. Two 
prosthetic annuli were used in this work. In aim 3A, the constructed annulus could dilate 
from a 6.5 cm
2
 D-shaped orifice to 13 cm
2 
and flatten from a maximum annular-height-
to-commissural-width ratio of 20%. In Aim 3B, the constructed annulus could 
asymmetrically dilate to 9.8 cm
2
 and conform to the shape of a size 26, 30, and 34 
Physio
TM
 annuloplasty ring.  For each study, PM positions were controlled by two 
mechanically adjustable positioning rods capable of adjustment to varying positions in 
the apical, lateral, and posterior directions at a resolution of ±0.25 mm. Transmitral flow 
was measured using an electromagnetic probe (accuracy ±0.05 L/min) (Carolina Medical 
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Electronics, FM501D, East Bend, NC) mounted upstream of the atrium. Transmitral 
pressure was monitored with transducers (accuracy ±1 mmHg) mounted in the atrium and 
ventricle (Validyne DC-40, Northridge, CA). 
 
Figure 4-4 Schematic of the Georgia Tech Left Heart simulator with components 
identified. 
 
4.3.5 Chordae Tendineae Force Transducers 
Miniature c-shaped force transducers have been used previously to quantify tethering 
forces of the MV’s chordae tendineae (Figure 4-5) [104-108]. These transducers are 
strain gage based, manufactured, tested, and calibrated before and after each experiment 
within our laboratory. During calibration, the linear regression coefficient of the 
relationship between the calibrated load and transducer voltage output is between 0.98-
1.00. The relative difference between measured and true values (accuracy) after 
calibration is less than 2% with a minimum measurable tension of approximately 0.01 N. 
Prior to each experiment, these transducers are sutured directly to selected chordae 
without altering the chordae’s native length. Once a transducer is sutured to a chord, the 
section of chordae located between the transducer’s measurement arms is transected such 
that all tensile loading of the chord is transferred to the transducer. Further details of 
instrumenting the chordae with these transducers can be found in the Methods Chapter.  
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Figure 4-5 Left: Chordal force transducer, Right: Attachment to the chordae to the 
strut and intermediary chordae of a mitral valve mounted to the mitral annulus as 
viewed from the apical aspect. 
 
4.3.6 Stereo-Photogrammetry 
Dual camera stereo-photogrammetry has been successfully used in previous studies to 
measure in vitro MV leaflet strains [113-115]. In this method, tissue dye (Thermo 
Scientific, Waltham, MA) is used to mark the A2 cusp with a 3x3 rectangular dot array 
(Figure 4.6).  Each leaflet marker is separated by approximately 1.5 mm and is 0.5 mm in 
diameter. These fiduciary markers are tracked throughout the cardiac cycle using two 
synchronized high-speed cameras (Basler Corp, Exton, PA) with Nikon macro lenses 
(105mm, f2.8; Nikon, Melville, NY) at 250 Hz. After calibration, acquired images are 
imported to a custom MATLAB program (See Appendix E) to calculate radial and 




Figure 4-6 Central A2 cusp of the anterior leaflet is marked with tissue dye then 
tracked throughout the cardiac cycle to quantify anterior leaflet strain. 
 
For image calibration, a 10 mm steel cube was positioned within the volume 
occupied by the MV leaflets such that each high-speed camera could image 7 of the 
cube’s corners. These calibration images were digitized within a custom MATLAB 
program (See Appendix E) (Mathworks, Natick, MA). Using the cube calibration images 
and those recorded during each experiment, direct linear transformation was used to 
calculate the 4D coordinates of each leaflet marker [116].  These coordinates were 
exported into a custom MATLAB program (See Appendix E) utilizing biquintic finite 
element interpolation to fit a surface to the recorded marker coordinates. Generated 
surfaces were used to determine the average radial and circumferential strains of the 
anterior leaflet at peak systolic closure [113-115]. Based on the magnification of the 
high-speed cameras, pixel size, and calibration cube, the 3D leaflet marker coordinates 
was determined to an accuracy of ±68 μm. This accuracy is in good agreement with 





4.3.7 Echocardiography  
All echocardiography imaging (in vitro and in vivo) was completed with an x7-2 probe 
and Phillips ie-33 Matrix machine (Phillips, Andover, MA). All images were analyzed 









































EXPERIMENTAL METHODS AND PROTOCOLS 
5.1 Specific Aim 1 Methods 
5.1.1 Transducer Spring Element Design: Healthy Animals 
The spring element for the healthy animal mitral annular force transducer possesses 
several key attributes to allow the identified forces to be measured. The spring element 
consisted of 4 measurement arms that extend from a central point of intersection labeled 
as section C in Figure 5-1. For this spring element, strain gages are mounted to the top 
and bottom of locations D and E to measure forces in the anterolateral and transverse 
directions. Two strain gages were used at each location in case one failed during 
experimentation. Sections E and D were designed with a slight curvature to amplify 
surface deformation during loading; thus improving the signal to noise ratio for the strain 
gages mounted to those areas. The spring element contained 4 holes (1 mm diameter) 
(label A in Figure 5.1) for device annular suturing in sections B and F. Two device-
annular suture holes were designed in Sections H and G.  
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Figure 5-1 Left: Spring element of the designed annular force transducer with 
selected highlights: (A) through holes for suturing the device to the mitral valve 
annulus, (B) anterior transducer arm, (C) central bridge area designed to both 
minimize transmitral blood flow obstruction and provide structural support, (D) 
location of strain gage to measure transverse force, (E) location of strain gage to 
measure anterolateral force, and (F) lateral transducer arm, (G) anterior 
commissure measurement arm, and (H) posterior commissure measurement arm; 
Right: Orientation of mitral valve with respect to the orientation of the transducer. 
 
During implantation, mattress sutures are passed through the annulus then through 
each hole in the transducer. This method of implantation is described later in Section 
5.1.8. To minimize obstruction to transmitral flow, the central bridge area was optimized 
to maximize structural strength and prevent mitral stenosis. This was achieved by 
utilizing the maximum radial forces reported by Hasenkam and Shandas (8 to 13.9 N) as 
boundary conditions for a Finite Element Analysis (FEA) model in the SolidWorks 2010 
program (Waltham, MA) [75,76]. Optimization of the bridge geometry was driven by the 
spring element’s ability to (i) be rapid prototyped, (ii) maintain linear elastic deformation 
under the estimated forces, and (iii) deform at the selected strain gage application sites 
within the range of ± 3% strain.  
To identify material candidates that fit the aforementioned criteria, a literature 
survey was performed and Somos 18420 was found to be a strong candidate for the 
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spring element’s material. Material properties for it are listed in Table 5-1. This material 
is resin based and commercially available for rapid prototyping. Its material properties 
combined with dimensional iterations to the central bridge allowed the spring element to 
satisfy each of the aforementioned constraints. During the literature survey, it was found 
this material had been utilized in another study evaluating apical-basal forces of the 
mitral annulus within a porcine model [118,119]. In this study, the material proved to 
have adequate biocompatibility under acute conditions, possibly due to the reported 
material’s low water adsorption characteristics.  
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Using this material and iterating the spring element’s design, the amount of mitral 
flow area obstructed by the central bridge area was 19%. These results are based on a 
mitral valve annular size equal to the outer circumference of the spring element. An FEA 
simulation that applied a 13.9 N load on both the anterolateral and transverse directions is 
pictured in Figure 5-2. Results showed strain gage areas on the atrial facing side reached 




Figure 5-2 Left: Top-view of the transducer with a load of 13.9 N placed in the 
anterolateral and transverse directions with the color green indicating a peak strain 
of approximately 1.8%; Right: Bottom view depicting the same loading conditions. 
 
The final criteria satisfied in the design of the normal annular force transducer 
spring element was allowing for several sizes to be manufactured. This allowed more 
flexibility in transducer-annular sizing for implantation. Three sizes were designed, each 
differing in major dimensions shown in Figure 5-3.  
 
Figure 5-3 Top-view of the acute animal spring element with dimensions noted. 
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5.1.2 Transducer Spring Element Design: Ischemic Mitral Regurgitation Animals 
A mitral annular force transducer spring element was specifically designed for the 
chronic IMR animals. This was necessary to counteract unforeseen loads acting on the 
transducer that for the first chronic IMR animal resulted in excessive transducer 
deformation (Figure 5-4). Post experiment, plastic deformation was found to be localized 
to the lateral and anterior commissure measurement arms. From observation, the 
deformation appeared to originate from a bending moment on the lateral measurement 
arm in the annular plane towards the anterior commissure. Some out of plane deformation 
was additionally observed in the anterior and posterior commissural arms.  
 
  
Figure 5-4 Left: Plastic deformation of the transverse and lateral measurement 
arms; Right: out-of-plane plastic deformation occurring in the anterior and 
posterior commissural measurement arms. 
 
To assess the excessive deformation, a more robust design was created and is 
pictured in Figure 5-5. The design possessed several differences from the healthy animal 
transducer spring element that included: (i) a different material (MicroFine Green Resin), 
(ii) an increase in the radius of curvature in each measurement arm, and an (iii) increase 
in the overall thickness and width of each measurement arm. Material properties of 
MicroFine Green are listed in Table 5-2. MicroFine Green has very similar material 
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properties to that of Somos18420; however, MicroFine Green enables the production of 
parts with the finest features and tightest tolerances (±0.002”) available in industry. Thus, 
the material may act more as a homogeneous material rather than a layered rapid 
prototyped part.  In the future, the use of a molded spring element may further improve 
element performance. 
Small Medium Large
A 29 31.25 33.25
B 32.6 34.75 36.75
C 23 23 23
D 3 3 3














Figure 5-5 Top-view of the chronic animal spring element with dimensions noted. 
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Unlike the normal transducer parent geometries, the chronic IMR transducer 
geometry was only fabricated in the medium size. To test the design’s ability to withstand 
known forces and a bending moment estimated to be responsible for the previous 
transducer’s plastic deformation, FEA was utilized. In Figure 5-6, the FEA images 
represent the distribution of stress in the measurement arms when a load of 13.9 N is 
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applied in the anterolateral and transverse directions. Additionally, a 6 N bending 
moment is applied on the lateral measurement arm. Results of this analysis show a peak 
strain of 1.8% (shown in red) occurring on the posterior facing wall of the lateral 
measurement leg and a peak strain of 0.9% at the designated strain gage locations.  
 
Figure 5-6 Left: Top-view of the chronic animal transducer spring element’s FEA 
stress results when subjected to a 13.9 N force in the anterolateral and transverse 
directions as well as a 6 N force applied on the lateral measurement arm towards 
the anterior commissure arm; Right: Bottom-view of the same deformation; 
deformation scales are increased to display displaced positions. 
 
5.1.3 Transducer Function 
The annular force transducers were designed to be strain gage based. These types of 
transducers are utilized in a wide span of applications, but all operate under a common 
principle [120]. Strain gages are adhered to a spring element which is designed to deform 
linear elastically when a range of expected forces is applied. Since the strain gages are 
adhered to the surface, they deform with the spring element which results in a change in 
the gage’s electrical output. Through calibration, changes in the electrical output of each 
gage can be correlated to a known force; thus allowing the transducer to be placed in the 
intended operating environment and measure the desired force. Accuracy and precision of 
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these devices is typically high but application specific [120]. Specifications of 0.03% or 
less are not uncommon in contemporary precision load cells. 
 
5.1.4 Transducer Fabrication 
The healthy and chronic IMR mitral annular force transducers were fabricated using 19 
items (See Materials Section) and 13 steps. The steps to fabricate these devices were as 
follows: 
 
Step 1: Surface Coat. One thin coat (<0.5 mm) of Loctite® M-31CLTM Hysol® Medical 
Device Epoxy Adhesive was applied to the spring element’s surface. This coat was used 
to provide a smooth surface for strain gage application. A secondary result of this coat is 
a slight increase in material stiffness. During the epoxy’s application, lateral suture holes 
located in each measurement arm were avoided to prevent hole occlusion. Following 
application, the adhesive layer was allowed to cure for 24 hours at room temperature. If 
suture passages are found occluded, a suture needle was heated under a flame and then 
passed through each hole to clear away excess epoxy.  
 
Step 2:  Strain Gage Preparation. Each strain gage was placed onto a glass surface and 
trimmed of excess material using a standard razor blade (Figure 5-7). This material was 
removed for two reasons: (i) for the strain gage to fit the geometric constraints of the 
spring element and (ii) to allow extra area around the gage for ample application of 




   
Figure 5-7 Left: The strain gage is trimmed to dimensions just outside the grid area 
allowing the gage to fit of each of the spring element’s measurement sections; 
Center: PCT-2M Gage Installation tape is laid over the gage and peeled upwards 
removing the gage from the cutting surface; Right: Strain gages adhered to the 
anterior measurement arm. 
 
Step 3: Surface Conditioning and Neutralizing. M-Prep Conditioner A was applied 
repeatedly to the surface of the spring element (at the areas where strain gages are to be 
bonded) using a cotton tipped applicator. Application was ceased once the tip of the 
applicator was no longer discolored by the scrubbing. Applying the conditioner aided in 
cleaning the spring element’s surface and removing dirt and other impurities. When 
clean, the surface was dried by wiping through the cleansed area with a single slow stroke 
of a gauze sponge.  Next, the conditioned surface was neutralized via M-Prep Neutralizer 
5A to bring the spring element’s surface to a bonding pH of 7.0 to 7.5. This was 
completed by applying the neutralizer to the cleaned surface with a clean cotton-tipped 
applicator. The surface was then dried by wiping through the area with a gauze sponge. 
 
Step 4: Strain Gage Alignment. With the grid and solder nodes facing upward on the 
glass surface, PCT-2M Gage Installation tape was laid over each gage (Figure 5-7). One 
edge of the tape was peeled upwards removing the gage from the work surface. Next, the 
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tape was placed on the designated area of the spring element making sure to align the 
gage along the desired measurement axis.  
 
Step 5: Strain Gage Adhesion. Once a gage was aligned in its designated position, the 
installation tape was peeled halfway from the spring element exposing the bottom side of 
the strain gage. A thin coat of M-Bond 200 Catalyst was applied to the bottom of the 
gage. Immediately following application, one drop (approximately 0.1 mL) of M-Bond 
200 was applied to the area beneath the gage. Using a finger or soft tool, the tape and 
corresponding strain gage was pressed to the geometry’s surface applying firm pressure 
to the gage area. Pressure was maintained over the gage area for 5 minutes. After this 
period, the installation tape was peeled from the spring element leaving the strain gage 
adhered to the spring element’s surface. 
 
Step 6:  Tin Strain Gage Tabs. PCT-2M Gage Installation tape was laid over each gage 
grid to protect from excess solder. After covering, each connection tab of the strain gage 
was tinned  (Tinning refers to depositing solder to the strain gage solder tabs).  
 
Step 7:  Wire Connection. Three 336-FTE three stranded wires were cut into 6’ 
segments. At one end of the wire, approximately 1” of the braided wire was unwound for 
soldering to the strain gages. After each wire was soldered to its respective strain gage, 
the wires were harnessed to the top of the transducer using 3-0 silk suture pictured in the 




Figure 5-8 Left: top view of the transducer with wires harnessed to the geometry’s 
surface using 3-0 suture; Right: isometric view of the transducer after wires have 
been connected and harnessed. 
 
Step 8: Rosin Removal.  M-Line Rosin Solvent was used to remove excess rosin from 
the soldered areas of each strain gage. The solvent was lightly brushed across each gage 
then wiped dry with a clean cotton applicator.  
 
Step 9: Strain Gage Surface Coating. Loctite® M-31CLTM Hysol® Medical Device 
Epoxy was applied in a thin coat (<0.5 mm) over each strain gage and solder nodes. 
Adhesive was allowed to cure for 24 hours. After the curing period, passages for suture 
on the measurement arms were checked and cleared of excess epoxy.  
 
Step 10:  Coating for Moisture Protection. One layer (<0.5 mm) of nitrile rubber was 
applied over each strain gage, solder nodes, and proximal wire. After 45 minutes of 
curing, the gage areas were checked for visible gaps (Center image of Figure 5-9). Any 
gaps found were re-layered and allowed an additional 45 minutes to cure.  
 
Step 11: Exit wire harness. All wires leaving the transducer were placed within a 1/8” 
inner diameter heat shrink tube. A heat gun was used to shrink the tube onto the wire. 
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3140 RTV Silicone Rubber was used to seal the gap between the heat shrink and 
transducer to prevent blood from entering the wire harness during experimentation. 
 
Step 12: Measurement Arm Cushion. To prevent annular irritation and/or tearing during 
implantation, a thin 3140 RTV Silicone Rubber layer was applied to the lateral faces of 
each measurement arm (Center and right image in Figure 5-9). On top of this layer, a 
High Purity Silicone Rubber Sheet (0.005” thickness) was placed to provide a uniform 
and flat surface.  
 
   
Figure 5-9 Left: Strain gage coated with epoxy (Step 9); Center: strain gages coated 
with nitrile rubber (Step 10); Right: application of 3145 silicone with the 
measurement arm cushions in place (Step 12). 
 
Step 13: Additional Moisture and Mechanical Protection. Dow Corning 3145 Silicone 
Adhesive was applied over each of the gages over the nitrile rubber coating. A thin coat 
(<1 mm) was applied and allowed to cure for 48 hours. Note: some experimental images 
do not picture this coating because this step was not introduced until 4 animal studies had 




5.1.5 Transducer Calibration 
To enable the measurement of planar mitral annular forces, the electrical outputs of the 
strain gages adhered to the transducer spring element were calibrated within a well-
defined calibration apparatus (Figure 4-1). The calibration apparatus possessed the ability 
to impose septal-lateral and transverse forces either independently or in concert. During 
calibration, the septal-lateral loading mechanism was used to calibrate both the septal-
lateral and transverse measurement arms.  Based on previous studies, each transducer was 
calibrated from 0 to 8.4 N (in 1.2 N increments) for 7 independent runs while submerged 
in a 37°C water bath to mimic the physiologic temperature of the ovine subjects.  
 
5.1.6 Assessing Transducer Accuracy and Precision 
The accuracy and precision of the transducer was assessed. After calibration, the resulting 
calibration value was used to test the transducer. The transducer was repositioned in the 
calibration apparatus and was loaded from 0 to 8.5 N in both measuring directions for 6 
independent trials. During these trials, the measured and true force was compared and the 
95% confidence interval determined.  
 
5.1.7 Assessing Measurement Errors 
To evaluate the presence of measurement arm cross-talk, the device was secured within 
the calibration apparatus and tested at various combinations of radial forces. To test the 
relative contribution of annular shearing, the device was held and shear moment applied 
to each measurement arm. During ventricular diastole, the mitral valve opens and flow is 
allowed to both passively and actively enter the left ventricle. When the transducer is 
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implanted, flow must pass around the transducer’s cross-members to fill the left ventricle. 
This diastolic flow has the potential to impart a force on the transducer affecting the 
magnitude of forces measured. Since these forces cannot be isolated during ovine 
experimentation, the transducer is implanted to a static mitral annulus within the Georgia 
Tech Left Heart Simulator. To match the peak transmitral diastolic flow rates in-vivo, the 
transducer forces were assessed at the following steady flow rates: 0, 5, 10 (sheep), 15 
(human), 20, and 30 L/min.  
 
5.1.8 Experimental Protocol 
Healthy and chronic IMR ovine animals (N=13) were intubated, anesthetized, and 
ventilated with isofluorane (1.5% to 2%) and oxygen. Surface electrocardiogram and 
arterial blood pressure was monitored. Cardiopulmonary bypass was initiated. After 
establishment of bypass, a left atriotomy was performed. Eight 2-0 Ethibond Exel 
Polyester sutures (Ethicon, Piscataway, NJ) were passed through the mitral annulus in 
positions corresponding to suture passages within the transducer’s measurement arms. 
These sutures were secured through these passages and consistently resulted in firmly 
securing the device to the mitral annulus. Visual inspection was used to verify transducer 
placement and orientation within the mitral annulus (Figure 5-10).  
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Figure 5-10 Transducer implanted in the mitral annulus of a healthy ovine animal. 
 
Following separation from cardiopulmonary bypass, epicardial echocardiography 
was completed. A high-fidelity pressure transducer (SPR-3505; Millar Instruments, 
Houston, TX) was passed percutaneously into the LV through the femoral artery for 
continuous measurement of LV Pressure (LVP). Surface electrocardiogram, LVP, and 
arterial pressure (Hewlett-Packard 78534C monitor; Hewlett-Packard Inc, Santa Clara, 
CA) were monitored continuously. Upon establishing baseline hemodynamics (90 mmHg 
peak LVP, 4.0 L/min cardiac output), forces resulting from mitral annular contraction 
were measured within the post-cardioplegic heart.  
To understand the effects of variations in peak LVP, forces were recorded in 1 
minute intervals for cardiac cycles with peak LVP of 125, 150, 175, and 200 mmHg.  
Elevated levels of LVP were achieved via intravenous injection of norepinephrine. After 
successful measurement of all endpoints, animals were euthanized with 1 g thiopental 
and 80 mEq potassium-chloride. Hearts were explanted and opened to verify placement 
and firm anchoring of the device to the mitral annulus. 
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5.1.9 Data Acquisition 
Mitral annular forces were continuously acquired using a compact Data Acquisition 
System (cDAQ 9174) and strain gauge bridge module (NI 9237; National Instruments). 
LVP was measured from the Millar pressure catheter’s control unit using an analog 
voltage module (NI 9215; National Instruments).  Forces and LVP were continuously 
monitored and recorded in 1 minute intervals using a custom-built LabVIEW program 
(National Instruments) at 1613 Hz. This rate was sufficient for force measurement as well 
as for the determination of the peak rate increase of force with time (dF/dt) during 
isovolumetric contraction.  
 
5.1.10 Data Processing and Experimental Endpoints  
All acquired data were processed offline using a custom Matlab program (See Appendix 
E) (Mathworks, Natick, MA). Force data corresponding to ten consecutive cardiac cycles 
reaching a peak LVP of 90, 125, 150, 175, and 200 mmHg were isolated for analyses. 
From these cyclic data sets, septal-lateral and transverse forces were computed as the 
change from their minimum diastolic value to maximum systolic value. The peak rate 
change of force (dF/dt) with time during isovolumetric contraction was additionally 
determined.  The computed cyclic forces and dF/dt were averaged over the 10 
consecutive cardiac cycles and are presented in Appendix A.  This analysis was repeated 




5.1.11 Statistical Analysis 
Measured forces and rates of force change with time were checked for normality using 
the Anderson-Darling test. Changes in force and dF/dt with increasing levels of afterload 
within both the control and chronic IMR group were tested using repeated measures 
analysis of variance (ANOVA). If a significant effect was revealed, a Dunnett’s post hoc 
was used to determine if forces measured at elevated levels of LVP were statistically 
greater than those measured at baseline conditions. To determine if differences in force 
and dF/dt existed between the healthy and chronic IMR group, a between groups repeated 
measures ANOVA test was used. If a significant difference was revealed, a conservative 
Bonferroni post hoc test was used to determine at which levels of ventricular afterload the 
differences exist. All statistical tests were completed using Minitab 16 (Minitab Inc, State 
College, PA). 
 
5.2 Specific Aim 2 Methods 
5.2.1 Annuloplasty Ring Stress Transducer 
5.2.1.1 Ring Stress Transducer Design 
A novel transducer was developed to measure in- and out-of-plane bending stresses 
endured by an annuloplasty ring from implantation and cyclic contraction of the mitral 
annulus. Similar to the shape of the native annulus, the ring’s core was designed to 
possess a kidney-shaped profile and was fabricated from 6-AL 4V titanium. This lower 
modulus alloy provided potential long-term biocompatibility and an excellent linear-
elastic element for strain gage measurements. The ring’s outer dimensions were based on 
 61 
mitral annular sizes measured in a healthy ovine model (Figure 5-10) [41], while the 
ring’s thickness was constrained to the dimensions of the miniature strain gages to be 
adhered to the ring’s surface (EA-031DE-350, Vishay Micro-Measurements, Malvern, 
PA) (Figure 5-11). These gages have a measurable range of ±3% strain and minimum 
measurable value of approximately 0.1 microstrain. 
 
 
Figure 5-11 Anatomical directions and relative dimensions of the annuloplasty ring 
stress transducer’s titanium core. 
 
 
5.2.1.2 Ring Stress Transducer Fabrication 
The materials required to fabricate the annuloplasty ring stress transducer can be 
reviewed in Table 4-2. Using the specified materials, the ring stress transducers were 
fabricated as follows: 
 
Step 1: Surface Preparation: The surface of the titanium ring was degreased using CSM-
2 Degreaser. Degreaser was wiped from the ring’s surface using gauze sponges until no 
discoloration of the sponges was observed. Following degreasing, the ring surface was 
wetted with M-Prep Conditioner A and subsequently sanded (400 grit). Following 
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sanding, the surface was washed with more M-Prep Conditioner A and then wiped dry 
with a gauze sponge. When dry, liberal amounts of M-Prep Neutralizer 5A was applied to 
the spring element. The surface of the spring element was scrubbed with a cotton-tipped 
applicator until no discoloration of the applicator was observed. At this point, physical 
handling of the spring element was minimized such that the neutralized surface was not 
contaminated with particulate or grease from fingers or objects (tweezers, hemostats, 
etc.).  
 
Step 2:  Strain Gage Preparation. 16 strain gages were prepared to construct 8 half-bridge 
circuits. Each half-bridge consisted of 2 strain gages and 1 lead wire terminal. For each 
half-bridge, 2 strain gages were removed via tweezers from their packaging and laid on a 
clean glass surface. Excess gage material was removed. One lead wire terminal was 
trimmed, cut in half, and laid on the cutting surface. With the strain gages and lead wire 
terminal arranged as pictured in Figure 5-12, PCT-2M Gage Installation tape was laid 
over each of the strain gages in preparation for strain gage positioning on the ring’s 
surface. 
 
Figure 5-12 Image of the strain gages and lead wire terminal ready for strain gage 
positioning. 
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Step 3: Strain Gage Positioning. A pen was used to mark the assigned position of each 
strain gage to be adhered to the titanium ring. These locations included the septal, lateral, 
and commissural ring segments on both the in-plane and out-of-plane surfaces of the ring. 
Single strain gages (without the lead wire terminal) were chosen to be placed on the 
ring’s outer and top surfaces. This was done to minimize the number of wires near the 
ring’s outer suture cuff. Once the positions were chosen, one edge of the tape covering 
the strain gage was peeled upwards removing the gage from the work surface. Next, the 
tape was placed on the designated area of the ring making sure to align the gage along the 
desired measurement axis. This was completed for each of the strain gage locations. 
 
Step 4: Strain Gage Adhesion. Once each gage was aligned in their designated position, 
the installation tape was peeled halfway from the spring element exposing the bottom 
side of the strain gage. The exposed backing of the strain gage (and/or lead wire terminal) 
was coated with a thin layer of M-Bond 43-B. The adhesive applicator was not allowed to 
touch the tape mastic. The adhesive on the gage backing was allowed to air-dry, by 
solvent evaporation, for 30 minutes at room temperature.  
Following the evaporation phase, the gage/terminal assembly was returned to its 
original position over the penned positioning mark (Step 4). A thick silicone gum pad and 
a metal backup plate (GT-14) was placed over the gage/terminal areas and clamped using 
spring clamps. The clamped gage/specimens were then placed into a cool oven whose 
temperature was raised to 375 ºF. Once reaching this ultimate temperature, the ring with 
bonded strain gages were allowed to cure for 2 hours. Upon completion of the curing 
cycle, the oven temperature was allowed to drop to 250 ºF before removing the ring.  
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Step 5:  Tin Strain Gage Solder Tabs and Lead Wire Terminals. PCT-2M Gage 
Installation tape was laid over each gage grid to protect from excess solder. After 




Figure 5-13 (A) Anatomical directions, (B) Image of the titanium annuloplasty ring 
core with bonded strain gages and lead wire terminals tinned, and (C) Planar 




Step 6:  Half Bridge Strain Gage Wire Connection. Three 336-FTE three stranded wires 
were cut into 6’ segments. At one end of the wire, approximately 1” of the braided wire 
was unwound for soldering to the strain gages. The wiring diagram and finished wired 







Figure 5-14 Left: Half-bridge configuration with strain gage, lead wire terminal, 
and wires shown (Note: Blue wire is actually white on the actual transducer); Right: 
Wired half-bridges. 
 
Step 7: Rosin Removal.  M-Line Rosin Solvent was used to remove excess rosin from 
the soldered areas of each strain gage. The solvent was lightly brushed across each gage 
then was wiped dry with a clean cotton applicator.  
 
Step 8: Strain Gage Surface Coating. Loctite® M-31CLTM Hysol® Medical Device 
Epoxy was applied in a thin coat (<0.5 mm) over each strain gage and solder nodes. The 
adhesive was allowed to cure for 24 hours (Figure 5-15). 
 
     
Figure 5-15 Left: Transducer’s strain gages and lead wire terminals are coated in 
Loctite® M-31CLTM Hysol® Medical Device Epoxy (Step 8); Right: Following 
harnessing the transducer’s wires (Step 12) , the entire transducer is dip-coated in 
synthetic rubber (Step 10). 
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Step 9: Wire Harnessing.  All of the strain gage wires were harnessed and then fed 
through 1.5 m segments of wire heat shrink at each of the rings trigonal segments. 
Following wire harnessing, the wire heat shrink was heated and shrunk to sheathed wires.   
 
Step 10:  Coating for Moisture Protection. The ring was coated with synthetic rubber 
(Figure 5-15) to provide a secondary moisture barrier and an anchoring material for the 
suture cuff (Plasti Dip, Performix, Blaine, MN). 
 
Step 11:  Suture Cuff Fabrication. To complete the suture cuff, cardiovascular polyester 
fabric (thickness 0.61±0.10 mm) (611 Double Velour Fabric, C.R. Bard, Murray Hill, NJ) 
was tightly sewn around the ring to allow for implantation similar to commercial 
annuloplasty rings (Figure 5-16). After fabrication, the ring exhibited a 6.9 cm
2
 outer 
area, 2.6 cm septal-lateral dimension, 3.3 cm transverse diameter, and thickness of 0.7 
cm. While the outer dimensions of the ring were comparable to a size 32 mm Carpentier-




5.2.1.3 Experimental Protocol 
One Dorsett Hybrid sheep (45 kg) was intubated, anesthetized, and ventilated with 
isofluorane (1.5% to 2%) and oxygen. Surface electrocardiogram and arterial blood 
pressure was monitored. After establishment of cardiopulmonary bypass, a left atriotomy 
was performed. Ten 2-0 Ethibond Exel Polyester sutures (Ethicon, Piscataway, NJ) were 
placed in the subjects mitral annulus and through the cuff of the instrumented 
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annuloplasty ring (Figure 5-16A). Prior to lowering and securing the ring into the mitral 
annulus, each of the ring’s strain gage bridges was zeroed. The annular sutures were 
secured to the ring in the following order: left fibrous trigone, right fibrous trigone, then 
each remaining suture proceeding clockwise from the left fibrous trigone (Figure 5-16B).  
After implantation, the strains imparted on the ring by the flaccid mitral annulus were 
recorded.   
Following atrial closure, degassing, and separation from cardiopulmonary bypass; 
continuous wave Doppler echocardiography was completed (Phillips ie33, Phillips, 
Amsterdam, Netherlands). A high-fidelity pressure transducer (SPR-3505; Millar 
Instruments, Houston, TX) was passed percutaneously into the LV through the femoral 
artery for continuous measurement of LV Pressure (LVP). Surface electrocardiogram 
(EKG), LVP, and arterial pressure (Hewlett-Packard 78534C monitor; Hewlett-Packard 
Inc, Santa Clara, CA) were monitored. Upon establishing baseline hemodynamics (90 
mmHg peak LVP, 4.0 L/min cardiac output), cyclic ring strains were measured within the 
post-cardioplegic heart. After successful measurement of all endpoints, the subject was 
euthanized with 1 g thiopental and 80 mEq KCl. The heart was removed and opened to 





Figure 5-16 (A) Ten 2-0 sutures are placed through the suture cuff of the 
annuloplasty ring transducer for implantation, (B) While on cardiopulmonary 
bypass the transducer is implanted to the mitral annulus, (C) Post-experimentation, 
the left atrium is removed and the transducer was inspected for firm anchoring to 
the mitral annulus.  
 
5.2.1.4 Data Acquisition 
Annuloplasty ring strains and LVP were continuously monitored using a compact Data 
Acquisition System (cDAQ 9174), strain gage bridge module (NI 9237), and analog 
voltage module (NI 9215) (National Instruments) at 1613 Hz.  Ring strains, LVP, and 
EKG were monitored and recorded in 1 minute intervals using a custom-built program 
within the LabVIEW software program (National Instruments).  
 
5.2.1.5 Data Analysis and Experimental Endpoints 
Recorded data were processed offline using a custom MATLAB program (See Appendix 
E) (Mathworks, Natick, MA). Within this program, measured strains were converted to 
stress using the elastic modulus of ring’s titanium core (114 GPa). From the processed 
data, 10 consecutive cardiac cycles reaching a peak LVP of 90 mmHg were isolated for 
further analysis. From this cyclic data set, ring stresses at each ring position were 
computed as the change from their minimum diastolic value to maximum systolic value. 
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All ring stresses and LVP were averaged over the 10 consecutive cardiac cycles and 
reported as a mean ± 1 standard deviation. 
 
5.2.2 Annuloplasty Ring Suture Force Transducer 
5.2.2.1 Suture Force Transducer Design 
Novel strain gage transducers were designed to isolate the tensile forces in individual 
sutures along an annuloplasty ring (Figure 5-13A). The spring element of each transducer 
was designed to consist of an annuloplasty ring mounting bracket and a suture force 
measurement arm (Figure 5-17A and 5-17B). The four holes in the mounting bracket 
allowed for each transducer to be directly sutured to the annuloplasty ring using 2-0 
Ti•Cron
TM
 (Covidien, Mansfield, MA). The spring element’s measurement arm was 
designed to replace the function of the ring’s suture cuff. During implantation, mattress 
sutures are passed through and tied to the top of the spring element’s measurement arm in 
the exact method used to secure sutures to a ring’s suture cuff (Figure 5-17C and 5-17D). 
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Figure 5-17 (A) Schematic of transducer with (a) mounting holes for ring mounting, 
(b) mattress suture passages, (c) strain gage for force measurement, and (d) exiting 
wires. (B) Completed transducer. (C) Schematic of implanted ring with suture 
induced transducer deformation and force measurement. (D) Device implantation. 
(E) Implanted transducer imaged using fluoroscopy. 
 
Combining finite element analysis (SolidWorks, Waltham, MA) with forces 
previously measured, the dimensions of spring element were optimized for suture force 
measurement (Figure 5-17A). This optimization was completed in a similar fashion to the 
steps taken in the annular force transducer. Based on these analyses, the spring element 
was manufactured from 316L stainless steel (Fineline Prototyping, Raleigh, NC). This 
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material was chosen for its excellent biocompatibility and structural strength, and also for 
its reliability as an excellent linear-elastic material for strain gage measurements. 
The ability of the developed transducers to measure suture forces is made possible 
by the adhered strain gages. As demonstrated in Figure 5-17C, forces applied to a suture 
result in the bending and deformation of the transducer’s measurement arm. Since the 
strain gages are adhered to the transducer, the strain gages deform with the measurement 
arm. Strain gage deformations result in changes in the gage’s electrical output. Through 
calibration, changes in electrical output are correlated to known forces providing the 
ability to convert measured electrical outputs to force measurements.  
 
5.2.2.2 Suture Force Transducer Fabrication 
Using the materials outlined in Table 4-3, the annuloplasty ring suture force transducers 
were fabricated as follows: 
 
Step 1: Surface Preparation: The surface of the spring element was wetted with M-Prep 
Conditioner A and subsequently sanded (400 grit). Following sanding, the surface was 
washed with more M-Prep Conditioner A and then wiped dry with a gauze sponge. When 
dry, liberal amounts of M-Prep Neutralizer 5A was applied to the spring element. The 
surface of the spring element was scrubbed with a cotton-tipped applicator until no 
discoloration of the applicator was observed. At this point, physical handling of the 
spring element was minimized such that the neutralized surface was not contaminated 
with particulate or grease from fingers or objects (tweezers, hemostats, etc.).  
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Step 2:  Strain Gage Preparation. Strain gages were removed via tweezers from their 
packaging and laid on a clean glass surface. Excess gage material was removed. 
 
Step 3: Strain Gage Alignment. With the grid and solder nodes facing upward on the 
glass surface, PCT-2M Gage Installation tape was laid over each gage. One edge of the 
tape was peeled upwards removing the gage from the work surface. Next, the tape was 
placed on the designated area of the spring element (Left of Figure 5-18) making sure to 
align the gage along the desired measurement axis.  
 
     
Figure 5-18 Left: Strain gage alignment (Strain gage is not adhered to the surface of 
the transducer spring element); Right: Strain gage is adhered to the spring element. 
 
Step 4: Strain Gage Adhesion. Once a gage has been aligned in its designated position, 
the installation tape was peeled halfway from the spring element exposing the bottom 
side of the strain gage. A thin coat of M-Bond 200 Catalyst was applied to the bottom of 
the gage. Immediately following application, one drop (approximately 0.1 mL) of M-
Bond 200 was applied to the area beneath the gage. Using a finger or soft tool, the tape 
and corresponding strain gage was pressed to the geometry’s surface applying firm 
pressure to the gage area. Pressure was maintained over the gage area for 5 minutes. 
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After this period, the installation tape was peeled from the spring element leaving the 
strain gage adhered to the geometry’s surface (Right of Figure 5-18). 
 
Step 5:  Tin Strain Gage Solder Tabs. PCT-2M Gage Installation tape was laid over each 
gage grid to protect from excess solder. After covering, each connection tab of the strain 
gage was tinned as pictured in the left of Figure 5-19. 
 
       
Figure 5-19 Left: Tinned solder nodes on a strain gage; Center: Wired strain gage; 
Right: Strain gage surface coating with epoxy. 
 
Step 6:  Half Bridge Strain Gage Wire Connection. Three 336-FTE three stranded wires 
were cut into 6’ segments. At one end of the wire, approximately 1” of the braided wire 
was unwound for soldering to the strain gages (Center of Figure 5-19). 
 
Step 7: Rosin Removal.  M-Line Rosin Solvent was used to remove excess rosin from 
the soldered areas of each strain gage. The solvent was lightly brushed across each gage 
then was wiped dry with a clean cotton applicator.  
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Step 8: Strain Gage Surface Coating. Loctite® M-31CLTM Hysol® Medical Device 
Epoxy was applied in a thin coat (<0.5 mm) over each strain gage and solder nodes. The 
adhesive was allowed to cure for 24 hours (Right of Figure 5-19). 
 
Step 9:  Coating for Moisture Protection. One layer (<0.5 mm) of nitrile rubber is applied 
over each strain gage, solder nodes, and proximal wire. After 45 minutes of curing, the 
gage areas are checked for visible gaps. Any gaps found are re-layered and allowed 
additional 45 minutes to cure (Figure 5-21).  
                                     
5.2.2.3 Suture Force Transducer Calibration  
Based on previous studies, all transducers were calibrated from 0-10 N for 5 independent 
trials [75,76]. To calibrate the transducers, a loose loop of suture was passed through the 
transducer’s measurement arm and through a table with two holes positioned to match the 
device’s mattress suture passages. The loop was knotted tightly by six square knots to 
prevent any slippage during trials. Weights ranging from 0.2-10 N (were suspended from 
the transducer’s suture loop beneath the table in a sequential fashion. Weights included 
20 g, 50 g, 100 g, 200 g, 500 g, and 1 kg. Correlations between applied forces and 
measured output voltages resulted in coefficients of determination exceeding 0.99.  
 
5.2.2.4 Assessing Transducer Accuracy and Precision 
Following calibration of the initial fabricated transducers, the derived calibration 
constants were used to assess transducer accuracy and precision. Transducers were 
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repositioned in the calibration apparatus and were loaded from 0 to 10 N for 3 
independent trials. Following these trials, the measured and true force was compared.  
 
5.2.2.5 Instrumenting the Annuloplasty Ring with the Suture Transducers 
Once calibrated, ten suture force transducers were attached to size 24, 26, 28, and 30 
Physio
TM
 rings (Edwards Lifesciences, Irvine, CA). Transducers were sutured to the ring 
as depicted in Figure 5-20. Using the pictured method, transducers were placed at each 
trigonal location and at near symmetric locations around the ring (Figure 5-21). In this 
configuration, 4 transducers were placed on the anterior portion of the ring with the 
remaining 6 on the posterior circumference. Since the transducers sit external to the 
ring’s suture cuff, the outer dimensions of the annuloplasty ring were increased by one 
Physio
TM




Figure 5-20 Method used to secure a suture transducer to the annuloplasty ring. 
 
Figure 5-21 Photograph of a size 24 Physio
TM
 ring instrumented with 10 suture 
force transducers. 
 
5.2.2.6 Experimental Protocol 
Healthy Dorsett hybrid sheep were intubated, anesthetized, and ventilated with 
isofluorane (1.5% to 2%) and oxygen. Surface electrocardiogram and arterial blood 
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pressure was monitored. After establishment of cardiopulmonary bypass, a left atriotomy 
was performed.  Ten 21 mm 2-0 Ti∙Cron
TM
 sutures (Covidien, Mansfield, MA) were 
placed in the mitral annulus and through the mounting holes of the transducers’ 
measurement arms (Figure 5-17C).  Prior to lowering and securing the ring into the mitral 
annulus, each of the transducers was zeroed to establish a zero force baseline. The 
annular mattress sutures were then secured to the ring in the following order: left fibrous 
trigone, right fibrous trigone, then each remaining suture proceeding clockwise from the 
left fibrous trigone. Each suture was secured with 5 surgeon’s knots. After securing the 
final suture, the suture forces resulting from implanting the ring to the flaccid mitral 
annulus were recorded. 
Following left atrial closure and separation from cardiopulmonary bypass; a high-
fidelity pressure transducer (SPR-3505; Millar Instruments, Houston, TX) was passed 
through the femoral artery to the LV for continuous measurement of LVP. Surface 
electrocardiogram , LVP, and arterial pressure (Hewlett-Packard 78534C monitor; 
Hewlett-Packard Inc, Santa Clara, CA) were monitored. Upon establishing baseline 
hemodynamics (100 mmHg peak LVP, 4.0 L/min cardiac output), cyclic suture forces 
were measured within the post-cardioplegic heart. Continuous wave Doppler 
echocardiography was used to quantify the mean diastolic transmitral gradient. To 
evaluate the effects of increasing afterload, suture forces were recorded continuously for 
cardiac cycles exhibiting a peak LVP of 125 and 150 mmHg.  Elevated LVP was 
achieved via intravenous injection of epinephrine. After successful force measurement, 
animals were euthanized with 1 g thiopental and 80 mEq KCl. The heart was explanted 
and opened to verify secure anchoring of the device to the annulus. 
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5.2.2.7 Data Acquisition  
Suture forces and LVP were continuously acquired using a compact Data Acquisition 
System (cDAQ 9174), strain gage bridge modules (NI 9237), and analog voltage module 
(NI 9215) (National Instruments) at 1613 Hz.  Suture forces and LVP were monitored 
and recorded using a custom LabVIEW program (National Instruments).  
 
5.2.2.8 Data Processing and Experimental Endpoints 
Recorded data were processed offline using a custom MATLAB program (See Appendix 
E) (Mathworks, Natick, MA). Cyclic force data corresponding to ten consecutive cardiac 
cycles reaching a peak LVP of 100, 125, and 150 mmHg were isolated for analyses. From 
these cyclic data sets, cyclic suture forces were computed as the change from their 
minimum diastolic value to maximum systolic value. The computed cyclic forces were 
averaged over the 10 consecutive cardiac cycles and are presented in Appendix B.  This 
analysis was repeated for each animal and peak level of LVP.  All results are reported as 
a mean ± 1 standard deviation. Due to the limited sample size, no statistical analyses 








5.3 Specific Aim 3 Methods 
5.3.1 Assessing the Accuracy of the Georgia Tech Left Heart Simulator 
5.3.1.1 Experimental Protocol  
Control (N=6) and chronic IMR ovine subjects (N=6) were intubated, anesthetized and 
ventilated with isofluorane and oxygen. Surface electrocardiogram and arterial blood 
pressure were monitored. A right thoracotomy was performed. Upon the heart’s 
exposure, epicardial Doppler echocardiography images were obtained to evaluate MR 
(Phillips IE33 Matrix, Phillips, Amsterdam, Netherlands).  MR was graded on a 0 to 4+ 
scale, where 0 represented no MR and 4+ represented severe MR with reversal of 
pulmonary vein flow.  
Using published techniques, 2 mm hemispherical piezoelectric transducers 
(Sonometrics, London, Ontario) were localized to the mitral annulus (N=12), A2 anterior 
mitral leaflet (N=5), and papillary muscles (N=2) and connected to a Series 5001 Digital 
Sonomicrometer (Sonometrics, London,Ontario) (Figure 5-22 and Figure 4-3).  After 
weaning each subject from cardiopulmonary bypass, a high-fidelity pressure transducer 
(±1mmHg) (SPR-3505; Millar Instruments, Houston, TX) was passed percutaneously 
into the LV through the femoral artery for continuous measurement of left ventricular 
pressure. Surface electrocardiogram, LVP, and arterial pressure (Hewlett-Packard 
78534C monitor; Hewlett-Packard Inc, Santa Clara, CA) were monitored.  
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Figure 5-22 Left: Geometric map of sonomicrometry crystals localized to the A2 
anterior leaflet and mitral annulus; AC: Anterior Commissure, PC: Posterior 
Commissure; Right: in-vivo image of crystals localized to the mitral annulus and 
anterior leaflet with directions of strain shown (See Figure 4-3 for crystals localized 
to the papillary muscles). 
 
Upon establishing baseline ovine hemodynamics (100 mmHg peak LVP; 3.3 
L/min cardiac output), the three-dimensional coordinates (resolution of ±0.01 mm) of 
each sonometric transducer were recorded at 200 Hz with simultaneous measurements of 
LVP. Following experimental completion, animals were euthanized with 1 g thiopental 
and 80 mEq KCl. Hearts were explanted and the LV opened through the interventricular 
septum to quantify the infarct size as a percentage of the LV. 
 
5.3.1.2 Mapping the Ovine Mitral Valve Geometry  
Acquired data sets of the annular, leaflet, and papillary muscle positions as functions of 
time and LVP were used to map the ovine MV geometry and quantify leaflet strain in 
both healthy and chronic IMR animals. Peak systolic closure was assigned as the time 
point of peak LVP. At this time point, the annular and PM coordinates were used to 
determine the relative position of the PMs with respect to the annulus, annular area, 
annular orifice shape, annular-height-to-commissural-width ratio. These actions were 
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completed for both the healthy and chronic IMR animals to calculate relative changes in 
MV geometry for in vitro simulation.  
 
5.3.1.3 In vitro Experimental Protocol 
Fresh ovine hearts were obtained and MVs excised (N=6) preserving their annular and 
subvalvular anatomy. MVs with an anterior leaflet height of 18-19 mm (as measured in 
our ovine animals (Table 6-8)), type 1 or 2 PMs [1], and with all leaflet chordae inserting 
directly into each PM were selected for experimentation. Selected MVs were sutured to 
the Georgia Tech Left Heart Simulator’s annulus using a Ford interlocking stitch.  For 
control conditions, the annulus was set to an area of 6.5 cm
2
 and annular height to 
commissural width ratio of 15% as measured in vivo (Table 6-8). During valve suturing, 
care was taken to place each suture just above the valve’s natural hinge and not through 
the leaflet tissue. Additionally, normal annular-leaflet geometric relationships were 
respected - the anterior leaflet occupied 1/3rd of annular circumference and commissures 
were aligned in the 2 and 10 o’clock positions.  
Following suturing the MV to the prosthetic mitral annulus, a tissue dye (Thermo 
Scientific,Waltham, MA) was used to mark the anterior leaflet in a square grid. In this 
method, the mitral leaflets area allowed to hang from the annulus and dry for at least 40 
minutes. During this period, the leaflets can be blotted with paper towel to assist in 
removing leaflet moisture. When dry, the atrial surface of the anterior leaflet’s A2 cusp is 
marked with a 1.5 mm x 1.5 mm square array (9 dots in the array) using a blunted tip of a 
17 mm needle. Using the aforementioned needle size, each of the dye markers were 
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approximately 0.5-1 mm in diameter. While the leaflet markers are drying (~30 minutes), 
the PMs and chordae are submerged in saline solution to maintain moisture.  
After the dye grid on the anterior leaflet was completed, each PM was attached to 
the PM control rods. Each PM was carefully positioned and fine-tuned to establish the 
control MV geometry as previously described [104]. Transmitral ovine pulsatile 
conditions were simulated (3.3 L/min Cardiac Output, 120 beats/min, 100 mmHg 
transmitral pressure). Mitral coaptation was then inspected via echocardiography such 
that the anterior leaflet spanned approximately 2/3rds of the A2-P2 diameter and the 
coaptation length was approximately 4-5 mm as measured in our healthy animals (Table 
6-8). If the control valve geometry conditions were successfully achieved, transmitral 
hemodynamics, 3D echocardiography (Philips ie-33), and dual camera high-speed images 
of the valve were acquired. 
To simulate a chronic IMR MV geometry, the valve annulus was flattened and 
asymmetrically dilated per the mean valvular distortions measured in our chronic IMR 
animals (Table 6-8). The PMs were adjusted per the mean displacements observed 
between the healthy and chronic IMR animals. Based on this data, the posteromedial PM 
was displaced 4 mm laterally, 6 mm posteriorly, and 2 mm basally. The anterolateral PM 
was displaced 2 mm laterally, 1 mm anteriorly, and 1.5 mm apically. These 
displacements were consistent with previously published data [55]. After the 
displacement of each PM, transvalvular hemodynamics was established and experimental 




5.3.1.4 Quantifying Anterior Leaflet Strain In vivo and In Vitro 
Sonomicrometry and tissue dye coordinates acquired in both the animal and bench 
experiments were used to compute the anterior leaflet strain. Using a custom MATLAB 
program (See Appendix E) (Mathworks, Natick, MA), biquintic finite element 
interpolation was used to fit a surface to the 3D anterior leaflet marker coordinates 
(Section 4.3.6) (Location of Program is in Appendix E). Generated surfaces were used to 
determine the mean radial and circumferential strains and strain rates endured by the 
anterior leaflet (Figure 5-23). Similar to previous studies, the referential leaflet strain 
configuration corresponded with the minimum LVP. 
 
 
Figure 5-23 (A) Schematic representation of the surgeon’s view of the mitral valve 
with the A2-P2 echocardiography measurements of leaflet coaptation identified; (B) 
Direct linear transformation was used to calculate the radial and circumferential 
anterior leaflet strain using two high-speed cameras tracking nine fiduciary leaflet 
markers.    
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5.3.1.5 Data Processing 
All in vitro hemodynamic data were processed offline within a custom MATLAB 
program (See Appendix E) and averaged over 10 consecutive cardiac cycles. In vitro 
regurgitation fractions were calculated as the total retrograde volume divided by the 
stroke volume. Echocardiography data were analyzed using Phillips QLab (v.7.0; Philips 
Healthcare; Andover, MA). Anterior leaflet strain was computed as outlined in Section 
5.3.1.5. 
 
5.3.1.6 Statistical Analysis and Experimental Endpoints 
To compare between animal groups and simulated conditions, a non-parametric Mann-
Whitney U test was used. In vitro comparisons made between the control and chronic 
IMR conditions were completed with a Wilcoxon Signed Rank test. All statistical 
analyses were completed using SPSS 20 (IBM, Armonk, NY). End points are expressed 
as a mean ±1 standard deviation. 
 
5.3.2 Evaluating the Effect of Undersized Annuloplasty on Subvalvular Tethering  
5.3.2.1 Chordae Tendineae Selection and Instrumentation  
Prior to each experiment, chordal force transducers were sutured directly to selected 
chordae tendineae to quantify cyclic tethering forces. Selected chordae included the 
anterior strut and posterior intermediary chords originating from both the anterolateral 
and posteromedial papillary muscles. In short, transducers were sutured directly to 
selected chordae using 17 mm RB-1 needle with 5-0 silk (Ethicon, Somerville, NJ) 
(Figure 5-24). Suture is passed directly above the transducer through the center of the 
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chord, then through the suture passage, then directly below the transducer through the 
chord as to not alter the native chordal length during suture knotting. Four surgeon’s 
knots are tied within the slot of the transducer against the native chord in succession. 
Once a transducer is secured to the chord, the section of chordae located between the 
transducer’s measurement arms is transected such that all tensile loading of the chord is 
transferred to the transducer. 
 
 
Figure 5-24 Schematic representation of securing a chordal force transducer to a 
selected chordae tendineae. 
 
5.3.2.2 Simulating Undersized Mitral Annuloplasty 
Fifteen ovine MVs with an anterior leaflet height of 20-25 mm were utilized in this study. 
Anterior leaflet height has been demonstrated to correlate with commissural width and 
thus healthy annular area in more than 90% of cases [1]. If the selected MV was found to 
possess any mitral chordae that inserted directly in the LV wall, the valve was discarded 
and another MV was selected for experimentation. No additional screening criterion was 
used in mitral valve selection. 
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 After suturing the excised MV to the simulator’s mitral annulus, 4 chordae 
tendineae were instrumented with dedicated chordal force transducers as described in 
section 5.3.2.1. Following instrumentation, the MV was mounted into the simulator and 
the annulus was conformed to a size 30 Physio
TM
 ring.  Upon establishing human left 
heart hemodynamics (5.0 L/min cardiac output, 70 beats/min, 120 mmHg transmitral 
pressure), each papillary muscle was carefully positioned and fine-tuned to establish the 
control MV geometry. Mitral coaptation was inspected via echocardiography such that 
the anterior leaflet spanned approximately two-thirds of the A2-P2 diameter. When the 
control valve geometry conditions were successfully achieved, the experimental 
endpoints of transmitral flow, left atrial pressure, left ventricular pressure, 2D 
echocardiography (Philips ie-33 Matrix, Philips Healthcare, Andover, MA), and chordal 
forces were acquired. 
To simulate chronic IMR due to an inferior myocardial infarction, the valve 
annulus was asymmetrically dilated to approximately 150% of the control valve area. The 
anterolateral papillary muscle was displaced 3 mm apically and 2 mm anteriorly, whereas 
the posteromedial papillary muscle was displaced 4 mm apically, 4 mm posteriorly, and 8 
mm laterally.  These changes were consistent with the geometric distortions measured 
and simulated in Specific Aim 3A. Papillary muscles were held in their displaced IMR 
positions for all levels of simulated annuloplasty (Figure 5-25). This was done to reflect 
the results of a previous porcine IMR study that demonstrated undersized Physio
TM
 ring 
annuloplasty to not induce an overall pattern of PM relocation [121]. 
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Figure 5-25 Summary of experimental conditions progressing from control to 
ischemic mitral regurgitation (IMR), oversized mitral annuloplasty, true-sized 
mitral annuloplasty, and undersized mitral annuloplasty (UMA). (Please note 
images are not drawn to scale). 
 
Upon establishing these conditions, all endpoints were acquired. Following the 
simulation of IMR, the annulus was sequentially conformed to the shape of 3 mitral 
annuloplasty ring sizes. These conditions included an oversized condition (size 34 
Physio
TM
 Ring), a true-sized condition (size 30 Physio
TM
 Ring), and an undersized mitral 
annuloplasty condition (size 26 Physio
TM
 Ring). These experimental conditions are 
sequentially shown in Figure 5-25. At each condition, all experimental endpoints were 
recorded.   
 
5.3.2.3. Data Processing 
All data were processed offline within a custom MATLAB program (See Appendix E) 
and averaged over 10 consecutive cardiac cycles. All data are expressed as a mean ± 
standard error. Mitral regurgitation volume was measured directly by an electromagnetic 
flow probe located upstream of the atrium and was calculated as the total retrograde 
volume occurring during MV closure. Echocardiography data were analyzed using 
Philips QLab (v.7.0; Philips Healthcare; Andover, MA).  
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5.3.2.4. Statistical Analysis and Experimental Endpoints 
Measured endpoints were checked for normality using the Anderson-Darling test. A 
general linear model using each valve as a random factor was used to investigate the 
effect of the valve and experimental condition on each of the measured endpoints. To 
decrease the probability of type I errors, a Bonferroni post hoc test was used to determine 
if significant differences in each metric existed between experimental conditions. All 




































6.1 Introduction to the Results 
The results of this work are organized and presented by Specific Aim. For Specific Aim 1 
(Section 6.2), the results of assessing transducer accuracy and performance are presented 
first (Sections 6.2.1-6.2.4) and followed by ovine animal characteristics, left heart 
hemodynamics, and mitral annular forces (Sections 6.2.5- 6.2.10). For Specific Aim 2 
(Section 6.3), a pilot study quantifying the stresses imparted on a prosthetic annuloplasty 
ring in a healthy ovine animal are described (Section 6.3.1) followed by the results of 
quantifying suture forces in healthy ovine animals (Section 6.3.2). Finally for Specific 
Aim 3 (Section 6.4), the results of Part A for mimicking healthy and chronic IMR ovine 
MV geometry and function within the Georgia Tech Left Heart Simulator is presented 
(Section 6.4.1). This analysis is followed by the results of Specific Aim 3 Part B in which 
the effect of IMR and undersized annuloplasty on leaflet coaptation, MR, and chordal 
forces is assessed (Section 6.4.2) 
6.2 Specific Aim 1 Results 
The baseline characteristics, hemodynamics, and tabulated forces for each of the studied 
animals in Specific Aim 1 are presented in Appendix A. A catalog of the locations of the 
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echocardiography data sets on the laboratory’s electronic server can be found in 
Appendix E.  
 
6.2.1 Accuracy and Precision of the Calibration Apparatus 
A digital force gauge (Chatillon, Largo, FL) was used to verify the incremental loading of 
the annular force transducer calibration apparatus (Figure 6-1). To test the septal-lateral 
loading mechanism, the driving screw was turned seven full rotations in half rotation 
increments to achieve a peak loading of 8.4 N. This loading was repeated for 10 
independent trials. The transverse loading mechanism was not tested given both the 
septal-lateral and transverse measurement arms of each transducer were calibrated using 
the septal-lateral loading mechanism. The mean septal-lateral force and 95% confidence 
interval for each measured load is pictured in Figure 6-1. For each rotation of the 
calibration apparatus’s bolt, force increased by approximately 1.2 N. For all bolt 





















































7 8.46 8.43-8.49  
Figure 6-1 Left: Mean force of 10 independent trials with a 95% confidence interval 
half-rotation bolt increments; Right:  Table displaying the values and intervals at 
each bolt rotation. 
 
6.2.2 Transducer Calibration, Accuracy, and Precision 
Each transducer was calibrated to determine the relationship between applied forces and 
output voltage. For all transducers, a linear relationship between voltage and calibrated 
force was observed in both the septal-lateral and transverse directions with correlation 
coefficients exceeding r
2
=0.98. To assess the accuracy and precision of each calibration, 
each of the devices was placed back into the calibration apparatus and forces applied in 
six independent trials. A representative plot of this assessment is plotted and tabulated in 
Figure 6-2. In cases where the transducer exhibited mean errors (calculated across all 





















































0 0.00 n/a n/a
1.2 1.16 1.15-1.17 3.2%
2.4 2.36 2.31-2.41 1.7%
3.6 3.60 4.51-3.68 0.1%
4.8 4.78 4.68-4.87 0.5%
6 5.97 5.85-6.09 0.4%
7.2 7.17 7.02-7.32 0.4%
8.4 8.37 8.19-8.54 0.4%
 
Figure 6-2 Comparison of measured to true forces for the septal-lateral direction of 
a representative calibrated transducer. 
 
6.2.3 Effect of Loading on Transducer Measurement Arm Cross-Talk  
During the design of the transducer, care was taken to isolate measurement directions 
resulting in the transducer’s cross-shaped geometry. Strain gages were adhered to the 
transducer’s spring element at locations more distant than close to the cross-arm 
intersection to minimize moment arm effects. Testing of these devices found peak 
loading (8.4 N) along one measurement arm to minimally influence the perpendicular 
arm resulting in measured forces less than 0.1 N.  
 
6.2.4 Effect of Transmitral Flow on the Force Transducer Measurements 
The transducer was implanted to the prosthetic annulus of the Georgia Tech Left Heart 
Simulator and studied under steady flow conditions to determine if transmitral flow 
creates any effect on force measurements. At transmitral flow rates similar to that 
estimated in the ovine subjects (10-20 L/min), the transducer measured negligible forces 
that were not discernible from the baseline noise levels. A representative image from 
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these in vitro experiments and its comparison to in vivo transmitral flow is pictures in 
Figure 6-3. 
 
    
Figure 6-3 (A) 3D Doppler echocardiographic image of the transducer mounted 
within the Georgia Tech Left Heart Simulator’s static mitral annulus; (B) 2D 
Doppler echocardiographic image of the transducer (FT) within the sheep subject, 
the left ventricle (LV), left atrium (LA), and mitral valve (MV) are labeled; (C) 
Transducer within the simulator displaying similar flow patterns and magnitudes to 
that experienced in-vivo. 
 
6.2.5 Animal and Left Heart Hemodynamic Characteristics 
Baseline characteristics of the control (N=6) and chronic IMR (N=6) animals are 
presented in Table 6-1.
 
For the chronic IMR animals, the mean MR grade measured 6-8 
weeks after myocardial infarction was 2.3 ± 0.5. Resulting MR grades were comparable 
with those achieved in previous studies utilizing an identical chronic IMR model [41]. 
When simulating worst-case hemodynamic loading conditions (LVP ranging from 150 to 
200 mmHg), LVP was carefully controlled within each animal. No statistical differences 
were observed between animal groups for measured levels of elevated LVP and heart rate 
(Table 6-2). During each study, real-time 3D echocardiography images were acquired to 
assess transducer anchoring throughout the experiment (See Appendix D for the locations 
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of the image files on the laboratory’s secure server). In all experiments, the transducer 
remained firmly secured to the mitral annulus.  
 




Chronic IMR Animals 
(N=6)
Weight [kg] 40.1 ± 7.4 39.7 ± 2.6
Heart Rate [bpm] 95 ± 15 96 ± 9
LVP [mmHg] 90 ± 2 92 ± 2
d(LVP)/dt [mmHg/s] 2105 ± 712 1253 ± 307
Graded MR 0 2.3 ± 0.5
Percent of infarcted endocardium [%] 0 19.0 ± 1.7
 
Table 6-2 Characteristics of the ovine subjects at elevated levels of left ventricular 
pressure. 
90 125 150 175 200
Control 90 ± 2 128 ± 3 151 ± 3 173 ± 3 201 ± 4
Chronic IMR 92 ± 2 124 ± 2 152 ± 2 177 ± 2 198 ± 4
Control 95 ± 15 116 ± 33 127 ± 32 140 ± 38 142 ± 35
Chronic IMR 96 ± 9 111 ± 11 117 ± 16 130 ± 22 143 ± 18
Heart Rate 
[beats/min]
Peak Left Ventricular 
Pressure [mmHg]
Target Peak Left Ventricular Pressure [mmHg]
 
6.2.6 Cyclic Annular Force Characteristics 
Among control and chronic IMR animals, forces in the septal-lateral and transverse 
directions were observed to compressively increase from ventricular diastole to mid-
systole. Representative unfiltered forces from both a control and chronic IMR animal are 
plotted with time and LVP in Figure 6-4. In both animals, slight elevations in force are 
seen during atrial systole followed by sharp rises during isovolumetric contraction. 
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During this period, septal-lateral and transverse forces were found to increase with LVP 
(p<0.001) and peak at approximately mid-systole. Implantation of the device was found 
to modestly affect mitral inflow velocities (Figure 6-5). 
 
 
Figure 6-4 Representative unfiltered forces from both a control (top) and chronic 




Figure 6-5 (A) Doppler echocardiographic image of mitral inflow from the Left 
Atrium (LA) to the Left Ventricle (LV)  in absence of the annular Force Transducer 
(FT); (B) Implanted transducer increases mitral inflow velocity. 
 
 
6.2.7 Change in Annular Forces with Increasing Afterload: Healthy Animals 
The peak change in septal-lateral force throughout the cardiac cycle was found to 
significantly increase at each peak level of LVP (p<.001). Septal-lateral force was 
observed to significantly increase at the p<.001 level from the baseline condition 3.9 ± 
0.8 N to 5.2 ± 1.0 N (125 mmHg), 5.9 ± 0.9 N (150 mmHg), 6.4 ± 1.2 N (175 mmHg), 
and 6.7 ± 1.5 N (200 mmHg) respectively. These results are plotted in Figure 6-6. Among 
all subjects and tested conditions, the peak change in septal-lateral force throughout the 




Figure 6-6 The mean change in septal-lateral force throughout the cardiac cycle 
increased significantly from baseline to each level of peak left ventricular pressure. 
 
For the transverse direction, a statistically significant difference in force was 
found between peak levels of LVP (p<.005). The change in transverse force throughout 
the cardiac cycle was seen to increase from the baseline condition 2.6 ± 0.6 N to 3.8 ± 1.0 
N (125 mmHg) p<.01, 4.6 ± 1.3 N (150 mmHg) p<.001, 4.3 ± 1.2 N (175 mmHg) 
p<.001, and 3.5 ± 0.7 N (200 mmHg) p<.05 (Figure 6-7). Although statistically not 
significant, the mean transverse force was observed to decrease from 150 to 200 mmHg. 
Since the mean septal-lateral force is much larger at 175 and 200 mmHg (Figure 6-8), 
shortening of the transverse diameter may be hindered and thus may translate to a lower 
transverse force. Among all animals, the largest observed change in transverse force 
throughout the cardiac cycle was 6.3 N at 150 mmHg.  
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Figure 6-7 The mean change in transverse force throughout the cardiac cycle 
increased significantly from baseline to each level of peak left ventricular pressure 
 
Measurements from each direction were subsequently compared to determine if 
forces in the septal-lateral direction were greater than those in the transverse. Results 
revealed the septal-lateral force to be significantly greater than the transverse force at a 
peak LVP of 90 mmHg (p<.05), 125 mmHg (p<.05), 175 mmHg (p<.001), and 200 
mmHg (p<.0005) (See Figure 6-8). Due to larger variances in the transverse force, no 





Figure 6-8 Comparison of each directional force at increasing levels of peak left 
ventricular pressure. 
 
6.2.8 Change in Annular Forces with Increasing Afterload: Ischemic Mitral 
Regurgitation Animals 
Septal-lateral force within the chronic IMR animals was found to statistically differ 
between increasing levels of afterload (p<0.001). These forces were observed to increase 
from the baseline 2.5 ± 0.6 N to 3.5 ± 0.7 N (150 mmHg) p<0.001, 3.7 ± 0.6 N (175 
mmHg) p<0.001, and 3.7 ± 0.8 N (200 mmHg) p<0.001. No significant differences were 
found between the baseline and 2.9 ± 0.6 N at 125 mmHg peak LVP. The largest septal-
lateral force measured among all chronic IMR animals was 4.5 N at 200 mmHg peak 
LVP. 
The changes in transverse forces throughout the cardiac cycle were also found to 
statistically differ with afterload (p<0.05). Transverse forces were observed to increase 
from the baseline 2.2 ± 0.9 N to 2.9 ± 0.9 N (150 mmHg) p<0.05 and 2.9 ± 1.2 N (175 
mmHg) p<0.05. Transverse forces measured at 125 mmHg (2.7 ± 0.8 N) and 200 mmHg 
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(2.7 ± 1.2 N) were found to be statistically not different from the baseline measurement. 
The largest transverse force measured within the chronic IMR animals was 4.6 N at 175 
mmHg peak LVP.  To determine if directional differences exist, septal-lateral and 
transverse forces were compared at each level of peak LVP. No statistical differences 
were observed between these directions within the studied chronic IMR animals. 
 
6.2.9 Change in Annular Forces with Increasing Afterload: Healthy versus Ischemic 
Mitral Regurgitation Animals 
To determine if an inferior LV infarction results in a decrease in mitral annular forces, 
chronic IMR forces were compared to those measured previously in a healthy ovine 
model. Among all animals, the mean change in septal-lateral force was found to 
statistically differ between increasing levels of afterload (p<0.001) and animal groups 
(p<0.001). Septal-lateral forces in the control animals were found to be significantly 
larger than those in the chronic IMR group at 90 mmHg (p<0.01), 125 mmHg (p<0.005), 
150 mmHg (p<0.005), 175 mmHg (p<0.005), and 200 mmHg (p<0.005). These results 
are plotted in Figure 6-9.  Among all animals, the mean change in transverse force was 
found to statistically differ with increasing levels of afterload (p<0.001) but not between 
animal groups. Although not significant, the mean transverse forces within the chronic 
IMR group were observed to be consistently lower in magnitude than those measured in 




Figure 6.9 Top: The measured change in septal-lateral force throughout the cardiac 
cycle was observed to to be significantly greater within the control animals at each 
level of peak left ventricular pressure; Bottom: No significant differences in the 
change in transverse force throughout the cardiac cycle was observed between the 
animal groups and left ventricular pressure levels. 
 
6.2.10 Rate of Change of Force during Isovolumetric Contraction: Healthy versus 
Ischemic Mitral Regurgitation Animals  
The peak rate of increase for force (dF/dt) during isovolumetric contraction was 
quantified for both the control and chronic IMR animals at elevated levels of LVP. 
Among all animals, septal-lateral dF/dt was found to significantly differ between 
increasing levels of peak LVP (p<0.005) and animal groups (p<0.05). Within the control 
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group, septal-lateral dF/dt was found to significantly increase from the baseline condition 
to 150 mmHg (p<0.01), 175 mmHg (p<0.005), and 200 mmHg (p<0.001) (Table 6-3). No 
significant differences were observed between the baseline and 125 mmHg. Within the 
chronic IMR group, the peak septal-lateral dF/dt was found to significantly increase from 
the baseline to 150 mmHg (p<0.005), 175 mmHg (p<0.001), and 200 mmHg (p<0.001). 
Similar to the control group, no significant differences were found between the baseline 
condition and 125 mmHg peak LVP. After adjusting for multiple comparisons 
(Bonferroni), no significant differences in septal-lateral dF/dt were found between the 
control and chronic IMR animal groups at each level of LVP.  
 
Table 6-3 Peak rate of change for septal-lateral and transverse forces during 
isovolumetric contraction  for the control and chronic IMR animals, signficance is 
reported to the baseline values at 90 mmHg peak LVP within each group and 
direction: * p<0.01, † p<0.005, and ‡ p<.001. 
 
90 125 150 175 200
Control 77 ± 31 126 ± 48 150 ± 72 * 169 ± 89 † 180 ± 95  ‡ 
Chronic IMR 39 ± 12 42 ± 6 64 ± 9 † 66 ± 7 ‡ 74 ± 12 ‡
Control 36 ± 16 70 ± 32 88 ± 42 † 85 ± 43 * 72 ± 48 
Chronic IMR 30 ± 18 40 ± 19 60 ± 17 † 68 ± 35 ‡ 62 ± 26 † 
Transverse dF/dt 
[N/s]





In the transverse direction, the peak dF/dt was found to significantly increase with 
afterload within all subjects (p<0.001), but did not significantly differ between groups 
(Table 6-3). In the control group, transverse dF/dt was found to significantly increase 
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from the baseline to 150 (p<0.005) and 175 mmHg (p<0.01). Within the chronic IMR 
subjects, transverse dF/dt was found to increase from the baseline to a peak LVP of 150 
mmHg (p<0.005), 175 mmHg (p<0.001), and 200 mmHg (p<0.005).  
 
6.3 Specific Aim 2 Results 
The baseline characteristics, hemodynamics, and tabulated forces for each of the studied 
animals in Specific Aim 2 is presented in Appendix B. A catalog of the locations of the 
echocardiography data sets on the laboratory’s electronic server can be found in 
Appendix E.  
 
6.3.1 Annuloplasty Ring Stress Pilot Study 
6.3.1.1 Animal Characteristics and Ring Transducer Implantation 
Prior to cardiopulmonary bypass, echocardiography revealed the ovine subject (45 kg) to 
exhibit an end-diastolic mitral annular area of 7.14 cm
2
 with septal-lateral and transverse 
dimensions of 2.45 cm and 3.37 cm, respectively. Negligible MR (grade 1+) was 
observed. During cardiopulmonary bypass and ring implantation, the transducer was 
found to slightly undersize the mitral annulus (Figure 6-10A and B). At implantation, a 
suture passed through the ring cuff inadvertently damaged the strain bridge measuring in-
plane stresses on the septal portion of the ring. As a result, the study proceeded with 7 of 
8 ring measurement locations. 
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Figure 6-10 (A) Ten 2-0 sutures are placed through the suture cuff of the 
annuloplasty ring transducer for implantation, (B) While on cardiopulmonary 
bypass the transducer is implanted to the mitral annulus, (C) Post-experimentation, 
the left atrium is removed and the transducer was inspected for firm anchoring to 
the mitral annulus.  
 
6.3.1.2 Ring Stresses at Implantation 
Following successful implantation; the stresses imparted on the ring by the flaccid 
annulus were measured. The distribution of stresses on the ring surface was 
heterogeneous with a combination of compressive (-) and tensile (+) stresses. On both the 
in- and out-of-plane surfaces, these stresses ranged from -3.17 to 5.34 MPa (Figure 6-11). 
The largest stress was observed on the apical-basal surface at the septal portion of the 
ring. While sutures were attempted to be placed at near symmetric locations around the 
ring’s circumference, the order of suture anchoring was hypothesized to play a significant 





Figure 6-11 Annuloplasty ring stresses measured after implanting the ring to the 
mitral annulus in the flaccid cardioplegic heart (all stresses are expressed in MPa) 
with arrows indicating compression (arrows pointing towards the ring) or tension 
(arrows pointing away from the ring) at each measurement location. 
 
6.3.1.3. Ring Stresses throughout the Cardiac Cycle 
After weaning from cardiopulmonary bypass and establishing baseline hemodynamics, 
local cyclic stresses in the ring were successfully measured. Two consecutive 
representative cardiac cycles of the ring stresses with LVP and EKG are plotted in Figure 
6-12. Through each cardiac cycle, ring stresses were observed to increase from 
ventricular diastole and peak during mid-systole. Exceptions to this observation included 
the lateral ring area (in the apical-basal direction) and the posterior commissural area (in 
the anterior-posterior direction) whose stresses became more negative during 
isovolumetric contraction indicating local tensile loading. The mean peak change in ring 




Figure 6-12  Left: Two consecutive representative cardiac cycles of the apical-basal 
and planar ring stresses plotted with left ventricular pressure and 
electrocardiography; Right: pictorial representations of the ring with arrows 
indicating  compressive stresses (arrows pointing towards the ring) or tensile 
stresses (arrows pointing away from the ring) at each measurement location at peak 
left ventricular pressure. 
 
Acquired 3D echocardiography images demonstrated the transducer to remain 
fixed in the annular plane throughout the experimental protocol. From Doppler 
echocardiography measurements, it was assessed that the implanted ring increased the 
mean transmitral pressure gradient from 1 mmHg (pre-implantation) to 8 mmHg at 126 
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beats/min. Combined with the inner orifice area of the ring transducer (1.6 cm
2
), ring 
implantation resulted in a moderate level of MV stenosis. Upon the study’s completion, 
the heart was explanted, and the transducer was found to remain firmly secured to the 
mitral annulus with no thrombus formation.  
 
Table 6-4 10-cycle ensemble averaged stresses at each annuloplasty ring location 
and direction expressed as a mean ± 1 standard deviation in MPa (positive values 




6.3.2 Annuloplasty Ring Suture Forces 
The baseline characteristics, hemodynamics, and tabulated forces for each of the animals 
in Specific Aim 2 is presented in Appendix B. A catalog of the locations of the 
echocardiography data sets on the CFM Lab’s electronic server can be found in Appendix 
E.  
 
6.3.2.1. Transducer Calibration, Accuracy, and Precision 
Each annuloplasty ring suture transducer was calibrated to determine the relationship 
between applied forces and output voltage. For all transducers, a linear relationship 
between voltage and calibrated force with correlation coefficients exceeding r
2
=0.98 
(Figure 6-13). To assess the accuracy and precision of each calibration, the devices were 
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placed back into the calibration apparatus and forces applied in five independent trials. A 
representative plot of this assessment for the same transducers plotted in Figure 6-13 is 


































































Figure 6-13 Representative calibration curves for the 10 suture force transducers 








































Figure 6-14 Representative comparison of measured to true forces for the 
transducers whose calibration curves are graphed in Figure 6-13. 
 
 
6.3.2.2 Baseline and Elevated Animal Characteristics  
Annuloplasty ring suture forces were successfully quantified in eight (59±10 kg) healthy 
ovine animals. Baseline characteristics of the animals are presented in Table 6-5. Four 
animals received true-sized rings. The rings used for true sizing included a size 26, two 
size 28’s, and a size 32 Physio
TM
 ring (Table 6-5).  All animals in the undersized ring 


















True-Sized 56 ± 10 28.5 ± 2.5 28.5 ± 2.5
Undersized 62 ± 10 30 ± 0.0 26 ± 0.0
 
  
Cyclic suture forces were acquired for 10 consecutive cardiac cycles reaching 
peak LVPs of 100, 125, and 150 mmHg. The mean LVP and heart rate corresponding to 
cycles for which the cyclic forces were recorded are presented in Table 6-6. From Table 
6-6, negligible differences in LVP and heart rate were observed between the undersized 
and true-sized ring groups. Transmitral pressure gradients were quantified both pre and 
post-annuloplasty by Doppler echocardiography. Animals receiving a true sized ring had 
negligible changes in the transmitral gradient while animals receiving an undersized ring 
exhibited a net increase of 3 ± 1 mmHg. During each study, real-time 3D 
echocardiography images were acquired to assess transducer anchoring throughout the 








Table 6-6 Characteristics of the ovine subjects at elevated levels of left ventricular 
pressure. 
100 125 150
True-Sized 101 ± 3 126 ± 1 151 ± 1
Undersized 104 ± 2 129 ± 3 152 ± 2
True-Sized 108 ± 29 119 ± 29 129 ± 29
Undersized 109 ± 15 121 ± 15 134 ± 18
Target Left Ventricular Pressure [mmHg]





6.3.2.3 Cyclic Suture Force Characteristics 
Among all levels of LVP, cyclic suture forces were observed to increase from ventricular 
diastole to mid-systole. Two representative cardiac cycles of measured forces with LVP 
is pictured in Figure 6-15. During onset of ventricular systole, suture forces exhibited 
sharp increases in force magnitude reaching their maximal values near mid-systole. 
During ventricular ejection, the magnitude of suture forces gradually decreased. This 
phase was followed by a sharp decrease in forces to their minimal diastolic values during 




Figure 6-15 Two representative cardiac cycles of measured suture forces with the 
corresponding left ventricular pressure trace. 
 
6.3.2.4. Effect of Ring-Annulus Sizing on Cyclic Suture Forces 
All suture forces (regardless of ring position) were averaged for each of the true-sized 
and undersized rings to assess the effects of ring-annulus sizing. These results are shown 
in Figure 6-16. For both the true-sized and undersized rings, cyclic suture forces were 
demonstrated to marginally increase with increasing levels of LVP. Mean suture forces 
for the undersized rings were demonstrated to increase from 2.3 ± 1.5 N (90 mmHg LVP) 
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to 2.7 ± 1.7 N (125 mmHg LVP) and 2.9 ± 1.9 N (150 mmHg LVP). For the true-sized 
rings, mean suture forces increased from 1.6 ± 9.7 N (90 mmHg LVP) to 1.9 ± 0.9 N 
(125 mmHg LVP) and 2.2 ± 1.0 N (150 mmHg LVP). Undersized ring suture forces were 
approximately 41%, 38%, and 34% larger than true-sized ring suture forces at peak LVPs 
of 100, 125, and 150 mmHg, respectively.  
 
 
Figure 6-16 Suture forces averaged by ring-annulus sizing. 
 
6.3.2.5. Effect of Ring-Annulus Sizing and Suture Position on Cyclic Suture Forces 
Based on the observed differences in cyclic force magnitudes between undersized and 
true-sized annuloplasty rings (Figure 6-17), the suture forces at each suture location were 
compared. Mean cyclic forces for all sutures were observed to increase with increasing 
levels of LVP (Figure 6-17). Cyclic suture forces were observed to range from 0.2 to 8.1 
N and from 0.3 to 4.1 N for the undersized and true-sized rings, respectively. 
From inspection, suture forces were elevated and depressed at similar suture 
locations regardless of ring-annulus sizing. The largest forces for both the undersized and 
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true-sized rings were observed at each trigone, 3 o’clock, and 9 o’clock positions. 
Similarly, the smallest forces were observed between the 7 o’clock and 8 o’clock 
positions. While further studies are required to evaluate this hypothesis, these trends may 
be likely due to suture securing order on the ring (left trigone, right trigone, then 
proceeding clockwise from the 11 o’clock position).  
 
 
Figure 6-17 Top: Undersized annuloplasty cyclic suture forces expressed as a mean 
± 1 standard deviation for each ring position; Bottom: True-sized annuloplasty 




Suture forces of the undersized rings were predominately greater than those 
measured for true-sized rings at each level of LVP. The percent differences between 
undersized and true-sized ring suture forces for each suture position and LVP is tabulated 
in Table 6-7. As a whole, undersized ring suture forces were larger. These differences 
were the greatest at ring locations between the left and right fibrous trigones. 
Paradoxically, suture forces at the 4 o’clock position were larger for true-sized rings at all 
levels of LVP. While further studies are required, this trend may be due to the 
disproportionately higher loads carried by the right trigone and the 3 o’clock position on 
the undersized rings which may lower cyclic forces at the 4 o’clock position.  
 
Table 6-7 Average percent increase in cyclic suture forces with an undersized ring.  
100 125 150 Mean ± 1 SD
Left Trigone 61% 55% 43% 53 ± 9 %
11 o'clock 50% 75% 83% 69 ± 17 %
1 o'clock 106% 97% 63% 89 ± 9 %
Right Trigone 175% 139% 107% 140 ± 34 %
3 o'clock 24% 15% 15% 18 ± 5 %
4 o'clock -4% -8% -17% -10 ± 7 %
5 o'clock 5% 14% 10% 10 ± 4 %
 7 o'clock 15% 7% 25% 16 ± 9 %
8 o'clock 30% 20% 19% 23 ± 6 %
9 o'clock -5% 8% 14% 6 ± 10 %














6.3.2.6 Variation of Suture Forces by Annuloplasty Ring Region 
Based on the observed trends with suture location and ring-annulus sizing, the variation 
of suture forces by annuloplasty ring region was investigated. Cyclic forces were 
averaged for sutures residing in two regions of the annuloplasty rings. The anterior region 
was specified to include sutures located between the left and right fibrous trigones. The 
posterior ring region consisted of all other suture locations (proceeding clockwise from 
the 3 o’clock to 9 o’clock positions). The results of these analyses are plotted in Figure 6-
18. Anterior ring suture forces were greater for the undersized rings for LVPs of 100 
mmHg (3.0 ± 1.7 N vs. 1.5 ± 0.8 N), 125 mmHg (3.4 ± 1.7 N vs. 1.8 ± 0.9 N), and 150 
mmHg (3.7 ± 1.8 N vs. 2.1 ± 1.1 N), respectively. Comparatively, posterior ring suture 
forces were similar between the undersized and true-sized rings at LVPs of 100 mmHg 
(1.9 ± 1.3 N vs. 1.7 ± 0.7 N), 125 mmHg (2.2 ± 1.5 N vs. 2.0 ± 0.9 N), and 150 mmHg 
(2.4 ± 1.7 N vs. 2.2 ± 1.0 N), respectively. 
 
 




6.4 Specific Aim 3 Results 
6.4.1 Part A: In Vitro Mitral Valve Simulator Mimics Systolic Valvular Function of 
Healthy and Chronic Ischemic Mitral Regurgitation Ovine Model 
The baseline characteristics, hemodynamics, and tabulated measurements for each of the 
studied animals in Specific Aim 3 is presented in Appendix C. Tabulated data from the 
corresponding in vitro simulation can additionally be found in Appendix C. A catalog of 
the locations of the echocardiography data sets on the laboratory’s electronic server can 
be found in Appendix E.  
 
6.4.1.1 Animal Characteristics 
Baseline characteristics of the control and chronic IMR animals are presented in Table 6-
8. Both animal groups exhibited similar weights, heart rate, peak LVP, and anterior 
leaflet heights. Similar to previous studies, the chronic IMR animals exhibited a reduced 
rate change of LVP during isovolumetric contraction (d(LVP)/dt) and mitral annular area 
increase of approximately 60% as modeled within the in vitro simulator.  
 
Table 6-8 Baseline characteristics of the ovine subjects; Note mitral annular area 





















Control 38 ± 2 98 ± 15 103 ± 6 1842 ± 493 0 1.8 ± 0.1 6.4 ± 1.2




The simulation of the chronic IMR valve geometry was a direct function of the 
annular perturbations measured in our animals and the relative PM displacements 
determined from historic data sets. From this data, the posteromedial PM was observed to 
have a mean relative displacement of 7.25 mm laterally, 10.05 mm posteriorly, and 1.75 
mm basally; while the anterolateral PM exhibited a mean relative displacement of 4.04 
mm laterally, 1.28 mm anteriorly, and 3 mm apically. These relative displacements were 
similar to those observed previously by Tibayan and colleagues [55]. In pilot studies, the 
use of theses absolute displacements resulted in PM-chordal tearing. We believe this 
tearing was a consequence of using post-mortem tissue whereas in vivo the MV is 
distended over a greater period of time (8 weeks) and has exhibited the capacity to 
actively remodel [122,123]. For these reasons, intermediary levels of these displacements 
were utilized (See Section 5.3.1.3). 
 
6.4.1.2 A2-P2 Leaflet Coaptation  
Leaflet coaptation across the A2-P2 annular diameter was evaluated for coaptation 
length, coaptation depth, and tenting area (Table 6-9). Measured values within each 
animal group were compared to those measured within the conditions simulated in vitro. 
For the control conditions, no significant differences were observed between the healthy 
animals and MV simulator in coaptation length (p=.681), coaptation depth (p=.559), and 
tenting area (p=.199) (Table 6-9). Similarly for the chronic IMR conditions, no 
differences were observed between models in coaptation length (p=.596), coaptation 
depth (p=.621), and tenting area (p=.879). While not reaching statistical significance, 
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coaptation length was consistently lower in the simulated conditions as verified by the 
comparatively greater coaptation depth.  
 
Table 6-9 A2-P2 coaptation characteristics between the animal and simulated 
valves; * denotes a p<0.05 significant difference between the chronic IMR and 








Animal 4.4 ± 0.4 1.8 ± 0.2 0.23 ± 0.07
Simulator 4.0 ± 0.4 2.1 ± 0.3 0.16 ± 0.05
Animal 3.2 ± 0.3 2.4 ± 0.8 0.27 ± 0.13





To demonstrate changes in coaptation within the GTLHS, each measure of 
coaptation was compared between the simulated control and chronic IMR conditions 
(Table 6-9). Results revealed the coaptation length to significantly decrease from the 
control to chronic IMR condition (p=.027) across the A2-P2 annular diameter. 
Additionally, coaptation depth (p=.046) and tenting area (p=.028) were observed to 
significantly increase with simulated chronic IMR. 
 
6.4.1.3 Mitral Regurgitation  
Mitral regurgitation was assessed between the chronic IMR animals and simulated 
conditions. Within the animal group, observed MR was consistent with previous studies 
reaching a mean grade of 3.17±0.75 [41].  For the simulated conditions, MR was 
quantified by direct measurement using an electromagnetic flow probe. The mean in vitro 
mitral regurgitation fraction was found to reach 46±6 % and mean grade of 3+.  In 
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comparison to the chronic IMR animals, in vitro MR jets were observed to be asymmetric 
and originate from the tethered A3-P3 leaflets. 
 
6.4.1.4 Anterior Leaflet Mechanics  
For control conditions, no significant differences were observed in the A2 leaflet strain 
between the control animals and simulated conditions in the radial (21±14 % vs. 32±18 
%, p=.230) and circumferential (6±10 % vs. 11±7 %, p=.364) directions. Similarly, no 
significant differences were observed between the chronic IMR animals and simulated 
IMR conditions and in the radial (21±11 % vs. 34±18 %, p=.151) and circumferential 
(7±9 % vs. 9±7 %, p=.586) directions respectively. To determine if leaflet strain 
increases from a control to chronic IMR valve geometry, radial and circumferential 
strains were compared between the simulated conditions. In comparison to the control 
condition, results revealed a significant increase in radial (p=.028) and circumferential 
(p=.028) strains.   
In addition to the peak measured values, the peak rate of change of these strains 
(d(ϵ)/dt) were determined during Isovolumetric contraction and compared between 
animal and simulation groups (Table 6-10). Since these values are largely a function of 
the rate at which LVP increases, all d(ϵ)/dt values were normalized by d(LVP)/dt (Table 
6-10). Results revealed no significant differences between the control animals and 
simulated control conditions in the radial (p=.873) and circumferential (p=.109) 
directions respectively. Similar results were observed between the chronic IMR animals 
in the radial (p=.631) and circumferential (p=.200) directions. To determine if leaflet 
strain rate increases from a control to chronic IMR valve geometry condition, radial and 
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circumferential strain rates were compared between the simulated conditions. In 
comparison to the control condition, results revealed a significant increase in the 
normalized radial (p=.005) and circumferential (p=.018) strain rates.   
 
Table 6-10 Normalized strain rate (d(ϵ)/d(LVP)); * denotes a p<0.05 and † denotes a 




Animal 0.24 ± 0.21 0.20 ± 0.13
Simulator 0.23 ± 0.05 0.11 ± 0.07
Animal 0.30 ± 0.18 0.20 ± 0.13
Simulator 0.52 ± 0.14 † 0.16 ± 0.06 *
Control
Chronic IMR




6.4.2 Part B: Effect of Annuloplasty on Subvalvular Tethering 
In part 1 of Specific Aim 3, in vitro simulations were demonstrated to mimic the systolic 
MV geometry, leaflet coaptation, regurgitation, and anterior leaflet strain of a healthy and 
chronic IMR ovine model.  Given the unique ability of the simulator to mimic systolic 
MV function, the simulator was utilized to assess the sequential effects of IMR and 
annuloplasty on mitral regurgitation, leaflet coaptation, and tethering forces of the strut 
and intermediary chordae tendineae.  
All raw data for the explanted mitral valves studies in part B of Specific Aim 3 is 
presented in Appendix D. A catalog of the locations of the echocardiography data sets on 




6.4.2.1 Mitral Regurgitation 
Mitral regurgitation was observed to significantly differ between experimental conditions 
(Table 6-11). Mean MR volumes expectedly increased from control to IMR (p<.001).  At 
the IMR condition, each regurgitation jet was asymmetric and originated from the 
tethered A3-P3 leaflets. Following IMR, MR volumes were significantly reduced with 
increasing levels of annuloplasty ring under sizing (p<.001). While oversized 
annuloplasty reduced MR volumes from the IMR condition, MR volumes with oversized 
annuloplasty remained significantly greater than that of the control (p<.001). Elimination 
of MR was successfully achieved with both true-sized and undersized annuloplasty. Both 
of these repairs resulted in MR volumes that were statistically not different from the 
healthy control. 
 
Table 6-11 Effect of the evaluated conditions on mitral regurgitation volume (MRV) 
and A2-P2 coaptation length (CL); asterisks (*) and dagger (†) denote significant 
differences of p<.001 relative to the healthy control condition and ischemic mitral 













MRV [mL] 27.6 ± 1.4 47.0 ± 2.2 * 37.4 ± 2.2 *† 27.5 ± 1.2 † 24.9 ± 1.2 †
CL [cm] 4.84 ± 0.13 3.19 ± 0.14 * 3.54 ± 0.11 * 3.90 ± 0.13 *† 4.75 ± 0.16 †
 
 
6.4.2.2 A2-P2 Leaflet Coaptation Length 
Leaflet coaptation length across the 12 to 6 o’clock annular diameter was observed to 
significantly differ between the tested conditions (p<.001) (Table 6-11). The largest 
reduction in coaptation length was observed between the control and IMR condition 
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(p<.001). Reshaping the mitral annulus to an oversized or true-sized ring slightly 
improved coaptation length but these improvements remained significantly less than the 
coaptation length occurring in the control condition (p<.001). Undersized annuloplasty 
was the only repair condition which successfully restored A2-P2 coaptation length to 
values statistically not different from the healthy control condition. 
 
6.4.2.3 Chordal Tethering from the Posteromedial Papillary Muscle 
Simulating an inferior myocardial infarction resulted in significant changes in chordal 
tethering for the posteromedial PM’s anterior strut and posterior intermediary chordae 
(Table 6-12). Anterior strut chordal forces were observed to approximately double with 
IMR (Figure 6-17). Compared to the IMR condition, undersized annuloplasty 
significantly reduced anterior strut chordal forces by approximately 27% (p<.05). Despite 
this result, anterior strut chordal forces at each level of annuloplasty remained 
significantly larger than forces measured in the control condition (Table 6-12).  
 
Table 6-12 Effect of the evaluated conditions on anterior strut (AS) and posterior 
intermediary (PI) chordal forces [N] (mean ± standard error) originating from the 
posteromedial (PM) and anterolateral (AL) papillary muscles; asterisks (*) and 
dagger (†) denote significant differences (p<.05) relative to the healthy control 
















AS 0.71 ± 0.08 1.23 ± 0.11 * 0.99 ± 0.10 *  † 0.91 ± 0.09 * † 0.88 ± 0.08 * †
PI 0.28 ± 0.03 0.55 ± 0.08 * 0.47 ± 0.07 * 0.47 ± 0.06 * 0.51 ± 0.07 *
AS 0.62 ± 0.11 0.80 ± 0.14 * 0.72 ± 0.12 0.68 ± 0.11 0.66 ± 0.10  †






Similar to the anterior strut chordae, the posterior intermediary chordal forces 
were observed to significantly increase with IMR (Table 6-12). However, statistically 
significant differences were not observed between the IMR condition and each level of 
annuloplasty. Among the tested conditions, posterior intermediary forces remained 
significantly greater than those observed during the control condition (p<.05). While not 
statistically significant, posterior intermediary forces demonstrated an increasing trend 
from oversized to undersized annuloplasty (Figure 6-19).  Following undersized 
annuloplasty, posterior intermediary chordal forces were only marginally reduced (by 
approximately 4%) from the IMR condition. 
 
 
Figure 6-19 Chordal forces from the posteromedial papillary muscle (PMPM) and 
anterolateral papillary muscle (ALPM) were normalized to the forces observed 
during the healthy control condition to demonstrate relative changes in cyclic 
chordal tethering with ischemic mitral regurgitation (IMR) and increasing degrees 
of annular under sizing. 
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6.4.2.4 Chordal Tethering from the Anterolateral Papillary Muscle 
Similar to chordae from the posteromedial PM, simulating an inferior myocardial 
infarction resulted in significant changes to anterior strut and posterior intermediary 
tethering from the anterolateral PM (Table 6-12). Anterior strut and posterior 
intermediary forces were both observed to significantly increase with IMR (p<.05). With 
increasing levels of annular under sizing, anterior strut chordal forces were found to 
significantly decrease between the IMR and undersized annuloplasty condition (p<.05). 
Similarly, posterior intermediary chordal forces were observed to significantly decrease 
from the IMR condition to true-sized (p<.05) and undersized (p<.05) annuloplasty 
respectively.  
 
6.4.2.5. Chordal Tethering Forces Summed by Papillary Muscle 
The strut and intermediary chordal forces from each PM were summed to examine if 
differences in cyclic tethering exist between each PM (Table 6-13). For both PMs, 
significant differences in summed chordal forces were observed between the tested 
conditions. For the posteromedial PM, summed forces were significantly greater than the 
control condition during IMR (p<.05) and each of the annuloplasty conditions (p<.05). 
Compared to IMR, summed forces on the posteromedial PM were observed to 
significantly decrease with oversized annuloplasty (p<.05), true-sized annuloplasty 





Table 6-13 Effect of the evaluated conditions on strut and intermediary chordal 
forces [N] summed by papillary muscle; asterisks (*) and dagger (†) denote 
significant differences (p<.05) relative to the healthy control condition and ischemic 













Posteromedial 0.98 ± 0.08 1.76 ± 0.11 * 1.50 ± 0.10 * † 1.41 ± 0.09 * † 1.42 ± 0.11 * †
Anterolateral 1.01 ± 0.12 1.41 ± 0.19 * 1.24 ± 0.18 * 1.18 ± 0.16 † 1.14 ± 0.14 †
 
 
Summed forces on the anterolateral PM were observed to significantly increase 
from the control condition to IMR  and oversized annuloplasty (Table 6-13).Compared to 
IMR, summed forces were observed to statistically decrease at true and undersized 
annuloplasty (p<.05), respectively. While not reaching statistical significance, summed 
forces on the posteromedial PM were observed to be greater than those on the 

























7.1 Introduction to the Discussion 
Three specific aims were evaluated in this work. In Specific Aim 1, a novel transducer 
was developed to measure the radially directed forces that may act on devices implanted 
to the mitral annulus. In an ovine model, radial forces were found to statistically increase 
with left ventricular pressure and were reduced in the setting of IMR. In Specific Aim 2, 
the suture forces required to constrain true-sized and undersized annuloplasty rings to the 
mitral annulus of healthy ovine subjects was evaluated. Suture forces were observed to be 
larger on the anterior aspect of the rings and were elevated with annular undersizing. In 
Specific Aim 3, an in vitro simulator’s ability to mimic healthy and IMR ovine mitral 
valve function was evaluated. After understanding the accuracy of the model, the in vitro 
IMR model was used to evaluate the progressive effects of annuloplasty undersizing on 
strut and intermediary chordal tethering. Compared to the IMR condition, increasing 
levels of undersizing annuloplasty significantly reduced regurgitation, increased 
coaptation, reduced posteromedial papillary muscle strut chordal forces, and reduced 
intermediary chordal forces from the anterolateral papillary muscle.  
 Similar to the organization of the Results Chapter, the Discussion is organized by 
Specific Aim. Specific Aim 1, 2, and 3 are sequentially presented in Sections 7.2, 7.3, 
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and 7.4, respectively. Each discussion additionally includes the limitations and clinical 
implications of the results.  
 
7.2 Specific Aim 1 
7.2.1 Discussion 
Ejection of the heart’s blood to the systemic circulation requires the left ventricle to 
generate enough pressure to open the aortic valve leaflets and empty the LV volume. This 
critical function is accomplished by the myocardium aligned circumferentially in the LV 
wall. During ventricular systole, the myocardium contract and reduce the LV diameter by 
generating forces that act along the direction of each myocardial fiber. These forces not 
only facilitate the generation of LVP, but at the basal level, reduce the mitral annular area 
and compress devices implanted to the mitral annulus. The septal-lateral and transverse 
forces measured in Aim 1 are vector components of the circumferentially generated 
myocardial forces.   
In comparison to prior studies, the radially directed forces measured within the 
healthy animals were in good agreement with the magnitudes previously reported 
[75,76]. The maximum forces reported to act on prosthetic Edwards-Duromedics mitral 
valves (6-8 N) in a porcine subject are similar to the maximum values reported herein 
(4.3-6.9 N) at comparable mean peak LVP (130 vs. 125 mmHg) and heart rate (144 vs. 
130 beats/min) [75]. A direct comparison between the directions of these maximum 
forces however cannot be made. Hasenkam reported the maximum force to act 30° 
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clockwise from the natural intercommissural line whereas the present study was limited 
to measurements in the septal-lateral and transverse directions.  
Similar to our results, Shandas et al [76] found the maximum annular force on St. 
Jude Medical Biocor
®
 stented prosthetic valves (between 4.4 and 13.9 N) to act in the 
septal-lateral direction. Compared to the present study, this larger range of peak force is 
likely due to the comparably smaller number of experimental subjects (n=2) and the 
limitations of using 3D intravascular ultrasound to map 2D deformation of the studied 
stented valves.  A key difference however was the timing of the peak force. Shandas 
described the peak force to occur during atrial contraction whereas our results are in good 
agreement with Hasenkam to occur during mid-systole. We believe the later timing to be 
correct as mid-systole would coincide with near peak LV contraction and thus peak force.  
A recent study by Jensen et al. measured the forces in traction sutures placed 
between the right fibrous trigone and the P1, P2, and P3 annular segments [124]. No 
difference in force was found between the P1, P2, and P3 segments across all levels of 
annular under sizing. The peak forces at 32% annular under sizing were 1.2±0.9 N, 
1.5±1.0 N, and 0.8±0.2 N for the trigone-P1, trigone-P2, and trigone-P3 segments, 
respectively. The maximum total suture forces in the mitral plane during downsizing 
increased from 0.12±0.03 N to 3.5±1.3 N (p<.005).While the forces measured in the 
aforementioned study are fundamentally different from the forces measured herein, these 
studies provides supplementary information for the forces which may push or pull on 
devices implanted in the mitral annulus.  
In the healthy animals, the cyclic change in septal-lateral forces was found to be 
larger than the cyclic change of forces in the transverse direction. This directional 
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difference is supported by a similar study describing the areal reduction of the mitral 
annulus throughout the cardiac cycle. Using sonometric crystals to three-dimensionally 
map the mitral annulus within 55 ovine subjects; Rausch et al. [46] found the septal-
lateral diameter to have a larger mean peak reduction (12.06%) than the transverse 
diameter (5.51%) given by p<.001. This result supports our findings in that a greater 
circumferential shortening of myocardial fibers aligned near the posterior annulus, results 
in not only a greater reduction in septal-lateral diameter but a greater vectorially resolved 
radial force.  
When comparing the results of the healthy and IMR animal groups an inferior LV 
infarction significantly decreased septal-lateral forces while modestly decreasing those in 
the transverse direction. This can be explained by the fact that an inferior infarction not 
only impairs the ability of the infarcted myocardium to contract, but additionally alters 
the cross-sectional geometry of the LV [41, 54, 125-127]. Due to infarction, the 
magnitudes of circumferentially directed forces in the postero-inferior wall are reduced 
and are directionally more oblique with respect to the geometric center of the LV. As a 
result, the relative contributions of the postero-inferior myocardium to the radially 
directed septal-lateral and transverse forces are reduced. We believe the septal-lateral 
force was decreased to a greater extent due to ligation of the OM3 coronary artery which 
has been previously demonstrated to impair more of the posterior wall [41, 125-127]. 
Lower forces observed in the chronic IMR animals have important implications in 
the development of minimally invasive and transcatheter IMR devices. These forces can 
inform bench and computational studies to evaluate the structural durability and relevant 
failure modes of these devices. International Standards Organization (ISO) standards and 
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Food and Drug Administration (FDA) guidelines recommend evaluating these devices 
under cyclic forces at magnitudes at least as severe as those anticipated in vivo under 
hypertensive conditions [128, 129].
 
While septal-lateral and transverse forces were 
observed to be reduced in the presence of IMR, a reasonable safety margin needs to be 
maintained to ensure long-term device durability and patient safety [130].
 
Findings within healthy animal subjects demonstrated directional differences in 
the change in force throughout the cardiac cycle. These differences and their exacerbation 
with increasing LVP can inform the structural strengthening of devices and worst-case 
loading conditions. Despite these findings, directional differences were not observed 
within the chronic IMR animals. An inferior infarction was found to significantly 
decrease septal-lateral forces, but not to a magnitude that was statistically different from 
those measured in the transverse direction. While transverse forces were consistently 
lower in the chronic IMR group, they were statistically not different from transverse 
forces measured in healthy subjects.   
In addition to cyclic force magnitudes, the rates at which these forces increase 
during ventricular contraction carry equal importance. These rates can more accurately 
inform device testing and the use of device materials (e.g., polymers) with rate dependent 
behavior [128-130].The rates measured herein were found to significantly increase with 
peak LVP, but did not significantly differ between directions and groups. While 
statistically significant differences in dF/dt were not observed between groups in the 
septal-lateral direction, we believe the large differences in magnitude are representative 
of a meaningful difference that might be observed to be statistically significant with a 
larger sample size. When combined with the peak magnitudes of these cyclic forces, 
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measured rates will contribute to more accurate experimental and computational models 
that further assist in optimizing device materials, design, durability and safety.  
The translation of the measured chronic IMR annular forces in the ovine model to 
that which may be anticipated in IMR patients requires careful attention. Healthy ovine 
animals and humans have been compared previously and shown to possess similar mitral 
annular areas, LV mass and wall thickness, and comparable LVP and d(LVP)/dt [1,131]. 
Ligation of the obtuse marginal coronaries infarcts approximately 20% of the LV mass, 
includes the posteromedial papillary muscle, and produces increasingly more severe MR 
with progressive LV remodeling [41,125-127]. Similar to clinical descriptions, 
abnormalities and reductions in both LV and MV contractility are observed with 
significant increases in end systolic and diastolic LV volumes [41,132,133]. While the 
size and age of infarcts in IMR patients widely vary, LV wall motion abnormalities are 
overwhelmingly located in the postero-inferior aspect of the LV, and usually involve the 
posterior papillary muscle [54].  
Given that our forces were measured under anesthesia and within the post-
cardioplegic heart, we believe mitral annular forces within humans suffering from a 
posterior infarct to be of greater magnitude than the forces reported herein at 125 mmHg 
peak LVP.  The forces expected in the human mitral annulus may present greater 
directional heterogeneity as coronary disease may be more widespread, diffused, and 
affect global LV contraction. We hypothesize a greater degree of localized myocardial 
infarction my result in a disproportionate systolic annular area reduction and potential 
shearing of devices in the mitral annulus. Moreover, annular under sizing as with 
restrictive mitral annuloplasty may differ from the results presented herein as the ring 
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will likely undergo cyclic tension from a contracting and grossly dilated LV. 
 
Future 
studies are required to not only describe these force profiles, but also understand the 
potential heterogeneity introduced by reshaping the mitral annulus to a given device.  
Beyond in-plane forces, it is important to note that out-of-plane forces also exist. 
Jensen et al [118,119] were the first to describe the magnitude and distribution of these 
forces on flat and saddled shaped annuloplasty rings. Although they are of lower 
magnitude, they play an equally important role in understanding the forces that may act 
on mitral annular devices. Currently no methods exist to resolve the three-dimensionality 
of mitral annular forces; however, we believe those acting within the annular plane are of 
greatest magnitude. Although challenging, future studies may wish to consider the 
magnitude of forces acting circumferentially around the mitral annulus. Combined with 
various models of myocardial strain mapping, material properties of the mitral annulus 
may be determined and computational models more accurately employed.  
Despite the advantages of the present study, several limitations exist in measuring 
these radially directed forces. Calibration of each transducer within our well-defined 
apparatus may not fully represent device fixation within the mitral annulus. Out-of-plane 
deformation was found to influence transducer signals. While out-of-plane transducer 
deformation was believed to be minimized by constraining the annulus to the semi-rigid 
flat transducer, it was not possible to determine how much out-of-plane bending 
contributed to observed forces. Although care was taken to match each transducer to the 
subject’s annular size, exact matching was not likely achieved. Implantation of one 
device in a healthy subject inadvertently induced trace mitral regurgitation. The 
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magnitude of forces measured within the chronic IMR model are likely to be dependent 
on infarct size and may change with a lesser or greater degree of myocardial infarction.  
Described forces are limited to this IMR model and may not represent the forces 
that may be seen in other mitral etiologies. As IMR repairs aim to reshape and reduce 
mitral annular area, transducers implanted within our chronic IMR subjects were true-
sized to the enlarged mitral annulus. This was done to reduce any unknown effects of 
transducer-annular sizing on measured forces. In each study, the transducers were found 
to be either slightly undersized or exhibit a snug but not oversized fit. Absolute forces 
experienced by each device due to implantation and function were difficult to quantify 
due to observed variations in the diastolic forces from combined changes in annular 
contractility. For these reasons, the change in force throughout the cardiac cycle is 
reported. As implantation of any device will likely alter the native mitral annular 
mechanics, any forces measured may not be equal to those with an implanted device. As 




7.2.2 Clinical Implications 
Mitral annular forces were measured for the first time in a healthy and chronic IMR 
animal model. Our findings provide a foundation for not only the forces that exist but the 
mean rates at which they are generated during left ventricular contraction. Our new 
understanding for the timing, magnitude, directionality, and variation of these forces with 
ventricular afterload will improve device development and testing. These data may be 
used to refine mitral annular device development and evaluation via finite element 
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modeling, fatigue testing, and regulatory assessment. With improved knowledge for the 
forces which may act on implanted annular devices, these data will ultimately assist in 
optimizing device durability, flexibility, and safety. 
 
7.3 Specific Aim 2 
7.3.1 Annuloplasty Ring Stress Transducer 
The stresses imparted on the ring at implantation were approximately 4-fold larger than 
the cyclic changes in stress throughout the cardiac cycle. From these initial results, 
implantation of the rigid ring transducer may of restricted the ability of the surrounding 
myocardium to systolically shorten. This can be explained by the fact that the ring 
transducer possessed a core whose relative thickness was 3 to 4 fold larger than 
commercially available rings. Results from implanting the rigid ring however compare 
favorably to previously observed reductions in annular dynamics from rigid ring 
implantation [134].  
Understanding annuloplasty ring stresses can aid in the improvement of ring 
design and develop a greater understanding for the mechanistic relationship between ring 
implantation and LV function. Evaluating the relationship between mitral annular 
geometries and ring stress may lead to improvements for optimizing complete rigid ring 
geometry and materials. Measured in-plane and out-of-plane stresses that are specific to 
differing ring designs can aid in identifying areas of elevated stresses and develop 
methods or techniques to reduce them. Moreover, these transducers can aid in 
 136 
understanding how increasing the number of ring-annulus sutures may impact regional 
ring stresses and basal LV function.  
While it was desired to isolate the magnitude and direction of forces acting on the 
annuloplasty ring, it was not possible to isolate directional forces through the use of a 
calibration apparatus. Since annuloplasty transducers are complete rings, a force applied 
to a given ring location will affect the material deformation at other ring locations. A ring 
deformation that is measured by a strain gage therefore can be the result of an infinite 
combination of directional forces acting at locations other than the intended calibrated 
location and direction. As a result, this pilot study aimed to quantify the ring material 
stresses that are a result of the multidirectional loading for which implanted annuloplasty 
ring endure. 
Several limitations exist in this study. In comparison to commercially available 
annuloplasty rings, the developed transducer is larger due to limitations in strain gage 
size. Measured ring stresses were likely affected by suture location and tie-down order. 
Increasing the number of implantation sutures may reduce ring stresses, but an optimal 
ratio of sutures to ring-annulus geometry is currently unknown. The physiological benefit 
of adding more sutures to reduce ring stress for a given ring-annulus geometry is also 
unknown and should be a subject of further investigation. Carefully controlling ring 
transducer manufacturing, methods of surgical implantation and the number of annular-





7.3.2. Annuloplasty Ring Suture Forces  
For the first time, the cyclic tensile forces required to restrain true-sized and undersized 
annuloplasty rings to the mitral annulus of healthy ovine animals were quantified. These 
data revealed preliminary insight to the variations in cyclic suture forces by ring-annulus 
sizing, suture position, ring region, and left ventricular pressure. Throughout the cardiac 
cycle, cyclic forces were observed to reach their maximal values during isovolumetric 
contraction. This timing is consistent with the timing of maximal mitral annular radial 
forces in Specific Aim 1 and maximal ring stresses in the pilot study of Specific Aim 2.  
 All suture forces (regardless of ring position) were averaged for each of the true-
sized and undersized rings to assess the effects of ring-annulus sizing and elevated levels 
of LVP. These preliminary results demonstrated undersized ring suture forces were 
approximately 41%, 38%, and 34% larger than true-sized ring suture forces at peak LVPs 
of 100, 125, and 150 mmHg, respectively. Based on these observed differences, the 
cyclic forces at each suture location were compared. Distinct similarities in the location 
of the largest and smallest suture forces were observed (Figure 7-1). For both groups of 
ring annular sizing, the largest forces were observed between the left and right fibrous 
trigones while the smallest forces were at the 7 o’clock suture position. Moreover, the 
overall trend in force magnitude by suture position was similar between the ring-annulus 
sizing groups and levels of LVP (Figure 7-1). While preliminary, the overall trends for 
force magnitude by suture position are believed to be in part due to suture securing order. 





Figure 7-1 Overall trends for force magnitude by suture position at an LVP of 125 
mmHg.  
 
Suture forces of the undersized rings were predominately greater than those 
measured for true-sized rings at each level of LVP (Table 6-7). The largest differences in 
cyclic force were found to exist at sutures located between the left and right fibrous 
trigones. When suture forces were averaged by ring region (anterior vs. posterior), the 
anterior region of undersized rings exhibited a mean force that was greater than the 
posterior region of undersized rings. The anterior region of undersized rings was 
additionally found to be larger than both the anterior and posterior regions of true sized 
rings. Interestingly, the mean force on the posterior portion of the undersized rings was 
approximately equal to mean forces for both regions of the true-sized rings.  
 The increased forces measured along the anterior annulus of the undersized 
annuloplasty rings are likely the result of a blunting of the normal annular saddle shape 
with the flat undersized annuloplasty ring. During systole the saddle shape of the anterior 
annulus is accentuated with the mid-anterior annulus being “elevated” toward the atrium 
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by the filling of the aortic root and the fibrous trigones being “depressed” toward the 
ventricle by LV contraction.  In a healthy heart, a flat undersized annuloplasty ring 
prevents this normal accentuation. The increased forces measured along the anterior 
annulus and fibrous trigones were likely the result of the annulus pulling away from the 
flat ring in these regions. The posterior annulus likely produces lower forces and small 
forcer variations throughout systole because its relatively flatter geometry is more stable 
throughout the cardiac cycle and similar to the flat annuloplasty ring. 
 These data provide preliminary insights and implications for annuloplasty ring 
design. The salutary effects of saddle shape annuloplasty on leaflet geometry and leaflet 
stress have been described [51]. These have included lowering mitral leaflet stresses and 
reducing chordal tethering. The data presented here also suggest saddled rings may 
potentially reduce suture forces on the anterior annulus. To fully understand these effects, 
future studies will evaluate the difference in suture forces between flat and saddled 
annuloplasty rings. These studies will additionally evaluate if regional LV distortions 
associated with IMR can exacerbate posterior ring suture forces. These data will provide 
critical knowledge for patient-ring selection and understanding ring dehiscence.  
To better understand what may contribute the most to ring dehiscence, careful 
comparison of observed forces to those which may cause suture failure, knot failure, or 
annular tissue tearing is required. A previous study evaluated the strength of surgeon 
knots thrown from 3-0 Ti∙Cron [8]. Five suture throws decreased the ultimate suture 
holding strength from 27 to 17.8 N. While 2-0 sutures are expected to exhibit a larger 
holding strength, results from 3-0 sutures are approximately 120% greater than the 
maximum force measured in this study (8.1 N at 150 mmHg peak LVP).  
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In comparison to suture and suture knot failure, annular tissue tearing may be a 
more likely failure mechanism in ring dehiscence. Among patients with varying MV 
disease, single sutures have been shown to tear from MV annular tissue with a mean 
force of 6.0 ± 4.5 N [9]. While this study used only 10 sutures to implant the undersized 
ring (~16-20 used for a IMR patient), the magnitude of annular tissue tearing forces is 
within the range of forces measured herein. Future studies are required to understand the 
effects of suture number on measured forces and the resulting potential for annular-tissue 
tearing.    
In our ongoing studies, evaluating the relative suture holding strength at differing 
annular locations will provide additional insight to the mechanisms of annular-tissue 
tearing and suture dehiscence. The observation that cyclic suture forces are greater for an 
undersized ring’s anterior region is in part paradoxical given suture dehiscence is more 
commonly observed on the posterior annulus. This may suggest the suture holding 
strength of the aorto-mitral curtain may be greater than that of the posterior mitral 
annulus. This hypothesis could be evaluated in ex-vivo studies by carefully controlling 
for suture bite width and depth around the circumference of the annulus. Sutures placed 
in the mitral annulus may be pulled in a controlled fashion whose tension during pulling 
and tissue tearing may be recorded by a load cell. 
Despite the advantages of the present study, several limitations exist. Measured 
forces were likely affected by suture bite width, bite depth, suture securing order, and use 
of anesthetic isoflurane. While isoflurane has been demonstrated to depress LV 
contractility [135], measurements at elevated LVP provide insight to the range of forces 
which may be anticipated in the awake, extubated, and ambulating animal. The use of 
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dobutamine to achieve elevated levels of LVP increased the subject’s heart rate from 97 
to 110 and 150 beats/min. Future studies will additionally evaluate the effects of heart 
rate on observed suture forces. All measurements herein are limited to Physio
TM
 
annuloplasty rings and healthy left ventricles. Future studies will aid in understanding the 
effects of ring shape, annular sizing, LVP, and LV dilatation on observed ring suture 
forces.  
 
7.3.3. Clinical Implications 
The presented preliminary study was successful in assessing the feasibility of developing 
a transducer to quantify the regional stresses imparted on a flat mitral annuloplasty ring 
due to implantation and cyclic annular contraction.  Understanding annuloplasty ring 
stresses can aid in the improvement of ring design and develop a greater understanding 
for the mechanistic relationship between ring implantation and LV function. Evaluating 
the relationship between mitral annular geometry and ring stress may lead to 
improvements for optimizing complete rigid ring geometry and materials. Measured 
stresses that are specific to differing ring designs can aid in identifying areas of high 
stress and develop methods or techniques to reduce them. Future studies should evaluate 
the effect of differing annuloplasty ring sizes, geometries, and implantation methods. The 
determination of these endpoints will significantly contribute to improved knowledge for 
the annulus-ring stresses, their relationship with LV function, and the safer development 







7.4 Specific Aim 3 
7.4.1 Assessing the Accuracy of the In Vitro Mitral Valve Simulator 
Simulated changes in systolic MV geometry from a healthy to chronic IMR ovine model 
were modeled within the Georgia Tech Left Heart Simulator. When simulating a chronic 
IMR MV geometry, significant decreases in coaptation length and significant increases in 
coaptation depth and tenting area were observed as clinically described [24,25,26,28]. 
These changes in leaflet coaptation were accompanied with MR jets of a magnitude 
similar to that observed in the ovine subjects. In comparison to the simulated controls, a 
chronic IMR MV geometry resulted in significant increases in both radial and 
circumferential anterior leaflet strains. This can be explained in that the IMR geometry 
increases the leaflet area exposed to the transmitral pressure resulting in a greater force 
and stretch within the leaflet tissue.  
The annular MV geometric changes and MR observed within our animals are in 
good agreement with previous studies [33,41,79,127]. Since the coronary anatomy varies 
very little between sheep and they do not form collateral vessels, these sheep provide a 
reliable and repeatable model of chronic IMR [127].  Due to the precise control that’s 
allowed by the simulator’s components, the simulated annular dilatation and PM 
displacement is also very repeatable.  During valve selection, great care was given to 
selecting valves of similar size to that in-vivo. While similar in size, the number of 
chordae per valve likely differed as did their geometric insertions into the PMs and 
leaflets. Even with this variability, the standard deviations found in the in vitro MR 
fractions, coaptation characteristics, and strain was reduced in comparison to previous 
studies [107,110,111,115]. 
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Given the consistency of both models, demonstrating negative results with a 
larger sample size would still not supersede or overcome the limitations of the in vitro 
simulator. For these reasons, the negative results reported herein are meaningful and 
highlights the unique ability of the simulator to mimic the systolic valvular distortions, 
coaptation characteristics, and anterior leaflet strain of a chronic IMR ovine model. These 
results additionally demonstrate the repeatability of the simulator and its ability to detect 
small differences between experimental conditions that are difficult in animal or human 
studies.  
For type IIIb dysfunctions, the surgical reconstructive goals are to cease MR and 
promote reverse LV remodeling [1,24,25]. The effectiveness of IMR repairs is dependent 
on the repair’s ability to compensate for the distended LV by restoring coaptation and 
ceasing MR during systolic closure [26,28,87]. For these reasons, in vitro simulators must 
aim to mimic the systolic closure of the leaflets; and moreover, aid in developing new 
methods and or techniques to maximize post-repair coaptation. Hence, the ultimate goal 
of our simulator is to mimic the systolic closure of the leaflets and provide a platform to 
investigate how to improve it in repair conditions.  
Several limitations are associated with both the in vitro simulator and the 
methodologies used in this study. The described mitral valve simulator can recreate the 
systolic geometric configurations of the mitral valve but at current does not incorporate 
the intricate mechanics associated with valvular-ventricular interaction.  Its inclusion 
would likely increase the accuracy of mimicking the dynamic in vivo valve function 
whose effects should be isolated in future studies. While at current the model can focus 
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on the geometry of the annulus, leaflets, and PMs, evaluating repairs that directly affect 
the ventricle will require appropriate in vivo geometric boundary conditions.  
The comparison of our simulated results is limited to an extensively studied 
inferior IMR ovine model and does not emulate the valvular distortion and function that 
may be seen in other etiologies. The IMR ovine model’s resulting valvular geometry are 
likely dependent on infarct size and may change with a lesser or greater degree of 
myocardial infarction. The evaluation of leaflet coaptation was limited to the A2-P2 
annular plane as the ability to quantify coaptation along the A3-P3 plane was limited due 
to the thin poorly coapting leaflets. In future studies, a broader spectrum of IMR valvular 
geometries (i.e. from more diffuse coronary disease or anterolateral infarction) should be 
simulated with similarities assessed between the in vitro and in vivo models. Dynamic 
leaflet motion within the simulator should additionally be evaluated.  
In our studied animals, implantation of the miniature sonomicrometry transducers 
to the anterior leaflet likely influenced the local deformation of the anterior leaflet and 
could be improved with the use of radio-opaque markers. For the computation of A2 
leaflet strain, the number of transducers that could be localized to the ovine anterior 
leaflet was limited to 5 whereas in the GTLHS strain was computed with 9 markers. 
Using 9 markers improves on strain interpolation and improves the accuracy of the strain 
computations.  While statistically significant differences between the measured 
parameters were not observed, the differences in the magnitudes between each metric are 
representative of that which may be observed with larger sample size.  
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7.4.2 Effect of Ischemic Mitral Regurgitation and Annuloplasty on Mitral Valve 
Function 
Computational tools exhibit significant potential for assessing how effective a proposed 
surgical strategy may be for addressing an IMR patient’s MV anatomy and dysfunction. 
While advances in structural modeling and medical imaging have been made, modeling 
the complex chordae tendineae remains challenging.  To date, most MV models have 
relied on idealized chordal structures whose inter-study variation has been demonstrated 
to impact modeling results [95,101]. These idealized chordae can number from a few 
dozen to several hundred, have no or limited branching, and exhibit poorly-defined 
insertions both in the mitral leaflets and papillary muscles. Compounding this uncertainty 
is the lack of experimental data providing boundary conditions for how the tethering of 
the chordae may change from IMR to UMA.  Addressing both of these challenges is 
critical for improving IMR surgical planning tools and advancing their predictive 
capabilities. 
Current best case scenarios utilize non-standard-of-care computed tomography 
(CT) imaging to generate high-resolution models of patient MV geometry and 
architecture [101]. The use of CT in this setting provides the ability to not only identify 
PM position but additionally demarcate major load bearing chordae that include the 
anterior strut and posterior intermediary chordae. Given CT may provide the best 
imaging modality to detail the MV’s subvalvular structures, these models still require the 
appropriate boundary conditions to accurately predict the function and response of the 
chordae tendineae to both IMR and UMA.    
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This study was successful in generating an in vitro ground-truth data that may be 
used as boundary conditions for IMR computational models. This study was the first to 
simultaneously quantify leaflet coaptation, MR, anterior strut, and posterior intermediate 
chordal forces in the sequential transition from a healthy control, to IMR, and through 
multiple levels of undersized annuloplasty. As the algorithms and methods used in 
computational solvers can vary considerably, these data will aid the further development 
of computational tools to increase confidence in the simulated results. Additionally, these 
data reduce some uncertainty associated with extracting limited data from previous 
studies which may not directly represent IMR or UMA.  
The presented data can enhance the modeling of idealized chordal structures 
within computational models (Figure 7-2). Computational models can assume a given 
chordal geometry and test the effect of IMR and or undersized mitral annuloplasty under 
similar transmitral hemodynamics. The computationally observed values or trends for 
leaflet closure and chordal forces can be compared to the results herein to parametrically 
evaluate how the chosen chordal geometry influences coaptation and tethering. Based on 
these differences, the assumed chordal geometry could be iteratively tuned in terms of 
both numbers and geometry to more accurately achieve a target coaptation geometry, 
MR, and force distribution. With a more finely tuned chordal architecture, higher 
confidence will exist for subsequent simulations of progressive disease or surgical 
repairs. These evaluations should be completed prior to the application of the developed 




Figure 7-2 Example iterative scheme for improving modeling of idealized chordal 
structures and geometry using the presented in vitro data. 
 
Summed chordal forces from each PM were used to examine if differences in 
cyclic tethering exist between each PM. Early studies by Jensen et al. demonstrated PM 
displacement to increase the cyclic PM forces [103]. With inferior myocardial 
infarctions, the posterior papillary muscle is displaced more than the anterior papillary 
muscle [1,2,24,41,54,55,58]. As a result, the summation of the intermediary and strut 
chordal forces is expected to be greater for the posteromedial PM. When the summed 
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forces between the PMs for each experimental condition were compared, no statistical 
differences were found (Table 6-13). This in part suggests that other chordae may be 
bearing additional loading and whose tethering also likely contributes to leaflet 
malcoaptation. Understanding the tethering of other chordae, their relationship to strut 
chordal tethering, and their effect on coaptation in IMR and annuloplasty may lead to 
improved mitral valve repair techniques [136,51]. 
Prior to this study, Nielsen et al. utilized a porcine model to evaluate the effect of 
acute IMR on marginal (also referred to in literature as primary) chordae tendineae forces 
for both PMs and leaflets [136]. For the anterolateral PM, anterior leaflet marginal 
chordal forces were observed to statistically increase from control to IMR (p<.05), while 
non-significant decreases were observed in posterior marginal chordal forces. For the 
infarcted posteromedial PM, posterior leaflet marginal chordal forces remained relatively 
unchanged from control to IMR; however, anterior leaflet marginal chordal forces were 
significantly decreased (p<.05). One explanation for these changes in chordal forces is 
that mitral leaflet malcoaptation (due to restrictive posterior leaflet motion) reduces the 
posterior leaflet surface area exposed to the LV pressure. The authors’ hypothesized this 
mechanism to reduce the chordal forces of the posterior leaflet and contribute to further 
mitral leaflet malcoaptation [136]. 
In comparison to previous studies, the chordal forces reported herein are in good 
agreement with in vitro and large animal studies. For a healthy MV geometry, mean 
anterior leaflet strut and intermediary chordal forces have been found to range from 
approximately 0.65-1.22 N (compared to 0.62-0.71 N in this study) [51,104,106,137].  
For the posterior leaflet, previous studies have reported a mean range of 0.25-0.78 N 
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(compared to 0.28-0.49 N in this study) [51,104,106,137]. Compared to the forces in this 
Aim, the larger range of choral forces measured for a healthy MV geometry is attributed 
to the wide range of MV sizes used in previous studies. As the magnitude of chordal 
forces is directly related to the area of the MV leaflets exposed to the transvalvular 
pressure gradient, the greater the valve size, the larger the chordal forces [51].  
While no previously published data exist for strut and intermediary chordal forces 
in IMR or UMA, an in vitro study has evaluated the effect of isolated papillary muscle 
displacement on strut and intermediary chordal tethering forces [104].  In the study, a 
parametric sweep of 5 mm displacements of both PMs in the apical, lateral, and posterior 
directions was performed.  Significant increases in anterior strut and posterior 
intermediary chordal forces were observed when both PMs were displaced in either the 
apical or apical and lateral directions. Compared to the present study, these conditions 
most closely resemble a condition of true-sized annuloplasty. Our results compare 
favorably to that of Jimenez et al. by demonstrating anterior strut and posterior 
intermediary chordal forces significantly increase from the control condition with a true-
sized annulus [104]. The results presented by Jimenez et al., Nielsen et al., and those 
herein provide complimentary information for how strut, intermediary, and marginal 
chordal tethering may be affected by either symmetric or asymmetric PM displacement 
towards the further development of computational MV models [104,136]. 
Despite the advantages of using an in vitro simulator to evaluate chordal tethering 
in IMR and annuloplasty, there are limitations associated with the experimental methods. 
A3-P3 leaflet coaptation was not quantified due to the difficulty in imaging the thin and 
poorly coapting ovine leaflets.  The described MV simulator can recreate the systolic 
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geometric configuration of the mitral valve but at present does not incorporate the 
diastolic relaxation of the mitral annulus and systolic papillary muscle contraction. While 
in patients both the annular and papillary muscle dynamics may be ablated with the 
implantation of a complete rigid undersized annuloplasty ring and LV ischemia, the 
inclusion and intelligent variation of these parameters within the simulator would likely 
increase modeling accuracy.  
Although only the anterior strut and posterior intermediate chordal forces were 
quantified, these chordae are known to bear the largest loads and have been demonstrated 
to most significantly contribute to leaflet malcoaptation in IMR [51]. With left ventricular 
dilatation and papillary muscle displacement, the strut and intermediary chordae tether 
the belly of each mitral leaflet and can lead to restricted leaflet motion, regional loss of 
coaptation, and MR [24,54,55,138]. Strut and intermediary chordae have additionally 
been implicated in UMA repair failure through long term post-operative left ventricular 
dilation, which further exacerbates sub-valvular tethering [26-28].  For these reasons, the 
data from this Aim can provide critical boundary conditions to further develop in silico 
platforms to model IMR and UMA.  
 
7.4.3 Clinical Implications 
This study was successful in utilizing a novel technology to quantify mattress suture 
forces for true-sized undersized annuloplasty rings implanted in a healthy ovine model. 
The developed methods and technology provide the means to evaluate how patient-ring 
selection, ring geometry, implantation technique, and left heart geometry affect mattress 
suture forces and how their magnitudes relate to potential for suture dehiscence. The 
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determination of these endpoints will significantly contribute to improved clinical 
knowledge and improve annuloplasty ring design and surgical repair techniques. (Need to 
expand once the final data is analyzed and discussion finished). 
Our findings in this study demonstrate the ability of an in vitro simulator to mimic 
A2-P2 leaflet coaptation, anterior leaflet strain, and MR characteristics of healthy and 
chronic IMR ovine animals at peak systole. These results provide a clinically relevant 
platform to evaluate the effect of IMR MV geometry on the effectiveness of current and 
future IMR repairs.  While limitations do exist, the use of the simulator to evaluate IMR 
repairs can provide mechanistic understanding for the effect of a given repair on MV 
geometry, function, and mechanics. These findings should provide key insight to the 
effect of MV geometry on repair effectiveness and contribute to our clinical 
understanding of the geometric based mechanisms that restore valvular competence. 
The present study provides for the first time a novel comprehensive data set for 
refining the ability of computational mitral valve models to simulate IMR and UMA.  It 
is the first study to parametrically evaluate MV coaptation, MR, and strut and 
intermediary chordal forces in the sequential transition from a control to IMR and 
annuloplasty geometry.  The quantification of these sequential effects is a significant 
finding and improves on the use of data from multiple studies whose materials and 
methods may not directly represent IMR or UMA [51]. This data is important for not 
only for improving computational modeling boundary conditions but also assessing 
modeling results. Combined with the results of previous studies [51], these data provide a 
ground-truth data set for the future development and refinement of MV computational 
models and future surgical planning tools.  
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CHAPTER 8 
CONCLUSIONS AND FUTURE WORK 
8.1 Specific Aim 1 
8.1.1 Conclusions 
• Mitral annular forces in the septal-lateral and transverse annular directions were 
measured for the first time in a healthy and chronic IMR animal model.  
• In both animal groups, septal-lateral and transverse forces were observed to statistically 
increase with increasing levels of left ventricular pressure.  
• The rate of change of septal-lateral and transverse forces during isovolumetric 
contraction were additionally quantified and demonstrated to significantly increase with 
increasing levels of left ventricular pressure.   
• In healthy animals, septal-lateral forces were statistically greater than transverse forces 
at left ventricular pressures of 90, 125, 175, and 200 mmHg.  
• In chronic IMR animals, an inferior left ventricular infarct significantly decreased 
septal-lateral forces while modestly lowering those in the transverse.   
• The quantified force magnitudes and their variation will significantly aid the further 





8.1.2 Future Work 
Due to the complex dynamics of the left heart, devices that are implanted to the mitral 
annulus must undergo a complex three-dimensional loading environment.  In 
combination, these forces may include planar compression, expansion, circumferentially 
directed stretching or compression, and out-of-plane bending (e.g. with the formation of 
the annular saddle).  Quantifying these forces and understanding their physiological 
variation will significantly impact both clinical and industrial knowledge.  Some of these 
studies may include but are not limited to: 
• Understanding the effects of device-annular sizing on mitral annular forces. 
• Quantifying the complex loads which may act on devices that are implanted to the 
heart’s coronary sinus. 
• Quantifying septal-lateral and transverse mitral annular forces in the setting of an 
anterior and or anterior/inferior myocardial infraction. 
• Determining methods to more accurately quantify absolute forces (versus changes in 
force throughout the cardiac cycle). 
• Understanding how annular force profiles may change when adjunct reconstructive 
techniques are employed (i.e. papillary muscle relocation, papillary muscle sling, 
ventricular reconstruction, leaflet augmentation, chordal transection, etc.). 
• Understanding if a physiological impact exists between the measured annular forces 





8.2 Specific Aim 2 
8.2.1 Conclusions 
• Mattress suture forces were quantified for the first time on true-sized and undersized 
mitral annuloplasty rings in a healthy ovine model.  
• Preliminary results demonstrate trends in annuloplasty suture forces and their variation 
with ring location and LVP 
• Suture forces for undersized annuloplasty rings were larger than those measured on 
true-sized rings. 
• Regardless of ring sizing, the largest suture forces were observed at locations including 
and between the left and right fibrous trigones.  
• Suture forces on the anterior portion of undersized annuloplasty rings were greater than 
suture forces observed on the posterior region of undersized rings and both the anterior 
and posterior regions of true-sized rings.  
• The methods developed and the technology provide the means to evaluate how patient-
ring selection, ring geometry, implantation technique, and left heart geometry affect 
mattress suture forces and how their magnitudes relate to potential for suture 
dehiscence.  
 
8.2.2 Future Work 
The data presented in Specific Aim 2 represent a small portion of an ongoing 
experimental investigation evaluating the influence of annuloplasty ring selection (with 
and without leaflet augmentation) on annuloplasty ring suture forces. Future studies in 
this investigation will include: 
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• Evaluating ring suture forces in a chronic IMR ovine model. 
• Investigating the effects of anterior, posterior, and bi-leaflet augmentation on ring 
suture forces. 
• Determining the effects of more extreme ring geometries (such as the profile 3D 
ring) on suture forces. 
• Determining if correlations exit between ring selection, suture forces, and left 
ventricular function both pre and post intervention.  
• Evaluating the effects of the number of sutures and the implantation method on 
observed ring-suture forces.  
 
8.3 Specific Aim 3 
8.3.1 Conclusions 
8.3.1.1 Part A 
• The Georgia Tech Left Heart Simulator was demonstrated to mimic the A2-P2 leaflet 
coaptation, anterior leaflet strain, and mitral regurgitation characteristics of healthy and 
chronic IMR ovine animals at peak ventricular systole.  
• Reported results provide a foundation to evaluate the effect of IMR MV geometry on 
the effectiveness of current and future IMR repairs.   
• Investigation of repairs targeting inferior myocardial infarcts should provide key 
insights into the effect of MV geometry on repair effectiveness and contribute to our 




8.3.1.2 Part B 
• For the first time, this aim provides a novel comprehensive data set for refining the 
ability of computational mitral valve models to simulate ischemic mitral regurgitation 
and undersized mitral annuloplasty.  
• This study is the first to parametrically evaluate mitral leaflet coaptation, mitral 
regurgitation, and strut and intermediary chordal forces in the sequential transition from 
a control to ischemic mitral regurgitation and annuloplasty geometry.   
• Combined with the results of previous studies, these data provide a ground-truth data set 
for the future development and refinement of mitral valve computational models and 
future surgical planning tools. 
 
8.3.2 Future Work 
Bench-top simulators exhibit a number of advantages which allow for parametric 
evaluations of MV function. While MV function has been extensively studied in vitro, a 
multitude of studies may still be conducted to both improve clinical knowledge and better 
inform computational mitral valve modeling studies. Some of these studies may include, 
but are not limited to: 
• Investigating the geometric limits of IMR repairs to evaluate to what extent certain 
repairs will fail with progressive LV dilatation. 
• Creating a library of mitral valve data sets for providing realistic boundary 
conditions (leaflet closure, leaflet strain, chordal forces, flow, pressure, particle 
image velocimetry) for MV computational models. 
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• Evaluating the effectiveness of different subvalvular based mitral valve repair 
techniques. 
• Transitioning in vitro modeling from functional to degenerative mitral valve disease 
scenarios. 
• Incorporating contracting annulus and papillary muscles to evaluate their 
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SPECIFIC AIM 1 DATA 
Table A-1 Septal-lateral forces [N] for each of the healthy animals at each target 
level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 3.7 4.7 5.2 5.9 6.3
Healthy Animal 2 5.1 6.9 7.6 8.3 9.2
Healthy Animal 3 4.4 5.9 6.5 7.3 7.4
Healthy Animal 4 2.6 4.8 5.2 5.4 4.9
Healthy Animal 5 3.8 4.9 5.8 6.0 6.1
Healthy Animal 6 3.6 4.3 5.3 5.5 6.4
Peak Left Venticular Pressure 
 
 
Table A-2 Septal-lateral force rate [N/s] during isovolumetric contraction for each 
of the healthy animals at each target level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 35 106 108 130 142
Healthy Animal 2 83 170 252 307 346
Healthy Animal 3 97 176 203 227 205
Healthy Animal 4 40 46 51 50 60
Healthy Animal 5 107 118 119 125 145
Healthy Animal 6 99 142 167 172 181










Table A-3 Transverse forces [N] for each of the healthy animals at each target level 
of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 2.5 4.7 5.4 4.3 4.1
Healthy Animal 2 3.5 5.2 6.3 5.9 3.6
Healthy Animal 3 2.0 2.5 2.6 2.9 2.8
Healthy Animal 4 2.0 3.4 4.9 5.3 4.3
Healthy Animal 5 3.2 3.5 4.6 4.2 3.8
Healthy Animal 6 2.3 3.2 3.5 3.3 2.5




Table A-4 Transverse force rate [N/s] during isovolumetric contraction for each of 
the healthy animals at each target level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 25 74 97 79 46
Healthy Animal 2 55 88 131 118 42
Healthy Animal 3 40 49 44 42 41
Healthy Animal 4 32 99 106 133 154
Healthy Animal 5 14 16 28 29 38
Healthy Animal 6 52 95 122 111 108




Table A-5 Mean left ventricular pressure for each of the healthy animals at each 
target level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 90 125 151 174 200
Healthy Animal 2 89 134 146 168 205
Healthy Animal 3 90 126 153 177 199
Healthy Animal 4 86 130 151 173 196
Healthy Animal 5 92 127 153 174 200
Healthy Animal 6 93 127 153 173 208




Table A-6 Mean heart rate for each of the healthy animals at each target level of 
peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
Healthy Animal 1 88 116 117 160 154
Healthy Animal 2 126 180 181 199 192
Healthy Animal 3 89 93 94 98 105
Healthy Animal 4 87 106 109 118 142
Healthy Animal 5 88 92 110 109 100
Healthy Animal 6 129 110 148 156 160




Table A-7 Septal-lateral forces [N] for each of the IMR animals at each target level 
of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 2.1 2.4 2.8 2.9 2.2
IMR Animal 3 1.8 2.2 2.9 3.7 3.9
IMR Animal 4 2.2 2.8 3.0 3.1 3.3
IMR Animal 5 3.1 3.5 4.0 4.4 4.5
IMR Animal 6 3.1 3.8 4.6 4.4 4.4
IMR Animal 7 2.9 3.0 3.7 3.8 3.6




Table A-8 Septal-lateral force rate [N/s] during isovolumetric contraction for each 
of the IMR animals at each target level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 21 47 72 75 59
IMR Animal 3 56 35 58 69 83
IMR Animal 4 49 45 60 54 86
IMR Animal 5 38 34 58 66 78
IMR Animal 6 36 47 77 65 75
IMR Animal 7 32 44 57 64 60




Table A-9 Transverse forces [N] for each of the IMR animals at each target level of 
peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 3.6 3.8 4.0 4.6 4.5
IMR Animal 3 2.6 3.3 3.6 3.6 3.3
IMR Animal 4 2.2 2.7 2.5 2.1 2.0
IMR Animal 5 1.6 2.0 3.1 3.4 2.6
IMR Animal 6 2.2 2.8 2.6 2.5 2.7
IMR Animal 7 1.1 1.6 1.4 1.2 1.0
Peak Left Venticular Pressure 
 
 
Table A-10 Transverse force rate [N/s] during isovolumetric contraction for each of 
the IMR animals at each target level of peak left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 43 64 68 87 83
IMR Animal 3 56 55 79 94 72
IMR Animal 4 31 33 42 29 36
IMR Animal 5 22 33 46 53 54
IMR Animal 6 23 43 79 114 95
IMR Animal 7 5 11 45 33 31
Peak Left Venticular Pressure 
 
 
Table A-11 Mean LVP for each of the IMR animals at each target level of peak left 
ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 90 126 151 176 202
IMR Animal 3 96 120 152 180 197
IMR Animal 4 92 125 153 177 199
IMR Animal 5 94 125 150 181 202
IMR Animal 6 91 124 156 176 201
IMR Animal 7 94 126 151 177 192





Table A-12 Mean heart rate for each of the IMR animals at each target level of peak 
left ventricular pressure. 
 
90 mmHg 125 mmHg 150 mmHg 175 mmHg 200 mmHg
IMR Animal 2 95 98 100 102 132
IMR Animal 3 105 117 122 130 140
IMR Animal 4 99 125 132 165 171
IMR Animal 5 81 110 112 119 132
IMR Animal 6 104 117 138 143 160
IMR Animal 7 93 100 102 121 128





































SPECIFIC AIM 2 DATA 


















Weight [kg] 52 62 65 43 72 70 54 52




26 32 28 28 30 30 30 30




26 32 28 28 26 26 26 26




Table B-2 Mean left ventricular pressure and heart rate for 10 consecutive cardiac 





















100 105 102 97 100 105 106 105 101
125 126 125 125 126 129 125 130 132
150 152 151 151 151 155 154 151 151
100 89 102 150 90 97 108 130 99
125 100 127 155 92 110 107 135 132
150 123 129 166 96 150 111 146 130











Table B-3 Mean suture forces [N] measured for cardiac cycles reaching a peak left 




















2.0 2.9 1.3 2.0 4.9 4.6 2.2 1.5
11 o'clock 1.4 1.6 2.5 0.6 2.5 2.7 1.8 2.1
1 o'clock 2.1 0.6 1.1 0.4 3.6 3.9 0.7 0.4
Right Fibrous 
Trigone
1.7 0.6 2.4 1.5 3.9 5.1 1.7 6.2
3 o'clock 1.7 2.5 1.7 2.5 1.4 1.6 5.9 1.3
4 o'clock 1.6 2.4 2.1 2.3 0.2 3.0 3.0 1.8
5 o'clock 0.9 1.9 2.7 1.3 2.0 2.9 0.8 1.5
7 o'clock 0.8 1.0 1.7 0.7 0.9 0.3 1.5 2.0
8 o'clock 1.0 1.4 1.5 0.8 1.0 1.9 0.6 2.5














Table B-4 Mean suture forces [N] measured for cardiac cycles reaching a peak left 




















2.3 3.4 1.9 2.2 5.5 5.2 2.5 2.1
11 o'clock 1.7 1.9 2.0 0.5 3.1 3.1 2.0 2.3
1 o'clock 2.6 0.6 1.6 0.3 4.4 4.1 0.9 0.6
Right Fibrous 
Trigone
1.9 0.8 3.3 1.7 4.9 5.9 1.9 5.8
3 o'clock 1.8 3.7 2.7 3.1 1.7 1.9 7.4 2.0
4 o'clock 2.0 2.9 3.0 2.7 0.3 3.4 3.9 2.1
5 o'clock 1.2 2.2 2.5 1.6 2.4 3.2 1.0 1.9
7 o'clock 1.2 1.0 1.8 0.8 1.1 0.4 1.4 2.2
8 o'clock 1.3 1.6 2.1 0.8 1.2 2.2 1.0 2.6
9 o'clock 3.4 3.3 1.6 0.5 3.7 4.0 0.7 1.3














Table B-5 Mean suture forces [N] measured for cardiac cycles reaching a peak left 




















2.9 3.9 2.3 2.4 5.7 5.7 2.7 2.3
11 o'clock 2.0 1.9 2.4 0.6 3.6 3.6 2.3 3.0
1 o'clock 3.3 0.7 1.9 0.3 4.5 4.2 1.0 0.7
Right Fibrous 
Trigone
2.3 1.2 4.1 2.0 5.6 6.6 2.0 5.8
3 o'clock 2.0 3.8 3.1 3.5 1.7 2.1 8.1 2.2
4 o'clock 2.1 3.4 3.3 3.0 0.2 2.3 4.5 2.8
5 o'clock 1.6 2.6 2.8 1.8 2.8 3.6 1.1 2.2
7 o'clock 1.0 0.9 1.9 0.9 0.9 0.6 1.5 3.0
8 o'clock 1.4 1.7 2.3 0.7 1.3 2.6 1.0 2.5
9 o'clock 3.6 3.7 1.8 0.7 4.2 4.7 0.7 1.6






































SPECIFIC AIM 3 (PART A) DATA 












MV03 36 87 93 6.4 18.5
MV07 41 110 114 6.5 18.2
MV09 37 81 101 6.3 16.8
MV11 42 95 97 6.2 17.6
GT28 37 92 100 6.3 17.7














MV 03 3.6 2 0.27
MV 07 4.4 1.4 0.2
MV 09 4.6 1.6 0.18
MV 11 4.8 1.9 0.21
GTB 28 4.5 1.8 0.19











Table C-3 Healthy Animal Anterior A2 Leaflet Strain and Strain Rate Normalized 
by d(LVP)/dt in the radial and circumferential leaflet directions. 
 
Animal Designation Radial Circumferential Radial Circumferential
MV 03 0.050 0.003 0.03% 0.03%
MV 07 0.114 0.092 0.13% 0.20%
MV 09 0.176 0.001 0.24% 0.22%
MV 11 0.421 0.227 0.09% 0.11%
GTB 28 0.161 -0.054 0.56% 0.27%
GTB 29 0.308 0.109 0.40% 0.38%
Strain Normalized Strain Rate
 
 












Percent of Left 
Ventricular 
Infarction 
GTB05 37 89 93 12.6 18.7 15.8%
GTB07 38 99 105 9.9 18.6 20.0%
GTB08 37 91 106 10.4 19.4 20.1%
GTB10 42 96 102 13.4 18.9 19.2%
GTB22 36 124 107 8.3 19.1 18.0%
















GTB 05 3.7 1.6 0.10
GTB 07 2.7 2.5 0.16
GTB 08 3.3 1.7 0.27
GTB 10 3.4 2.1 0.4
GTB 22 3.1 2.5 0.26





Table C-6 Ischemic Mitral Regurgitation Animal Anterior A2 Leaflet Strain and 
Strain Rate Normalized by d(LVP)/dt in the radial and circumferential leaflet 
directions. 
 
Animal Designation Radial Circumferential Radial Circumferential
GTB 05 0.144 0.094 0.33% 0.30%
GTB 07 0.139 0.013 0.13% 0.09%
GTB 08 0.358 -0.002 0.48% 0.16%
GTB 10 0.088 0.018 0.07% 0.04%
GTB 22 0.248 0.239 0.29% 0.40%
GTB 23 0.307 0.035 0.53% 0.19%
Strain Normalized Strain Rate
 
 










H 4.6 1.9 0.19
G 3.8 1.7 0.1
M 3.7 1.7 0.11
N 4.2 2.4 0.15
P 3.4 2.5 0.21




Table C-8 Results of simulating healthy animal mitral valve geometry: Anterior A2 
Leaflet Strain and Strain Rate Normalized by d(LVP)/dt in the radial and 
circumferential leaflet directions. 
 
Experiment Radial Circumferential Radial Circumferential
H 0.37 0.17 0.16% 0.06%
G 0.04 0.02 0.22% 0.09%
M 0.33 0.10 0.21% 0.10%
N 0.19 0.05 0.19% 0.09%
P 0.46 0.11 0.22% 0.06%
J 0.55 0.22 0.31% 0.21%




Table C-9 Results of simulating ischemic mitral regurgitation animal mitral valve 









H 3.9 3.1 0.28
G 2.6 2 0.16
M 3.6 1.6 0.19
N 2.5 3.4 0.37
P 2.7 4.3 0.52
J 3 2.4 0.33
 
 
Table C-10 Results of simulating ischemic mitral regurgitation animal mitral valve 
geometry: Anterior A2 Leaflet Strain and Strain Rate Normalized by d(LVP)/dt in 
the radial and circumferential leaflet directions. 
 
Experiment Radial Circumferential Radial Circumferential
H 0.39 0.16 0.29% 0.10%
G 0.06 0.00 0.41% 0.16%
M 0.35 0.11 0.40% 0.10%
N 0.24 0.10 0.42% 0.18%
P 0.54 0.03 0.71% 0.12%
J 0.49 0.17 0.54% 0.23%



















SPECIFIC AIM 3 (PART B) DATA 
Table D-1 Mitral regurgitation [mL] for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Control 23.7 21.1 23.7 22.9 27.0 21.8 21.9 25.7
IMR 49.0 42.2 31.0 41.5 47.3 52.4 36.2 47.8
Oversized Annuloplasty 43.1 30.4 25.1 34.2 41.5 39.6 21.4 33.7
True Sized Annuloplasty 26.4 19.7 20.3 27.3 28.7 21.9 22.1 28.7
Undersized Annuloplasty 22.6 17.9 17.6 19.2 24.4 20.2 23.1 28.3
Experimental Condition J K L M N O P
Control 28.4 34.8 33.9 27.4 38.3 31.3 31.3
IMR 47.3 55.2 60.1 37.7 47.9 46.4 63.6
Oversized Annuloplasty 39.7 44.8 48.5 32.2 39.7 35.1 52.8
True Sized Annuloplasty 31.4 33.6 31.3 27.5 33.5 28.6 31.5





















Table D-2 Coaptation length [cm] for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Control 0.59 0.48 0.48 0.54 0.53 0.48 0.41 0.47
IMR 0.36 0.33 0.41 0.33 0.29 0.35 0.33 0.31
Oversized Annuloplasty 0.37 0.35 0.43 0.34 0.32 0.37 0.34 0.28
True Sized Annuloplasty 0.43 0.32 0.51 0.41 0.36 0.41 0.35 0.43
Undersized Annuloplasty 0.56 0.46 0.45 0.52 0.49 0.49 0.38 0.48
Experimental Condition J K L M N O P
Control 0.45 0.49 0.38 0.51 0.49 0.47 0.50
IMR 0.39 0.33 0.18 0.36 0.27 0.29 0.27
Oversized Annuloplasty 0.40 0.37 0.27 0.36 0.36 0.33 0.40
True Sized Annuloplasty 0.41 0.41 0.32 0.39 0.35 0.33 0.41






Table D-3 Cyclic force [N] for the anterior leaflet strut chord originating from the 
posteromedial papillary muscle for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Control 0.95 0.61 0.77 0.90 1.25 1.17 0.63 0.70
IMR 1.68 1.22 1.63 1.52 1.82 1.91 0.97 1.23
Oversized Annuloplasty 1.58 1.06 1.51 0.51 1.30 1.60 0.85 1.09
True Sized Annuloplasty 1.10 1.09 1.40 0.55 1.15 1.48 0.78 1.03
Undersized Annuloplasty 1.05 1.06 1.40 0.57 1.07 1.42 0.79 0.99
Experimental Condition J K L M N O P
Control 0.73 0.02 0.62 0.49 0.92 0.42 0.50
IMR 1.20 0.21 0.90 0.79 1.00 1.31 1.07
Oversized Annuloplasty 1.02 0.17 0.86 0.77 0.86 1.10 0.67
True Sized Annuloplasty 0.88 0.14 0.80 0.73 0.93 1.07 0.60






Table D-4 Cyclic force [N] for the posterior leaflet intermediary chord originating 
from the posteromedial papillary muscle for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Control 0.16 0.22 0.33 - 0.28 0.26 0.38 0.35
IMR 0.28 0.23 0.61 - 0.36 0.57 0.51 0.62
Oversized Annuloplasty 0.25 0.16 0.64 - 0.37 0.38 0.42 0.49
True Sized Annuloplasty 0.27 0.26 0.63 - 0.36 0.40 0.40 0.44
Undersized Annuloplasty 0.32 0.32 0.87 - 0.34 0.42 0.43 0.45
Experimental Condition J K L M N O P
Control 0.20 0.56 0.30 0.14 0.33 0.38 0.04
IMR 0.38 1.12 0.86 0.29 0.83 0.92 0.13
Oversized Annuloplasty 0.33 0.98 0.67 0.31 0.82 0.73 0.07
True Sized Annuloplasty 0.31 0.90 0.77 0.30 0.70 0.72 0.09






Table D-5 Cyclic force [N] for the anterior leaflet strut chord originating from the 
anterolateral papillary muscle for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Healthy 0.82 0.29 0.89 1.84 0.75 0.60 0.04 0.44
IMR 0.50 0.62 0.76 2.21 0.37 1.15 0.17 0.52
125% Annuloplasty 0.51 0.52 0.77 1.91 0.45 0.91 0.15 0.43
True Sized Annuloplasty 0.57 0.52 0.73 1.69 0.46 0.77 0.16 0.49
Undersized Annuloplasty 0.55 0.49 0.68 1.60 0.44 0.70 0.19 0.56
Experimental Condition J K L M N O P
Control 0.14 0.72 0.23 0.96 0.48 0.41 0.63
IMR 0.46 1.19 0.27 1.32 0.88 0.52 1.06
Oversized Annuloplasty 0.40 1.10 0.26 1.32 0.79 0.37 0.91
True Sized Annuloplasty 0.38 1.09 0.17 1.30 0.77 0.40 0.73





Table D-6 Cyclic force [N] for the posterior leaflet intermediary chord originating 
from the anterolateral papillary muscle for each of the experiments and conditions. 
 
Experimental Condition A B C D E F H I
Healthy 0.49 0.17 0.20 0.67 0.34 0.03 0.90 0.34
IMR 0.39 0.68 0.24 0.68 0.45 0.11 1.07 0.46
125% Annuloplasty 0.38 0.48 0.24 0.61 0.44 0.07 0.87 0.37
True Sized Annuloplasty 0.49 0.50 0.24 0.46 0.43 0.07 0.76 0.46
Undersized Annuloplasty 0.56 0.57 0.24 0.35 0.42 0.08 0.77 0.56
Experimental Condition J K L M N O P
Control 0.81 0.83 0.01 1.05 0.49 0.22 0.82
IMR 1.34 1.34 0.02 1.14 0.62 0.34 1.73
Oversized Annuloplasty 1.05 1.19 0.03 1.13 0.57 0.26 1.39
True Sized Annuloplasty 0.79 1.10 0.04 1.08 0.57 0.25 1.14


















CATALOG OF THESIS DATA STORAGE 
E.1 Specific Aim 1 Data on the Laboratory’s Electronic Server 
E.1.1 Healthy animal mitral annular force data that includes processed cyclic forces at 
each level of left ventricular pressure: 
alicia3/home/asiefert3/Thesis Data/Aim1/Healthy Animal Forces/ 
E.1.2 Healthy animal echocardiography data sets:  
alicia3/home/asiefert3/Thesis Data/Aim1/Healthy Animal Echos/ 
E.1.3 IMR animal mitral annular force data that includes processed cyclic forces at 
each level of left ventricular pressure: 
alicia3/home/asiefert3/Thesis Data/Aim1/IMR Animal Forces/ 
E.1.4 IMR animal echocardiography data sets:  
alicia3/home/asiefert3/Thesis Data/Aim1/IMR Animal Echos/ 
 
E.2 Specific Aim 2 Data on the Laboratory’s Electronic Server 
E.2.1 Annuloplasty ring stress transducer study: 
 E.2.1.1 Annuloplasty ring stress transducer data: 
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Stress/Data 
E.2.1.2 Annuloplasty ring stress transducer echocardiography data set:  
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Stress/Echos 
E.2.2 Annuloplasty ring suture force studies: 
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E.2.2.1 Undersized annuloplasty ring suture force data and images: 
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Suture 
Forces/Undersized Ring Data and Images 
E.2.2.2 Undersized annuloplasty ring suture force echocardiography data sets: 
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Suture 
Forces/Undersized Ring Echos 
E.2.2.3 True-sized annuloplasty ring suture force data and images: 
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Suture 
Forces/True Sized Ring Data and Images 
E.2.2.4 True-sized annuloplasty ring suture force echocardiography data sets: 
alicia3/home/asiefert3/Thesis Data/Aim2/Annuloplasty Ring Suture 
Forces/True Sized Ring Echos 
 
E.3 Specific Aim 3A Data on the Laboratory’s Electronic Server 
E.3.1 In-vitro data: 
E.3.1.1 In-vitro data sets: 
alicia3/home/asiefert3/Thesis Data/Aim3A/In Vitro Data/Data 
E.3.1.2 In-vitro echocardiography data sets: 
alicia3/home/asiefert3/Thesis Data/Aim3A/In Vitro Data/Echos 
E.3.2 Animal data 
E.3.2.1 Sonomicrometry data sets for the healthy and IMR animals: 
alicia3/home/asiefert3/Thesis Data/Aim3A/Animal Data/Sonomicrometry 
E.3.2.2 Echocardiography data sets for the healthy and IMR animals: 
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alicia3/home/asiefert3/Thesis Data/Aim3A/Animal Data/Echos 
 
E.4 Specific Aim 3B Data on the Laboratory’s Electronic Server 
E.4.1 echocardiography data sets 
alicia3/home/asiefert3/Thesis Data/Aim3B/Echos 
E.4.2 Chordal force transducer calibrations and experimental files 
alicia3/home/asiefert3/Thesis Data/Aim3B/ Chordal Force Transducer 
Calibrations and Experimental Files 
E.4.3 Processed hemodynamic, chordal Force, and coaptation data 
alicia3/home/asiefert3/Thesis Data/Aim3B/Processed Data 
 
E.5 Matlab and LabView Programs 
E.5.1 Suture force transducer analysis 
alicia3/home/asiefert3/Thesis Data/Matlab and LabView Programs/Suture Force 
Transducer Analysis/ 
E.5.2 Suture Force Data Acquisition 
alicia3/home/asiefert3/Thesis Data/Matlab and LabView Programs/Suture Force 
Data Acquisition 
E.5.3 Chordal Force Processing 
alicia3/home/asiefert3/Thesis Data/Matlab and LabView Programs/Chordal Force 
Processing 
E.5.4 Heartbreaker Data Acquisition and Hemodynamic Post Processor 
alicia3/home/asiefert3/Thesis Data/Matlab and LabView Programs/Heartbreaker 
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E.5.5 Area Calculator 
























CATALOG OF PUBLICATION AND CONFERENCE DATA 
STORAGE 
 
F.1 Publication Documents and High Resolution Images 
F.1.1 PDFs of the publications 
alicia3/home/asiefert3/Thesis Data/Publications/PDFs of Publications 
 
F.1.2 Specific Aim 1 publications  
F.1.2.1 In Vivo Transducer to Measure Mitral Annular Forces 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 1/Tech Note for 
Journal of Biomechanics 
F.1.2.2 Dynamic Assessment of Mitral Annular Force Profile in an Ovine Model 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 1/Healthy 
Animals for The Annals of Thoracic Surgery 
F.1.2.3 Contractile Mitral Annular Forces are Reduced in an Ovine Model of 
Ischemic Mitral Regurgitation 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 1/ Healthy vs. 
IMR Animals Journal of Thoracic and Cardiovascular Surgery 
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F.1.3 Specific Aim 2 publications  
F.1.3.1 Suture Forces in Undersized Mitral Annuloplasty: Novel Device and 
Measurements 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 2/ Ring Suture 
Forces Tech Note for The Annals of Thoracic Surgery 
F.1.3.2 In Vivo Mitral Annuloplasty Ring Transducer: Implications for 
Implantation and Annular Downsizing. 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 2/ Annuloplasty 
Ring Stress Transducer Tech Note Journal of Biomechanical Engineering 
 
F.1.4 Specific Aim 3 publications  
F.1.4.1 In-Vitro Mitral Valve Simulator Mimics Systolic Valvular Function of 
Chronic Ischemic Mitral Regurgitation Ovine Model 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 3/ Simulator 
Validation Annals of Thoracic Surgery 
F.1.4.2 Quantitative Evaluation of Annuloplasty on Mitral Valve Chordae 
Tendineae Forces to Supplement Surgical Planning Model Development 
alicia3/home/asiefert3/Thesis Data/Publications/Specific Aim 3/ Annuloplasty 
Undersizing Cardiovascular Engineering and Technology 
 
F.1.5 Other Publications  
F.1.5.1 Isolated Effect of Geometry on Mitral Valve Function for In-Silico Model 
Development 
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alicia3/home/asiefert3/Thesis Data/Publications/Other Publications/NIH 
Specific Aim 1 Computer Model Boundary Conditions 
F.1.5.2 Accuracy of a Mitral Valve Segmentation Method Using J-Splines for 
Real-Time 3D Echocardiography Data 
alicia3/home/asiefert3/Thesis Data/Publications/Other Publications/MV 
Segmentation Accuracy 
F.1.5.3 In-Vitro Comparison of Doppler and Catheter Measured Pressure 
Gradients in 3D Models of Mitral Valve Calcification 
alicia3/home/asiefert3/Thesis Data/Publications/Other Publications/Mitral 
Stenosis Journal Submission 
F.1.5.4 Mitral Valve Annular Downsizing Forces: Implications for Annuloplasty 
Device Development 
alicia3/home/asiefert3/Thesis Data/Publications/Other Publications/C-Ring 
Annulus Downsizing 
F.1.5.5 In vitro assessment of available coaptation area as a novel metric for the 
quantification of tricuspid valve coaptation.  
alicia3/home/asiefert3/Thesis Data/Publications/Other Publications/Tricuspid 
Valve Coaptation Area 
 
F.2 Conference Proceedings 
F.2.1 Specific Aim 1 Conference Proceedings 
F.2.1.1 In-Vivo Force Measurement of the Contractile Mitral Annulus 
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alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
1/2012 Mitral Conclave New York 
F.2.1.2 Quantification of Dynamic Annular Forces in an Ovine model of Ischemic 
Mitral Regurgitation 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
1/2012 ACC Chicago 
F.2.1.3 Novel Method to Quantify Forces with the Heart’s Native Valves 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
1/2013 GTRIC 
 
F.2.2 Specific Aim 2 Conference Proceedings 
F.2.2.1 Annuloplasty Ring Stresses: Implications for Implantation and Annulus 
Downsizing 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
2/2013 Mitral Conclave New York 
F.2.2.2 Annuloplasty Suture Forces: Preliminary Insight for Identifying the 
Mechanisms of Ring Dehiscence 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
2/2014 Heart Valves in the Big Apple 
 
F.2.3 Specific Aim 3 Conference Proceedings 
F.2.3.1 Mechanistic Comparison of Restrictive Annuloplasty and Adjunct 
Anterior Leaflet Augmentation for Ischemic Mitral Regurgitation 
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3/2014 AATS Toronto 
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alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
3/2013 BMES Seattle 
F.2.3.3 Boundary Conditions for Mechanobiological Testing of Mitral Valve 
Leaflets 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
3/2012 Biomechanics in Vascular Biology and Cardiovascular Disease 
F.2.3.4 In Vivo Validation of an In Vitro Model of Ischemic Mitral Regurgitation 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Specific Aim 
3/2012 BMES Atlanta 
 
F.2.4 Scanned Historical Slides 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Scanned Historical 
Slides 
 
F.2.5 Other  
F.2.5.1 Edwards Lifesciences Presentation 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Other/2014 
Edwards Lifesciences 
F.2.5.2 Dr. Y’s Moorehouse College Talk 
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alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Other/2014 Dr Y 
Moorehouse Talk 
F.2.5.3 Accuracy of a Mitral Valve Segmentation Method for Real-Time 3D 
Echocardiography Using Disease Mitral Valve Models 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Other/2013 
SHVD Venice Italy 
F.2.5.4 Dr. Y’s Isreal Mitral Talk 
alicia3/home/asiefert3/Thesis Data/Conference Proceedings/Other/2012 MV 
Isreal Talk 
F.2.5.5 Dr. Y’s University of Texas Mitral Talk 
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University of Texas 
F.2.5.6 Dr. Y’s Mitral Prizker  
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Mitral Pritzker 
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